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Abstract 
This thesis constitutes an assessment of a Quality Improvement (QI) programme delivered 
to healthcare professionals managing patients with non-ST elevation Acute Coronary 
Syndromes (ACS). This is a mixed methods evaluation of a QI programme encompassing a 
range of quantitative analyses and a qualitative semi-structured interview programme. 
 
Data from ACS registries demonstrate that management of non-ST elevation ACS is sub-
optimal with respect to guideline recommendations. A range of interventions such as 
educational programmes, financial incentives and publication of performance have been 
implemented in healthcare showing evidence of improved standards of care. Whilst these 
results are encouraging, further research is needed to understand the factors that facilitate 
improvement and whether results achieved are sustained. 
 
The European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-
ACS) project was a cluster-randomised QI programme for healthcare professionals delivered 
to 38 hospitals in five European countries. Data for 2,582 non-ST elevation ACS admissions 
were entered onto a web-based database over approximately 12 months. The primary 
outcome was a composite of eight guideline-recommended treatments for ACS compared 
before and after delivery of the QI intervention. Additional exploratory analyses have been 
performed to assess: the use of risk stratification methods and effect of patient risk, effect of 
patient and hospital characteristics, long term results of the QI intervention and a qualitative 
evaluation based on semi-structured interviews conducted with healthcare professionals. 
 
The EQUIP-ACS QI intervention led to increased use of ACS treatments. Improvement 
achieved was not consistent across all patients however and those with comorbidities 
received poorer management. Use of risk stratification was independently associated with 
improved management. Improvement was sustained at two of the centres one year after the 
programme, although a trend for decline over time was observed. Qualitative interviews 
revealed a range of factors that may influence delivery of QI and should be considered for 
future QI programmes.  
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CHAPTER 1. Introduction and Literature review 
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1.2.2 Electrocardiogram (ECG) 
Classification of ACS is based on the admission electrocardiogram (ECG) and cardiac 
markers detected in blood tests. Patients with persistent ST-segment elevation on the ECG 
are defined as ST elevation MI (STEMI) and those without persistent ST-segment elevation 
on the ECG are defined as non-ST elevation ACS (Non-ST ACS). Non-ST elevation ACS 
patients may have any of the following on their presentation ECG: transient ST-segment 
elevation, ST-segment depression, T-wave inversion, flat T waves, or no ECG changes 
where diagnosis is made purely on the basis of cardiac markers measured in blood.(Hamm 
C.W., Mollman, Bassand, & Van de Werf 2009;Hamm et al. 2011) 
1.2.2.1 Cardiac troponin 
Non-ST elevation ACS patients are further classified into non-ST elevation MI (NSTEMI) and 
unstable angina (UA) on the basis of the release of cardiac troponin into the blood. In the 
presence of chest pain and ECG changes, elevated cardiac troponin indicates myocardial 
damage. Troponin rises within 4 hours of symptom onset and can remain elevated for up to 
two weeks.(Thygesen et al. 2007) Classification of ACS is summarised in Figure 1. 
 
Figure 1. Classification of ACS 
1.2.2.2 Comparison of STEMI and Non-ST elevation ACS 
It is estimated that about two thirds of ACS are non-ST elevation and about a third are 
STEMI, although this varies in different populations. (Fox et al. 2010b;Yeh et al. 2010) In-
Acute Coronary Syndromes 
Non-ST 
elevation ACS ST elevation MI 
Non-ST 
elevation MI Unstable Angina 
Cardiac markers 
ECG 
Negative Positive 
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observational cohort rather than a clinical trial population which tends to be more selected. 
The difference in prognostic value may be associated with the omission of important clinical 
factors such as history of heart failure, blood pressure and heart rate and also the fact that 
age is treated as a binary factor i.e. above or below 65 years.(Aragam et al. 2009;Ginghina 
et al. 2011;Gray and Henderson 2011;Khalill et al. 2009)  
1.2.3.2 Management of non-ST elevation ACS 
Evidence from the literature is used to develop guidelines which provide recommendations 
for optimal management of patients based on an evaluation of all available evidence. Clinical 
practice guidelines (CPG) have been developed in all therapeutic areas and are regularly 
updated to reflect the latest evidence (Grimshaw et al. 2004).  
 
CPGs provide recommendations for the management of ACS on the basis of evidence 
accumulated from clinical trials, observational registries and other data sources. CPGs 
provide a classification for each recommendation according to the level of evidence 
available. CPG committees set up specific groups or ‘Task Forces’ to develop and update 
guidelines on a regular basis and membership of the groups is comprised of experts in the 
field.  
 
In the UK, CPGs are developed and published by the National Institute for Health and Care 
Excellence (NICE). NICE guidelines are publicly available and are published in a range of 
formats; as public information or full clinical guidelines available online, and as short clinical 
guidelines that can be downloaded in a booklet format. NICE has published guidelines on all 
aspects of ACS management including early management of unstable angina and NSTEMI 
and secondary prevention of MI (Gray et al. 2010;National Institute for Health and Clinical 
Excellence (NICE) 2010;National Institute for Health and Clinical Excellence (NICE) 
2015;NICE 2013) Development groups for NICE guidelines are made up of healthcare 
professionals with expertise in the relevant areas but also include patient or carer 
representatives.  
 
The European Society of Cardiology (ESC) publishes guidelines on the management of non-
ST elevation ACS(Hamm et al. 2011;Task Force for Diagnosis and Treatment of Non-ST-
Segment Elevation Acute Coronary Syndromes of European Society of Cardiology et al. 
2007). Task Force membership for ESC consists of healthcare professionals who are 
primarily cardiologists. ESC guidelines are published as full clinical guidelines in the 
European Heart Journal and can also be purchased as pocket guidelines and a mobile 
application version from the ESC website. 
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 The American College of Cardiology and American Heart Association (ACC/AHA) have also 
published guidelines on the management of non-ST elevation ACS (Amsterdam et al. 2014). 
The process for development of guidelines is similar to the ESC and the guidelines are 
published in the journal Circulation. 
 
The ESC and AHA/ACC guidelines for management of non-ST elevation ACS make similar 
recommendations but comparison of these with the NICE guideline recommendations 
highlights some minor differences: 
i. ESC and ACC/AHA guidelines classify patients into three risk categories whereas 
NICE uses 6 risk categories in accordance with the Myocardial Ischaemia National 
Audit Project (MINAP) database definitions. 
ii. NICE are the only guidelines to provide a public version and also include lay 
members on guideline development groups 
iii. NICE guidelines place more emphasis on non-medicinal secondary prevention 
measures than the ESC and ACC/AHA i.e. cardiac rehabilitation programme, 
smoking cessation and modifications to diet and physical activity 
iv. Recommended timelines for coronary angiography are within 72 hours for ESC and 
ACC/AHA but within 96 hours for the NICE guidelines. For very high risk admissions 
ACC/AHA and ESC recommend angiography within 24 hours of admission to 
hospital. 
 
The CPGs described above define best care for non-ST elevation ACS including diagnosis, 
in-hospital treatment and long-term management for secondary prevention of further events. 
Key recommendations made by the above guidelines are summarised below. 
1.2.3.3 Acute treatment with medical therapy 
Non ST elevation ACS are treated with the following during the acute phase: 
i. Anti-ischaemic agents i.e. beta-blockers, nitrates, calcium channel blockers 
ii. Dual antiplatelet therapy i.e. aspirin and one of: clopidogrel, prasugrel or ticagrelor 
iii. Glycoprotein IIb/IIIa inhibitors 
iv. Anticoagulants 
1.2.3.4 Coronary revascularisation  
In non-ST elevation ACS patients, coronary revascularisation is performed in selected 
patients to relieve angina and myocardial ischaemia, and to reduce the risk of MI or death. 
Revascularisation is performed by percutaneous coronary intervention (PCI) or coronary 
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artery bypass surgery (CABG). International guidelines state that coronary angiography 
should be performed in intermediate to high risk patients to determine the appropriate 
revascularisation strategy.(Amsterdam et al. 2014;Gray et al. 2010;Hamm et al. 
2011;National Institute for Health and Clinical Excellence (NICE) 2010) 
 
Risk stratification guides the decision on the need for and the timing of angiography and 
revascularisation. At one end of the spectrum of non-ST elevation ACS, low risk patients will 
be managed conservatively with angiography being performed only in selected cases 
whereas very high risk patients will be referred for urgent angiography, i.e. within 24 hours of 
admission, and subsequent revascularisation if appropriate. As noted earlier, the current 
recommendation from the ESC guidelines(Hamm et al. 2011) is that patients with 
‘intermediate’ to ‘high’ risk scores should be referred for angiography within 72 hours. The 
ESC guidelines define ‘intermediate’ risk as a GRACE score of 109-140 which is equivalent 
to an in-hospital mortality rate of 1-3%, and ‘high’ risk as a GRACE score of more than 140 
equivalent to in-hospital rate of 3% mortality.(Hamm et al. 2011) 
1.2.3.5 Long-term treatment 
The following treatments are prescribed for secondary prevention of further ACS events: 
i. Antiplatelet: aspirin and clopidogrel or prasugrel 
ii. Beta blockers 
iii. Statins 
iv. Angiotensin Converting Enzyme (ACE) inhibitors or Angiotensin II Receptor Blockers 
(ARB) if ACE are not tolerated 
v. Enrolment in a cardiac rehabilitation programme 
vi. Smoking cessation 
vii. Modification to diet and physical activity 
1.2.4 Adherence to guidelines 
1.2.4.1 Clinical registries 
Data on the management of ACS are collected via national and international registries, in 
order to assess adherence to clinical practice guidelines. In Sweden, the RIKS-HIA registry 
of all acute MI admissions started in 1995 and in 2009 the registry was merged with all 
cardiac registries in Sweden into what is now called the SWEDEHEART registry.(Jernberg et 
al. 2010;Stenestrand et al. 2001) Similarly, the Euro-Heart Survey captures data on all 
cardiovascular disease from a number of centres across Europe.(EUROASPIRE II Study 
group 2001;Hasdai et al. 2002;Mandelzweig et al. 2006) In the UK, the MINAP 
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registry(Birkhead et al. 2004;Herrett et al. 2010) was set up to assess management of MI 
and in the US the Get-With-the-Guidelines (GWTG) registries evaluate adherence to 
ACC/AHA guidelines across the range of cardiovascular diseases.  
 
In the case of coronary artery disease (CAD) two national US registries, the National 
Cardiovascular Data ACTION Registry and the GWTG-CAD Registry were merged in 2007 
into one comprehensive CAD registry called ‘ACTION Registry-GWTG’.(Peterson et al. 
2009;Roe et al. 2009) Another important registry of ACS is the Global Registry of Acute 
Coronary Events (GRACE) registry mentioned earlier. GRACE is a global database of ACS, 
capturing data from 123 hospitals in 14 countries. Clusters of hospitals were identified in 
each country to ensure that a range of hospitals were represented and data collection 
started in 1999. 
1.2.4.2 Sub-optimal adherence to guidelines 
It has been shown that improved guideline-adherence for management of ACS is associated 
with improved clinical outcomes. (Allen et al. 2004;Fermann et al. 2009;Fox et al. 
2007a;Mukherjee et al. 2004;Roe et al. 2005;Rosamond et al. 2008) Data from the 
CRUSADE observational programme from more than 60,000 patients, admitted for ACS 
from 2001 to 2003, demonstrated that in-hospital mortality was significantly reduced for 
patients in the highest quartile of ACC/AHA guideline adherence.(Peterson et al. 2006) 
Improvement of 10% in guideline-adherence was associated with a 10% reduction in in-
hospital mortality. 
 
Despite the evidence that guideline-adherence is associated with improved outcomes, the 
registries described earlier report a considerable gap between guideline recommendations 
and management of ACS.(Birkhead et al. 2004;Blomkalns et al. 2007;Bueno et al. 
2005;Cabana et al. 1999;Collinson et al. 2000;Erhardt et al. 2008;Grimshaw et al. 
2004;Hasdai et al. 2002;Mandelzweig et al. 2006;McNamara et al. 2014) Data from the 
GRACE registry have also confirmed this gap.(Fox et al. 2002b;Steg et al. 2002) Registries 
have shown that, even in the case of overwhelming evidence of clinical benefit, the adoption 
of a new treatment into practice is often delayed (Bassand 2000). There is some evidence of 
improvement over time but the standard of care still remains sub-optimal. (Mandelzweig et 
al. 2006;Yan et al. 2007b) 
 
In addition to demonstrating sub-optimal management of ACS in general, it appears that 
adherence to guidelines varies in different patient populations, with a tendency to under-treat 
high risk and elderly patients (Banihashemi et al. 2009;Brilakis et al. 2009;Collinson et al. 
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cycle, which was based on the work of Shewhart(Shewhart 1931) and is a tool commonly 
used in QI work. 
 
Other pioneers in industrial quality improvement include Philip Crosby who promoted the 
concepts of achieving zero defects in a process and getting things right the first time, and 
Armand Feigenbaum who was the Chief of Manufacturing at General Electric in the 1960s 
and considered management and leadership to be crucial for improving quality.(Boaden et 
al. 2008) 
 
The application of QI methodology to healthcare dates back to 1918 and Ernest Avery 
Codman(Codman 1918) whose work highlighted the importance of measuring standards of 
care and making these results available to patients as well as healthcare professionals. 
Codman is considered the pioneer of outcome-based patient care, a concept central to 
healthcare delivery today. Donabedian developed these concepts further, defining 
healthcare as a complex multi-factorial system and establishing a model which comprised 
structure, process and outcome (Donabedian 1988). This idea has been the basis for QI 
work since its inception and introduces the idea of process-driven improvement. 
 
The contemporary ‘guru’ of QI in healthcare is Donald Berwick, former president of the 
Institute for Healthcare Improvement (IHI), a not-for-profit organisation leading improvement 
programmes throughout the world and also a key adviser to the U.S. Department of Health 
as Administrator of the Centers for Medicare & Medicaid Services (Berwick 2008). Berwick 
has applied the principles of industrial quality improvement described above to improving 
healthcare and his work emphasises the importance of understanding current performance 
requiring accurate measurement, and of setting appropriate targets. Recently, Berwick was 
invited to conduct a review of the Mid-Staffordshire NHS services following the Francis 
report.(Berwick 2013;Francis 2013) 
1.3.2 QI models  
1.3.2.1 The ‘model for improvement’ and PDSA cycle 
One of the earliest and most commonly used tools in QI work is the Plan-Do-Study-Act 
(PDSA) model, originally termed Plan-Do-Check-Act (PDCA).(Deming 1986;Shewhart 1931). 
PDSA is used to improve work processes: an idea for change is conceived, the idea is then 
tested, results from tests are reviewed and actions taken either to modify the idea and re-
test, or to implement it on a larger scale if it is effective. PDSA can lead to a chain of multiple 
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cycles and is an efficient structured method of implementing ideas for improvement in the 
healthcare setting.  
 
The ‘Model for Improvement’ is a QI approach developed by the Associates in Process 
Improvement. The approach is based on PDSA and aims to implement and test rapid 
changes to improve a process.(Langley et al. 1994;Langley et al. 2009) The Model for 
Improvement asks three key questions to identify a need for change and assess the ability of 
this change to lead to an improvement. The model is summarised in Figure 2.  
 
Figure 2. The PDSA (Deming) cycle and model for improvement  
(NHS Institute for Innovation and Improvement 2015) 
1.3.2.2 Cause and Effect Analysis 
The cause and effect diagram, also known as ‘fish-bone’ diagram, was developed by Kaoru 
Ishikawa in the 1960s.(Ishikawa 1982) The tool is used to identify a problem and break this 
down into potential causes, or categories of causes. This can help to identify a solution to 
the problem by addressing each cause in turn. Categories are sometimes defined as: 
people, process, management. A theoretical example ‘cause and effect’ diagram is shown in 
Figure 3. 
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Figure 3. Cause and effect diagram 
1.3.2.3 Statistical Process Control  
Statistical Process Control (SPC) originates from the work of Shewhart(Balestracci 
1998;Berwick 1991;Shewhart 1931) and is widely used in assessment of healthcare as a 
measurement tool rather than a full QI method. SPC is applied either as a stand-alone tool 
or in combination with other tools.(Carey 2002;Thor et al. 2007). SPC uses statistical 
methods to measure performance. Performance over time is plotted on a control chart and 
this can be used to demonstrate time-periods of reduced or improved performance but also 
to assess the impact of a QI intervention. SPC is also a valuable tool for assessing variation 
in performance and the method aims to improve performance and reduce variation, with the 
aim of creating a more reliable and stable process.(Levett and Carey 1998) 
1.3.2.4 Six Sigma 
Six sigma is a QI method originating from statistical models, notably those of Shewhart 
(Shewhart 1931) described above, which focuses on reducing variation and defects in a 
process. The name comes from the Greek symbol for standard deviation ‘σ’, in reference to 
variation around a mean value, as the method sets a target of achieving a defect-free result 
99.99966% of the time which is equivalent to 6 standard deviations.(Boaden, Harvey, 
Moxham, & Proudlove 2008;Harry 1990) The model was developed by the manufacturing 
industry to reduce product variation, with Motorola designing the original model in the 1980s 
and further modifications introduced by General Electric.(Boaden et al. 2008) It uses both 
statistical data-driven tools and change management principles. 
 
The full Six Sigma method is not widely used in healthcare, although there are many 
references to using Six Sigma principles and tools.(Liberatore 2013;Silich et al. 
Problem 
(effect) 
Cause 1 Cause 2 
Cause 3 Cause 4 
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2012;Simmons 2002;Taner 2013) Assessment of these references shows that it is not 
always correctly applied and that results are not always in favour of using the 
method.(DelliFraine et al. 2014;Liberatore 2013) 
1.3.2.5 LEAN 
Another model adopted from Industry is the LEAN model for improvement. LEAN is 
attributed to Toyota and its main principles are focussed on improving the flow of a work 
process by eliminating waste and unnecessary steps.(Bhasin and Burcher 2006;Womack et 
al. 1990;Womack and Jones 1996)  
The LEAN model incorporates the following tools: 
a) Value stream or process mapping: To outline a work process, identify waste or 
redundant steps, problem areas, bottlenecks and propose methods to eliminate these 
and create reliable processes. The Toyota method identifies 7 possible forms of waste: 
Overproduction, waiting, transport, inappropriate processing, unnecessary inventory, 
unnecessary motion and defects. 
b) 5S: Five principles of lean thinking: sort, simplify, shine/scrub, standardise, sustain 
c) Kaizen Blitz/Rapid Improvement Events: Intensive period of improvement work to 
implement radical change, following initial data gathering. Influenced by the Japanese 
concept of ‘kaizen’ which refers to continuous management 
 
LEAN principles are widely applied in health care, an important example being the NHS 18 
week pathway, a Department of Health initiative aiming to reduce waiting times from GP 
referral to hospital treatment (Department of Health 2004;Manos et al. 2006). Another 
important use of LEAN methodology in the NHS is the Productive Series, which is an 
initiative set up by the NHS Institute for Innovation and Improvement and now managed by 
NHS Improving Quality. The Productive Series aims to streamline NHS processes and 
reduce waiting time in a range of settings such as GP practices, wards and operating 
theatres.(NHS Institute for Innovation and Improvement 2013) 
 
A range of programmes conducted recently have combined tools from the LEAN and Six 
Sigma models. The combined ‘LEAN Six Sigma’ approach is proving to be more popular 
than use of Six Sigma on its own. (Ahmed et al. 2013;Fischman 2010;Mason et al. 2014). 
1.3.2.6 Theory of constraints (TOC) 
The Theory of Constraints (TOC), developed by Goldratt(Goldratt and Cox 1984) is based 
on the principle that every system has at least one constraint and that this is an opportunity 
for improvement. TOC identifies 5 focussing steps: (i) identify the constraint, (ii) decide how 
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to exploit this constraint, (iii) subordinate everything else to the above decision, (iv) elevate 
the system’s constraint and then, (v) go back to the first step if a new constraint has arisen. 
TOC is not widely used in healthcare. This may be because further work is needed to adapt 
the theory to the healthcare setting and at present only Goldblatt has focussed on the 
application of this method in industry.(Breen et al. 2002;Patwardhan et al. 2006;Sadat et al. 
2013)  
1.3.2.7 Total Quality Management (TQM) 
Total Quality Management, sometimes called Continuous Quality Improvement (CQI), is a 
continuous organisation-wide strategy to achieve a high quality process. This means that 
quality improvement is built-in to all aspects of an organisation in order to continually 
improve standards. This approach is not clearly defined but rather it is a concept for 
continuous improvement derived from the manufacturing industry and can include any 
combination of QI tools and models described above. Central themes to TQM include 
ensuring an organisation meets the ‘customer’s’ needs, that quality is derived from the 
processes within an organisation and the importance of individuals contributing to each 
process. TQM uses measurement of data to identify problem areas within a process and 
identify areas for improvement.(Watson 1995;Wilkinson et al. 1992) 
1.3.3 Benchmarking and reliability in QI 
The manufacturing industry has implemented these and other models in order to achieve 
reliable work processes. The principal focus has been identifying problem areas, referred to 
as ‘defects’, and subsequently finding possible solutions to these which are tested out in a 
controlled environment before implementation on a large scale. The aviation and automobile 
industry in particular have used these tools and QI experts have turned to this approach to 
inform benchmarking in healthcare.  
 
The Institute for Healthcare Improvement (IHI) has studied how targets are set in industry 
and concludes that tolerance of ‘defects’ is much lower than in healthcare. Private 
healthcare and insurance companies have experience in implementing QI tools to identify 
problem areas and suggest effective methods to overcome these within an organisation. As 
in the case of corporate businesses, tolerance levels of errors are extremely low as they 
translate into important financial losses. The IHI describes this phenomenon with 
mathematics i.e. 10-1 defects are considered reasonable in healthcare whilst in Industry 
anything less than 10-3 is unacceptable.(Nolan et al. 2004) This means that clinicians are not 
dissatisfied if more than one in 10 patients do not receive a life-saving treatment and rates of 
70-80% are tolerated (Resar 2006). Although healthcare is not equivalent to the 
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manufacturing industry, the concept described by the IHI strives to achieve reliable 
processes in healthcare and highlights that there is considerable room for improvement. 
 
Literature demonstrates that levels of recommended treatments are surprisingly low. For 
example McGlynn et al (McGlynn et al. 2003;Schuster et al. 2005) report that just over 50% 
of patients receive recommended care in the United States whether this be preventative, 
acute or chronic treatment, and similar rates have been reported in Europe, for example the 
treatment of ACS according to the Euro-Heart Survey.(Mandelzweig et al. 2006) The low 
rates reported appear to be tolerated in healthcare, more than would be the case for the 
manufacturing industry. 
1.3.4 Clinical Quality Improvement 
1.3.4.1 Clinical Practice Guidelines and educational programmes 
The importance of CPGs and evidence-based practice was noted earlier in this chapter. 
Much of clinical QI work is built on the dissemination of CPGs and training initiatives to raise 
awareness and implementation of these (Califf et al. 2002;Farquhar et al. 2002;Ferlie and 
Shortell 2001). This approach was used in the PROMIS-UK study(Booth et al. 2006) 
whereby the ESC guidelines formed the basis for educational sessions and tools provided to 
participating centres. The QI intervention in PROMIS was delivered using a cluster-
randomised design, enabling a robust comparison of the intervention and control groups. A 
modest improvement in implementation of the ESC guidelines was noted.  
 
Another example of a cluster-randomised educational intervention was a training programme 
for GPs treating alcohol related disorders (Ruf et al. 2009). This latter study implemented 
training via an internet-based system but the results were modest, with a limited number of 
GPs showing a commitment to using the systems. 
 
The Discharge Management of Acute Coronary Syndrome (DMACS) project also involved 
the use of educational initiatives to enhance compliance with guidelines for management of 
ACS. Comparison of data collected before and after delivery of the educational initiative 
showed an improvement in prescription of four guideline-recommended treatments and 
referral for cardiac rehabilitation during the study measurement period.(Peterson et al. 
2012;Wai et al. 2012) 
 
While knowledge of current guidelines is central to delivering high quality clinical care, QI 
programmes based on educational interventions have shown only modest results and 
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demonstrate weaknesses when factors such as staff changeover and on-call staff are 
considered(Grimshaw et al. 2004;Grol 2001).  
1.3.4.2 Care pathways 
Care pathways are used in clinical practice to standardise evidence-based healthcare 
processes. Pathways can be designed to translate CPGs into daily practice, to map out a 
clinical process so as to ensure steps are not omitted or duplicated and finally to act as 
decision-support tools. Use of care pathways has shown encouraging results, particularly in 
improving the use of evidence-based treatments. The National Heart Attach Alert Program 
conducted a systematic review of use critical pathways in management of ACS and reported 
that improvement in use of guideline recommended treatments was observed. (Cannon et al. 
2002) Another systematic review of ‘decision support systems’ across a range of settings 
and therapeutic areas showed that interventions including a clinical pathway in the form of a 
decision support system were statistically more likely to improve clinical practice.(Kawamoto 
et al. 2005) There are also examples in the setting of cardiovascular disease indicating that 
use of evidence-based treatments increases in the presence of formalised clinical 
pathways.(Ketola et al. 2000;Mehta et al. 2000;Scott 2009). 
1.3.4.3 Clinical governance 
Clinical governance is a system which imposes a legal duty on organisations to deliver a 
high quality of care and to be accountable for patient care. This places a responsibility on the 
NHS to continuously improve standards of care.(Scally and Donaldson 1998;Secretary of 
State for Health 1997) Clinical governance strives to improve patient care by focusing on the 
following: education and training, clinical audit, clinical effectiveness, research and 
development, openness, risk management and information management. 
1.3.4.4 Pay-for-performance 
Pay-for-performance schemes have shown noteworthy results. The majority of these taking 
place in countries where the contribution of private healthcare is important, such as the 
U.S.(Centers for Medicare and Medicaid services;Glickman et al. 2008;Lindenauer et al. 
2007). There are also successful examples from public health systems and an important 
example is the Quality and Outcomes (QOF) framework, an incentive and rewards scheme 
for GPs set up by the NHS in 2004 (Campbell et al. 2007;Campbell et al. 2009). 
Improvements were seen in chronic treatments for asthma, diabetes and coronary heart 
disease but it appears that once targets were reached, no further improvement was 
achieved. It is also not clear whether the improvements noted can be attributed to payment 
incentives only as a range of other improvement initiatives were ongoing at the time. Thus, 
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financial incentives can lead to improvements but these can be small and the ultimate 
improvement is limited by targets. It may be that the targets set in QOF were not challenging 
enough and should have been revised to encourage further improvement in patient 
care.(Calvert et al. 2009;Langdown and Peckham 2014) 
1.3.4.5 Performance measurement  
Evidence shows that publication of hospital performance can lead to improvements and this 
can take the form of public ‘scorecards’ showing a hospital’s performance with respect to 
evidence based indicators, or audits and disease registries which have the facility to 
feedback results to participating centres.(Cannon et al. 2009;Kiefe et al. 2001;Scott 2009;Tu 
et al. 2009)  
 
A systematic review conducted by Fung and colleagues to assess the effect of public 
performance measures on quality improvement(Fung et al. 2008) found a lack of evidence of 
impact. There were few examples in the literature of studies to evaluate public reporting 
systems and the effect these have on quality of care. There was some evidence that 
hospitals undertake local QI initiatives in response to publication of clinical audit data, with 
the majority of these examples taking place in US hospitals, but there were also examples in 
the UK setting indicating that publication of performance measures can dis-incentivise QI 
work in some cases.(Mannion et al. 2005;Mannion and Goddard 2001;Mannion and 
Goddard 2003)  
 
In the UK, the Society for Cardiothoracic Surgery started publishing consultant outcome data 
in 2005 on their website.(Society for Cardiothoracic Surgery in Great Britain and Ireland 
2015) This initiative was reported to be successful as it was associated with an improvement 
in patient outcomes.(Bridgewater et al. 2007;Bridgewater et al. 2013)  
 
In 2013, public reporting of individual consultant data was extended to include eleven 
surgical specialties following the plans set by the ‘Everyone counts’ initiative. (NHS 
Commissioning Board 2014) Data is currently available on the NHS choices website (NHS 
Choices 2015) for individual consultants in the following specialties: adult cardiac surgery, 
bariatric surgery, colorectal surgery, endocrine and thyroid surgery, head and neck cancer 
surgery, interventional cardiology, lung cancer, neurosurgery, orthopaedic surgery, 
urological surgery and vascular surgery. 
 
This initiative built on the initial decision to publish all hospital mortality data in 2009, 
following the Mid Staffordshire NHS Foundation Trust scandal(Francis 2013), expanding this 
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to include mortality and complication data for all NHS Trusts and all consultants. This 
initiative was driven by NHS England and managed by the Healthcare Quality Improvement 
Partnership (HQIP), an independent organisation with a focus on quality of care using 
clinical audit data.(Healthcare Quality Improvement Partnership 2014)  
 
There is currently no information available about whether the public’s choices are 
determined by availability of individual consultant data and this would merit further 
evaluation. It is also important to note that volume of procedures for some of the specialties 
is low which could mean that the data presented for individual consultants are not 
adequately powered to be representative.(Walker et al. 2013)  
 
The MINAP, ACTION-GWTG and SWEDEHEART(Birkhead et al. on behalf of the MINAP 
Steering Group 2004;Herrett et al. on behalf of the MINAP Academic Group 2010;Jernberg 
et al. 2010;McNamara et al. 2014;Roe et al. on behalf of the CRUSADE and ACTION-
GWTG Registry Participants 2009;Xian et al. 2010) registries cited earlier are examples of 
performance monitoring in ACS, enabling direct comparison with other participating 
organisations as well as providing data on temporal trends for management of 
cardiovascular disease. The latest ESC guidelines on management of non-ST elevation ACS 
now recommend continuous performance monitoring to improve adherence to 
guidelines.(Hamm et al. 2011) 
1.3.5 QI organisations 
In addition to government improvement initiatives, there are a numerous large-scale QI 
programmes ongoing which are led by independent, not-for-profit organisations. The Institute 
for Healthcare Improvement (IHI) (Institute for Healthcare Improvement 2015) is considered 
a global leader in evaluation of QI work. The field of evaluation of QI methodology is known 
as Improvement Science and IHI is a leader in this field. The IHI has developed some of the 
established tools used to implement QI initiatives, notably the ‘Breakthrough Series’, a QI 
approach developed to effect rapid improvement changes in healthcare settings.(Institute for 
Healthcare Improvement 2003)  
 
The IHI Breakthrough Series is divided into ‘Learning Sessions’ and ‘Action Periods’. 
Representatives of the participating organisations and QI experts attend the Learning 
Sessions where they discuss the area requiring improvement and methods to achieve this. 
There are usually about 3 Learning Sessions, enabling participants to discuss their progress 
over the course of the programme during collaborative meetings. The Action Periods take 
place between Learning Sessions and the participating teams use this time to test ideas to 
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improve their work processes and evaluate them. Testing and implementation of ideas for 
improvement is carried out using the ‘Model for Improvement’ which was described earlier in 
this chapter.(Institute for Healthcare Improvement 2003;Langley, Nolan, & Nolan 
1994;Langley et al. 2009) 
 
In the UK, the leader in improvement science was the NHS Institute for Innovation and 
Improvement which has now closed and been replaced by NHS Improving Quality 
(NHSIQ).(2015a) The NHS Institute ran national QI programmes but also developed training 
and education opportunities for healthcare professionals to encourage local QI projects. The 
Institute also instigated a number of QI initiatives, targeting issues such as surgical 
outcomes and hospital-acquired infections and reducing waiting time for referral to hospital 
as mentioned earlier (Boaden et al. 2008;Department of Health 2004;Institute for Healthcare 
Improvement 2003). The Health Foundation (2015b) in the UK is an independent charity 
leading in evaluation of quality improvement programmes for healthcare and improvement 
science. The Health Foundation has recognised the need for rigorous research of QI 
methods and is undertaking a range of tasks to further improvement science in the UK 
including funding fellowships, reviews of literature(The Health Foundation 2011) and forming 
a partnership with the British Medical Journal Quality and Safety Journal to support 
publication of QI research. 
1.3.6 QI in Acute Coronary Syndromes 
1.3.6.1 Observational QI programmes 
Several programmes assessing ability of QI to improve management of ACS have been 
conducted. The Can Rapid Risk Stratiﬁcation of Unstable Angina Patients Suppress 
ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) 
initiative was an observational study of non-ST elevation ACS admissions conducted in over 
400 US hospitals. The initiative comprised a registry of all non ST elevation ACS 
admissions, an educational programme for clinicians and a data feedback tool. Assessment 
of compliance with ACC/AHA guidelines over time showed modest improvement in 
treatment.(Bhatt et al. 2004;Hoekstra et al. 2002;Mehta et al. 2006;Ohman et al. 2004) 
The Guidelines Applied in Practice (GAP) initiative was a QI programme for AMI 
management that took place in ten acute care hospitals in Michigan. The ten QI hospitals 
were selected from a group of 31 hospitals taking part in the Southeast Michigan Hospital 
Profiling Project. A further 11 hospitals from the group were identified as non-randomised 
‘control’ centres. The QI intervention consisted of an initial training meeting, a QI toolkit to 
encourage prescription of key treatments, identification of local opinion leaders at 
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participating sites, visits to sites by trial team and measurement of data before and after the 
QI intervention. Statistically significant improvements of 5-10% were observed for use of 
aspirin and beta-blockers at admission, and also for aspirin and smoking cessation 
counselling at discharge. Prescription of aspirin at discharge improved more in the QI group 
compared to the control group by 5%, all other changes in treatments were not statistically 
significant. (Mehta et al. 2002)  
 
Both GAP and CRUSADE were observational studies so it is important to note that 
background temporal improvements in use of guideline-recommended treatments cannot be 
excluded. In the case of GAP, baseline data were collected at least a year before the QI 
intervention was delivered which means that practice could have changed considerably over 
the course of the study. 
 
The ‘Get With The Guidelines’ (GWTG) programme discussed earlier, was created by the 
American Heart Association (AHA) and the American Stroke Association (ASA) (Horwich et 
al. 2009;Laskey 2010;Lewis et al. 2008;Smaha 2004) to improve the care of patients with 
cardiovascular disease by improving adherence to guidelines. GWTG has programmes in 
each of the following areas: stroke, atrial fibrillation, heart failure, resuscitation and coronary 
artery disease. GWTG uses a number of the QI tools described in this chapter. Participating 
hospitals are given access to a web-based data collection and patient management tool, 
interactive workshops and performance feedback. A study was performed to compare 
guideline adherence at GWTG-CAD hospitals to non-GWTG-CAD hospitals using data 
collected from January to June 2004.(Lewis et al. 2008) Data for 223 GWTG hospitals and 
3407 non-GWTG hospitals were obtained from the publicly available Centers for Medicare 
and Medicaid Hospital Compare database. Adherence to guidelines, defined as a composite 
of eight AMI treatments, was 4.7% higher in the GWTG hospitals than in the non-GWTG 
hospitals. Adherence to the GWTG-CAD performance measures, expressed as a composite 
of four key AMI treatments, was also higher for GWTG hospitals, by 6.5%. The GWTG 
programme has now been merged with the CRUSADE registry mentioned above, providing 
a rich database and incorporating QI feedback reports (Peterson et al. 2009).  
 
The Quality Improvement in Coronary Care (QUICC) study took place in 38 hospitals in 
Sweden from July 2001 to April 2004, using data collected on the RIKS-HIA clinical 
registry.(Carlhed et al. 2006;Carlhed et al. 2012) The study had a matched control design; 
19 hospitals were invited to take part in the QI programme and they were matched to 19 
‘control’ hospitals on RIKS-HIA database that were not aware they were being used as a 
comparator. The QI intervention was multifactorial and included a performance feedback tool 
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and interactive workshops. The intervention was influenced by the IHI Breakthrough 
Series(Institute for Healthcare Improvement 2003) and implemented use of PDSA cycles to 
test ideas for improving performance.(Deming 1986) Comparison of performance before and 
after delivery of the QI intervention demonstrated improvements in five guideline 
recommended ACS treatments. The improvements observed were statistically higher for four 
out of five treatments in the case of the QI hospitals and ranged from 5-15%. The 
improvements observed for the QUICC study provided encouraging evidence of guideline 
adherence improving after QI but as the study was not randomised, results cannot be 
attributed solely to the effects of the QI intervention. Furthermore, the QI centres were 
invited to participate in a programme and would have been motivated to perform well, 
whereas the 19 control hospitals were not aware that the programme was ongoing. 
1.3.6.2 Randomised QI programmes 
There are also some examples of randomised controlled trials (RCTs) of QI initiatives in 
ACS.  The Administrative Data Feedback for Effective Cardiac Treatment (AFFECT) trial 
was a randomised trial conducted in 76 acute care hospitals in Quebec, Canada. The trial 
evaluated use of a confidential feedback report card on 12 AMI process of care measures 
and hospitals were randomised to receive the report either immediately after randomisation 
or 14 months after randomisation. The report cards provided feedback on all AMI admissions 
during 1999-2000 and performance during the post intervention period was assessed using 
data from 2002-2003. There was no difference between the groups for the primary outcome 
of prescription of beta-blockers at discharge. No significant difference was observed for use 
of ACE-inhibitors, lipid-lowering treatments or aspirin.(Beck et al. 2005) The authors 
hypothesised that a more intensive feedback report may be required to achieve a greater 
improvement. 
 
The Enhanced Feedback for Effective Cardiac Treatment (EFFECT) trial was a cluster-
randomised QI programme that took place in 86 hospitals in Ontario, Canada from 2002. 
Hospitals were randomised to receive a public report card either ‘early’ (January 2004) or 
‘late’ (September 2005). The study had two co-primary endpoints: a) a composite of 12 AMI 
process of care indicators and b) a composite of five indicators or congestive heart failure 
(CHF). Comparison of data collected during the baseline phase with the follow-up phase 
(April 2004 – March 2005) showed no significant difference between the two groups of 
hospitals. Surveys conducted during the trial revealed that the majority of hospitals 
randomised to the early feedback group undertook QI initiatives following receipt of the 
public report card but these were locally driven and varied considerably. The authors of the 
study also note that some of the delayed feedback centres undertook QI activities even 
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though they had not received any feedback about their baseline performance. Publicity 
surrounding the study meant that the delayed group were not fully blinded to the nature of 
the QI intervention and this could have led to contamination of the control group.(Tu et al. 
2009) 
 
Two further randomised QI programmes have been conducted in ACS since the EQUIP-
ACS project, which is the QI programme this thesis will evaluate. These are the BRIDGE-
ACS trial and the CPACS trial. The BRIDGE-ACS trial took place in 34 hospitals in Brazil 
from 2011 to 2012, and over 1000 patients were enrolled over the course of the trial. 
(Berwanger et al. 2012a;Berwanger et al. 2012b) Half the hospitals were randomised to 
receive a multi-faceted QI intervention and the other half were randomised to the control 
group. The QI intervention included use of reminder tools, checklists, educational materials, 
on-site visits from the trial team and web-based and telephone training. The primary 
outcome was a composite of ACS treatments given acutely and at discharge. An 
improvement of about 8% in the composite of all treatments was observed in the intervention 
group compared to the control group. Patients were followed up for 12 months after 
discharge from hospital but the study was not powered to detect a difference in clinical 
endpoints. 
 
Another cluster-randomised QI project reported recently was the CPACS trial.(Du et al. 
2014) The study was conducted in 75 centres in China from October 2007 to August 2010 
recruiting a total of 3500 patients, i.e. approximately 50 cases per centre. The study 
implemented clinical pathways for risk stratification, STEMI and NSTEMI/Unstable Angina 
patients as the QI tool. Centres were allocated to receive this either ‘early’ i.e. at the start of 
the study (intervention group), or ‘late’ i.e. 12 months later (control group). A statistically 
significant improvement of 10% was observed for prescription of discharge medications 12 
months after the intervention was delivered. Improvement in prescription of discharge 
medication was not accompanied by an improvement in clinical endpoints, but the study was 
not adequately powered to assess this.  
1.3.7 Need for randomised controlled trials of QI 
The QI methods described above have been evaluated primarily in observational studies 
and hence have not taken background changes into consideration. This can only be 
achieved robustly by measuring performance before and after an intervention and by 
evaluating an intervention in a randomised setting (Krumholz and Herrin 2000;Perneger 
2006). There are some recent examples of randomised QI programmes but the majority of 
these have used simple interventions based on one QI approach, showing modest or no 
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science research methods. As the context that a QI intervention is delivered in could vary 
widely, it is not adequate to determine whether an intervention has succeeded; it is also 
important to determine how and why it may or may not be effective.(Walshe 2007;Walshe 
and Freeman 2002) 
 
Qualitative methodology, as applied to healthcare, uses data from previous work to develop 
a theoretical framework for the research. Qualitative research uses a range of methods such 
as interviews with healthcare professionals and patients, focus groups, questionnaires and 
observation techniques to obtain qualitative data and formulate hypotheses (Ampt et al. 
2009;Anderson et al. 2007;Bryman 2004). In this respect, qualitative methodology is the 
reverse of quantitative since data from previous work are collected and analysed to form a 
hypothesis, whereas in quantitative research the hypothesis exists at the outset and 
research is conducted in order to confirm or reject this hypothesis.  
 
The process of generating a hypothesis from data collected is called ‘Grounded Theory’ and 
was developed by Glaser and Strauss.(Glaser and Strauss 1967) Grounded Theory 
analyses data collected from interviews or similar sources and sorts this into codes or 
themes, these are then compared to further data to arrive at a range of key themes. Analysis 
using qualitative methods has been applied to a range of healthcare settings to enrich the 
understanding of areas such as patient compliance and adherence to guidelines and can 
provide valuable information regarding implementation of QI interventions.(Mehrotra et al. 
2003;Miles and Huberman 1994;Pope et al. 2000;Pope and Mays 2006;Sandelowski 1996) 
1.4.1 ‘Mixed methods’ research  
An emerging area of healthcare research involves combining qualitative and quantitative 
methods, also referred to as ‘mixed methods research’. The five main designs for mixed 
methods research are outlined below.(Andrew 2009;Creswell and Plano Clark 2007) 
1. Convergent parallel design 
Qualitative and quantitative methods are used in parallel and given equal weight. Results are 
analysed independently before they are ‘mixed’ to obtain an overall interpretation. Beck and 
Gable used a convergent parallel design to evaluate the prevalence of secondary traumatic 
stress in labour ward nurses and explore nurses’ experiences of attending traumatic births. 
464 nurses were asked to complete the Secondary Traumatic Stress Scale for the 
quantitative aspect of the study. The qualitative component consisted of asking 322 nurses 
to describe their experiences of being present at traumatic births. 35% of the nurses 
reported moderate to severe symptoms of secondary traumatic stress and the qualitative 
findings helped the researchers to understand the context for this and make 
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recommendations about providing educational support to nurses in future. (Beck and Gable 
2012) 
2. Sequential explanatory design 
In this approach, priority is given to the quantitative aspect of the study which is conducted 
first. Qualitative studies are conducted afterwards to provide an explanation for quantitative 
findings. The two methods are conducted in sequence and overall results are triangulated at 
the end.  
 
An example of a study with a sequential explanatory design is a mixed methods assessment 
of the Health Foundation’s Safer Patients Initiative (SPI) which was a QI programme to 
improve quality and safety of care in 24 acute hospital Trusts between 2004 and 2008. The 
study used semi-structured interviews and surveys with participating Trusts to evaluate 
perceptions of SPI at a local level. Analysis of qualitative and quantitative results identified 
organisational culture and multi-professional engagement as important factors for 
implementation of QI work.(Benn et al. 2009) 
 
Other examples of mixed methods studies using the sequential explanatory design include 
an investigation of referral rates for cardiac interventions by clinical specialty using an 
electronic decision tool and semi-structured interviews (Bowling et al. 2006), and a study to 
explore factors contributing to pre-hospital delay for STEMI episodes in Saudi Arabia, which 
used quantitative questionnaires and qualitative interviews.(Alshahrani et al. 2014) 
3. Sequential exploratory design 
For this sequential design, priority is given to the qualitative approach which takes place first 
and a subsequent quantitative study is conducted to evaluate qualitative findings. An 
example of sequential exploratory design study is the “No more couch potato” study 
conducted by Mooney et al to assess the role of pre-operative cardiac rehabilitation for 
patients waiting for CABG surgery.(Mooney et al. 2007) A pilot qualitative interview 
programme was conducted with eight participants to support design of a quantitative study 
for patients on the waiting list for cardiac bypass surgery. The key themes identified will be 
used to support design of the quantitative phase of the study which will evaluate the effect of 
cardiac rehabilitation on clinical outcomes. 
4. Embedded design 
In this design a small qualitative component is embedded within a larger quantitative study 
or vice versa. This could be a case study which enhances the results of the overall method. 
5. Multiphase design 
This design combines both parallel and sequential approaches and is usually implemented 
to evaluate a complete programme of research rather than a single research study. 
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• Assessment of the effect of patient and hospital characteristics on delivery and outcome 
of the EQUIP-ACS QI intervention 
• Longer term results of EQUIP-ACS QI intervention 
• Qualitative evaluation of EQUIP-ACS QI intervention using semi-structured interviews 
with healthcare professionals that took part in the QI programme 
• Triangulation of quantitative and qualitative results using a mixed methods approach to 
assess effectiveness of the EQUIP-ACS QI programme and make suggestions for 
further work.  
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CHAPTER 2. European Quality Improvement 
Programme for Acute Coronary Syndromes; the 
EQUIP-ACS project. Methods, Results and 
Discussion 
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2.2.3 Eligibility criteria 
Investigators were asked to enter data for consecutive eligible patients admitted to their 
hospital for treatment of non-ST elevation ACS over an 11-month period. The eligibility 
criteria are listed in Table 1. Patients treated at another hospital prior to admission at the 
participating hospital were excluded. Patients over 80 years of age were also excluded from 
the study as the Steering Committee considered that there was not sufficient evidence to 
support standardised guideline-recommended treatment in this population. 
 
Inclusion criteria Exclusion criteria 
Patients with a good clinical history of ACS 
and at least one of the following: 
1. New or transient ST or T wave changes 
on the ECG consistent with acute 
myocardial ischaemia 
2. Elevation of serum troponin or other 
cardiac markers to levels indicative of 
myocardial necrosis according to local 
laboratory values 
1. Evidence of persistent ST elevation on 
the ECG 
2. Use of early reperfusion therapy 
(thrombolysis or primary PCI) 
3. Patients >80 years 
4. Patients transferred from another 
hospital 
 
 
Table 1. Patient eligibility criteria 
2.2.4 Ethical and regulatory considerations 
The trial had multi-centre research ethics approval in each of the countries and institutional 
approval was obtained at each participating hospital prior to the start of the trial. The 
Sponsor of the trial was the Royal Brompton and Harefield NHS Foundation Trust and a 
research contract was in place between each participating organisation and the Sponsor.  
 
To ensure that consecutive patients could be enrolled, and to avoid the influence of selection 
bias, ethical and institutional approval to collect anonymous routine in-hospital data without 
seeking individual patient consent was obtained in each country. The rationale for 
proceeding without seeking individual consent was that there were no changes to patient 
treatment as a result of the study and all data collected would be anonymised. The study 
was carried out in accordance with the NHS Research Governance Framework for Health 
and Social Care, the Declaration of Helsinki and the Data Protection Act. 1998(Department 
of Health 2005;Parliament 1998;World Medical Association 2008)  
2.2.5 Data collection  
Data were entered onto a web-based database developed by Uppsala Clinical Research 
(UCR) and adapted from the Swedish RIKS-HIA database. (Peterson et al. 
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2007;Stenestrand, Wallentin, & for the Swedish Register of Cardiac Intensive Care (RIKS-
HIA) 2001;Stenestrand and Wallentin 2003) An example of the UK version of the case report 
form is included in Appendix 1. This was translated into local languages and included a 
report-generating facility which provided real-time information about local performance and a 
comparison with other participating centres. The report-generating facility provided two types 
of reports: 
a) Control charts: these reports summarised the proportion of patients that received a 
treatment over the course of the study at a particular centre. The database generated 
a chart of each of the 8 treatments and the example included below is for prescription 
of anticoagulation. Each ‘X’ represents 10 patients and the dashed horizontal line 
represents the mean performance during that phase of the study for that centre.  
 
 
Figure 4. Example control chart summarising use of anticoagulation at one of the 
centres during the trial 
 
b) Performance compared with top three hospitals: These reports included tables 
summarising the number and percentage of patients receiving each of the 
treatments, compared with the corresponding percentages achieved at the top three 
hospitals. These results were also presented in a graphical form as shown in Figure 
5 below for Barnet hospital. 
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Key 
ACE/A2: ACE-inhibitors/angiotensin-II receptor blockers; Anticoag: anticoagulation; Beta: beta-
blockers; Clopi: clopidogrel prescribed at discharge; Clopi dose: clopidogrel loading dose; Coron: 
coronary angiography; Risk: risk stratification; Statin: statin within 4 days of admission 
 
Figure 5. Example bar chart summarising use of all 8 treatments at Barnet hospital, 
compared with the ‘top 3 hospitals’ 
 
Database and study training was delivered to investigators by telephone and there was a 
run-in phase to allow centres to familiarise themselves with the protocol and data collection 
system. Data collection for the study was commenced in January 2008 for all centres and 
lasted for 11 months (4 months baseline phase, 4 months QI intervention phase and 3 
months post-QI intervention).   
2.2.6 Data management  
Key data were reviewed on a regular basis in order to monitor quality and completeness of 
data entered by investigators, and to ensure timely entry of study data onto the web-based 
system. Investigators were allowed to enter data either in ‘real-time’ i.e. while the patient is 
still in hospital, or retrospectively. Data were reviewed both directly off the web-based 
system and as files downloaded into Microsoft Access®, the latter being used for preparing 
Steering Committee and data management reports.  
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2.2.7 Trial oversight 
A trial Steering Committee (consisting of the 5 National Coordinators, the Trial Manager and 
2 QI experts) was responsible for overseeing the progress and conduct of the study. The 
Steering Committee developed and approved the protocol and all subsequent amendments, 
had oversight of study set-up, recruitment, delivery of the QI programme and reviewed 
results prior to presentation and publication. 
2.2.8 Data Monitoring Committee 
This was an open-label study with no study intervention at the patient level. Centres knew 
which group they had been allocated to and patients received routine care for non-ST 
elevation ACS. It was not therefore necessary to convene a Data Monitoring Committee for 
this study. This decision was ratified by the Steering Committee and Sponsor of the trial. 
2.2.9 Quality Improvement intervention  
Centres randomised to the QI programme were asked to set up a local QI team and 
nominate a senior cardiologist and another health professional (junior physician or nurse) to 
attend the QI meetings and act as local “champions” for the QI programme. The QI training 
was led by QI experts involved in the delivery of the Swedish Quality Improvement in 
Coronary Care (QUICC) study.(Carlhed et al. for the QUICC study group 2006) The EQUIP-
ACS QI programme was delivered during three one-day meetings, held approximately 5-12 
weeks apart.  
 
The QI intervention implemented in the EQUIP-ACS project was similar to that used in the 
QUICC study which was based on the IHI’s Breakthrough series(Institute for Healthcare 
Improvement 2003) and included use of PDSA cycles, elements of LEAN thinking, Cause 
and Effect diagrams and control charts. 
2.2.10 Outcome measures 
The primary outcome of the study was a composite of eight outcome measures based on 
guideline-recommended ACS treatments. The outcome measures were identified from the 
ESC guidelines, focussing on recommendations with the highest level of evidence from the 
literature. (Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute 
Coronary Syndromes of European Society of Cardiology 2007) The following treatments for 
non-ST elevation ACS were selected: 
1) Risk stratification using a formal, documented method and performed within 24 hours of 
admission 
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2) Coronary angiography performed within <72 hours of admission in intermediate to high 
risk patients, where intermediate to high risk patients are defined as: 
1) Elevated troponin levels 
2) Dynamic ST or T wave changes (symptomatic or silent) (≥0.5mm) 
3) Diabetes mellitus 
4) Reduced renal function (GFR<60mL/min/1.73m2) 
5) Depressed LVEF<40% 
6) Early post-MI angina 
7) PCI within 6 months 
8) Previous CABG 
9) Intermediate to high risk according to a risk score 
 
3) In-hospital anticoagulation for all patients  
4) Beta-blockers at discharge in patients with reduced LV function. For the purposes of the 
programme, reduced LV function was defined as LVEF≤50% 
5) Statins prescribed within 4 days of admission for all patients 
6) ACE-inhibitors in patients with LVEF<40%, hypertension, diabetes or chronic kidney 
disease 
7) Clopidogrel loading dose administered within 24 hours  
8) Clopidogrel prescribed at discharge 
 
Each of the individual non-ST elevation ACS treatments was also assessed as a secondary 
outcome. 
2.2.11 Goals of QI programme 
The study outcome measures were also defined as the “goals” of the QI programme so that 
the QI teams could use these to assess ACS management at their sites and observe 
changes in management over the course of the QI programme. The local QI teams had 
access to reports summarising use of the above treatments via the online database and they 
were encouraged to meet on a regular basis and review their results. Reports summarising 
rates of these quality indicators were also reviewed during the QI meetings. 
2.2.12 QI meetings 
The first meeting was held at the end of the baseline phase. Centres were asked to work in 
teams and analyse their local work processes using established QI tools.(Bodenheimer et al. 
2007;Institute for Healthcare Improvement 2003) The teams were asked to represent their 
patient pathways using process maps in order to analyse these processes systematically 
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and identify any problem areas or barriers. The barriers identified were then broken down 
using ‘case and effect’ diagrams(Ishikawa 1982) to identify potential causes and help the 
teams to identify strategies to resolve these. 
 
Results from the baseline phase were presented and discussed, and potential areas for 
improvement were identified. In addition to continuing to enter data for eligible patients onto 
the trial database, centres were asked to continue to review their results via the online 
reports, analyse their local work processes and identify the main barriers to delivering 
optimal care. 
 
Barriers to achieving optimal results were presented by each of the teams at the second 
meeting. The teams also came up with potential solutions to these which were reviewed and 
assessed using Plan-Do-Study-Act cycles.(Shewhart 1931) The QI teams were asked to 
continue holding regular local meetings, to work together to identify at least 2 improvement 
ideas that could be implemented in their departments and to test these out using the QI tools 
provided during the programme. 
 
At the third and final meeting, the teams presented the improvement ideas they had 
developed and the results achieved after these were implemented in their departments. The 
group discussed how to continue local improvement work after the end of the EQUIP-ACS 
project and suggested further improvement ideas that could be tested and implemented.  
 
Throughout the delivery of the QI intervention, centres continued to enter data for all eligible 
patients, met with their teams on a regular basis to review local results and were invited to 
attend conference calls and communicate with each other via a web-portal. Use of the web-
portal was limited however and only a few comments were posted over the course of the QI 
intervention phase. 
2.2.13 Statistical Methods 
2.2.13.1 Sample size estimations in cluster-randomised trials 
In order to estimate the sample size for a cluster-randomised trial, it is necessary to correct 
for clustering of data within a centre. This is required to account for the fact that patients 
within a centre are likely to be treated in a similar way and cannot be treated as statistically 
independent entities. This effect leads to variation between clusters, and the relationship 
between this variation and the variation within a centre is represented by the intra-cluster 
correlation coefficient (ICC) (Eldridge et al. 2004;Kerry and Bland 1998a;Kerry and Bland 
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1998b;Killip et al. 2004). The ICC, also represented by the symbol ‘ρ’ can be calculated by 
the equation below: ICC or 𝜌𝜌 =  𝑠𝑠𝑏𝑏2(𝑠𝑠𝑏𝑏2 + 𝑠𝑠𝑤𝑤2 ) 
where sb2 = the variance between clusters, and sw2 = the variance within clusters.  
 
Values for the ICC range from 0 to 1 and for EQUIP-ACS, the ICC was estimated as 0.2 
taking into account the ICC found for the PROMIS-UK study.(Booth et al. 2006) 
 
The formula to calculate the sample size for a cluster-randomised trial is: 
Ncluster = [1 + (𝑚𝑚 − 1) × ICC] Nsimple 
Where “N
cluster
” and “N
simple
” are the sample sizes for cluster randomisation and simple 
randomisation respectively. “m” is the number of patients per cluster (i.e. per hospital). 
2.2.13.2 Sample size estimation for EQUIP-ACS 
A scoring system was used to estimate the sample size on the basis of previous work in the 
PROMIS-UK study(Booth et al. 2006). Not all patients are eligible for each of the eight ACS 
treatments and it was estimated that 3 of the 8 are applicable to all patients, the other 5 
applying to a subset of patients or being contraindicated in some cases. The scoring system 
assigns ‘1’ for a treatment given and ‘0’ for not given. A realistic maximum score per patient 
was taken to be 5 (out of 8) and a range of possible differences in score between the QI and 
non-QI centres was considered. A maximum score of 5 means that each point is equal to 
20% i.e. an improvement of one treatment is equivalent to 20% or 1 point on the scoring 
system. For the EQUIP-ACS sample size estimation an improvement of approximately 8%, 
was considered clinically meaningful. 
 
The sample size calculation was based on a direct comparison of results during the post-QI 
phase of the study only as the main power of the study was expected to be in this phase. 
Using approximately 40 centres, the power calculation showed that 500 patients per group 
(1000 in total) would be required during the post-QI implementation phase of the study to 
detect a difference in score of 0.3-0.4 between the two groups. A difference in score of 0.3-
0.4 corresponds to approximately 8% improvement in number of indicators achieved.  
 
The range of sample sizes considered for the trial is summarised in Table 2 below and the 
scenario selected is highlighted in bold type. The power (β) in each case was 80% and the 
significance level (α) was 5%. 
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ICC 
Centres per 
Group 
Patients per 
Centre Patients per Group SD 
Detectable 
Difference 
0.1 20 20 400 0.9 0.312 
0.1 20 25 500 0.9 0.302 
0.1 20 30 600 0.9 0.295 
0.1 20 40 800 0.9 0.286 
0.1 20 50 1,000 0.9 0.281 
0.2 20 20 400 0.9 0.401 
0.2 20 25 500 0.9 0.394 
0.2 20 30 600 0.9 0.390 
0.2 20 40 800 0.9 0.384 
0.2 20 50 1,000 0.9 0.380 
Table 2. Sample size calculation based on score of medication use 
2.2.13.3 Statistical analysis 
The statistical analysis plan was agreed by the trial Steering Committee and trial statisticians 
prior to receiving the final database for analysis (Flather et al. 2010).  All analyses were 
performed by the trial statistician using STATA® software. All analyses presented here were 
repeated by the author of this thesis following further data cleaning. 
2.2.13.4 Baseline characteristics 
Baseline characteristics for each group (QI centres, non-QI centres) and each time-point 
(baseline, post-QI) were analysed to look for changes over time and differences between 
groups. Categorical variables were analysed as numbers and percentages, N(%) and the 
χ2−squared test used to assess any differences between the two groups. Continuous 
variables were reported as mean ± SD and the t test used to assess any differences. In the 
case of continuous variables that are not normally distributed, the median and interquartile 
range (IQR) are reported. 
2.2.13.5 Primary outcome 
The primary outcome was determined by comparing the change in composite of all 8 
indicators from baseline between the QI and non-QI groups. This analysis was carried out by 
multi-level hierarchical logistic regression to take account of the clustered nature of the data. 
(Zucker 2003)  
 
Indicator variables for time period and allocation were entered as fixed effects. Other centre-
level covariates that were entered as fixed effects were country and ability to perform PCI on 
site, since these were stratification factors in the randomisation. The interaction between 
allocation and time period gave a P-value and an estimate of the treatment effect expressed 
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Table 3. Number of patients recruited by centre during the Baseline and Post-QI 
phases 
Centre name Baseline phase 
Post-QI 
phase 
Non-QI centres   
Hospital del Mar IMAS 28 27 
Hospital de Tortosa Virgen de la Cinta 25 20 
Hospital Josep Trueta Girona 51 60 
Hospital Universitario Germans Trias 26 34 
Hôpitaux Drome de Romans-sur-Isere 13 14 
Centre Hospitalier Guy Thomas de Riom 2 4 
Dept A' CHU Hôpital G. Montpied 13 7 
Dept B' CHU  Hôpital G. Montpied 5 19 
Ospedale Civile di Mirano 32 30 
Ospedale Livorno 66 22 
Ospedale Generale Provinciale di Macerata 31 25 
Radomski Szpital Specjalistyczny 24 14 
Szpital we Wloclawku 92 44 
Szpital w Ciechanowie 30 20 
Szpital w Siedlcach 22 21 
Szpital Zachodni 16 35 
Warwick Hospital 6 0 
Yeovil District Hospital 25 23 
York District Hospital 73 55 
Sub-total non-QI centres 580 474 
QI centres   
Hospital de Terrassa 21 15 
Hospital Universitario Joan XXIII de Tarragona 43 46 
Hospital Universitario Valle d'Hebron 101 93 
Centre Hospitalier d'Ussel 9 7 
Centre Hospitalier de Chambéry 27 10 
Centre Hospitalier Universitaire de Grenoble  32 28 
Centre Hospitalier Pierre Bazin, Voiron 9 7 
Centre Hospitalier d'Annecy 20 19 
Ospedale Morgagni-Pierantoni, Forli 33 20 
Ospedale M. Bufalini- Cesena 9 49 
Medical Academy of Warsaw 81 47 
Swiętokrzyskie Centrum Chorob Serca 157 92 
Szpital w Grojcu 32 33 
Szpital w Plocku 16 37 
Szpital Specjalistyczny SPZOZ w Radomiu 26 31 
Antrim Area Hospital 29 36 
Barnet General Hospital 74 79 
Basildon Hospital 59 46 
Royal Albert Edward Infirmary, Wigan 35 20 
Sub-total QI centres 813 715 
Total 1,393 1,189 
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2.3.2 Baseline characteristics 
Baseline characteristics in the two groups were similar before and after the QI programme; 
mean age was 65.5 years, 70% male, 28% had prior MI, and 44% presented with ST 
depression on the ECG. The proportions of patients with a confirmed ACS diagnosis 
(myocardial infarction or unstable angina) at discharge for the non-QI centres at baseline 
and post-QI implementation were 97.1% and 95.6%, and for the QI centres the rates were 
93.5% and 92.2% respectively. Table 4 summarises key baseline characteristics. 
Characteristics for patients recruited by each group and during the baseline and post-QI 
phase are shown. 
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Description*  
 
Non-QI centres QI centres 
Baseline 
phase 
N=580 
Post-QI 
phase 
N=474 
Baseline 
phase 
N=813 
Post-QI 
phase 
N=715 
Demographics 
Age, years (mean [SD]) 65.8 [10.2] 66.1 [10.6] 65.1 [11] 65.6 [10.5] 
Male  419 (72.2) 341 (71.9) 553 (68.0) 482 (67.2) 
Diabetes 165 (28.6) 133 (28.1) 190 (23.5) 197 (27.6) 
Hypertension 374 (64.9) 306 (65.0) 547 (68.0) 481 (67.8) 
Smoker 143 (25.7) 121 (27.3) 212 (27.6) 166 (24.6) 
Prior MI 164 (28.6) 136 (28.9) 228 (28.6) 203 (28.6) 
History of heart failure 81 (14.0) 53 (11.2) 91 (11.5) 63 (8.9) 
Prior PCI 101 (17.5) 81 (17.2) 154 (19.1) 130 (18.4) 
Prior CABG 39 (6.8) 37 (7.8) 72 (8.9) 68 (9.5) 
Prior Stroke 39 (6.7) 20 (4.2) 47 (5.8) 49 (6.9) 
Renal disease 60 (10.4) 37 (7.8) 72 (9.1) 55 (7.7) 
Symptom onset to admission, 
hours (median [IQR]) 
7 
[3, 19] 
7.4 
[3.3, 14.9] 
7.3 
[2.8, 18.6] 
6.0 
[2.7, 18.4] 
Pathological Q-wave 49 (8.5) 47 (9.9) 84 (10.4) 54 (7.6) 
RBBB 35 (6.0) 21 (4.4) 45 (5.6) 27 (3.8) 
ST-depression 259 (44.9) 217 (45.9) 357 (44.1) 313 (43.8) 
Pathological T-wave 133 (23.1) 107 (22.6) 241 (29.8) 181 (25.3) 
Heart rate, bpm (Mean [SD]) 81.5 [21.4] 79.4 [22.1] 80.2 [20.3] 78.9 [20.7] 
SBP, mmHg (Mean [SD]) 141.9 [24.6] 
141.3 
[23.9] 
144.0 
[27.3] 143.0 [25.5] 
DBP, mmHg (Mean [SD]) 81.6 [14.5] 79.9 [14.3] 82.4 [15.0] 81.3 [14.3] 
Elevated cardiac troponin   
(according to local cut-off) 545 (94.1) 443 (93.5) 611 (75.4) 572 (80.0) 
Medications at admission     
ACE inhibitors  240 (42.3) 168 (38.0) 216 (33.5) 216 (35.4) 
A2 receptor blockers 60 (10.6) 45 (10.2) 82 (12.8) 85 (13.9) 
Warfarin 22 (3.9) 20 (4.5) 35 (5.3) 34 (5.5) 
Aspirin 263 (46.1) 189 (42.7) 279 (43.1) 267 (43.7) 
Clopidogrel 71 (12.5) 46 (10.4) 90 (13.7) 74 (12.0) 
Beta blockers 213 (37.8) 147 (33.2) 247 (38.5) 230 (37.6) 
Calcium antagonists  99 (17.5) 87 (19.7) 134 (20.9) 114 (18.7) 
Diuretics 131 (23.2) 97 (22.0) 173 (26.9) 137 (22.4) 
Statins 242 (42.6) 191 (43.4) 271 (42.0) 267 (43.5) 
Discharge diagnosis 
Myocardial infarction 400 (69.0) 333 (70.3) 456 (56.1) 437 (61.1) 
Unstable angina 163 (28.1) 120 (25.3) 304 (37.4) 222 (31.1) 
Death in-hospital 
Death 7 (1.2) 7 (1.5) 17 (2.1) 13 (1.8) 
*All values are N(%) unless otherwise indicated 
Table 4. Baseline characteristics for patients recruited during the baseline and post-QI 
implementation phase of the EQUIP-ACS study 
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2.3.3 Primary outcome measure 
The primary outcome measure, a composite of eight recommended non-ST elevation ACS 
treatment strategies, was calculated from the difference in improvement between the two 
groups. The proportion of quality indicators fulfilled i.e. ACS treatments given after the QI 
training was compared to the proportion of indicators fulfilled during the baseline phase for 
each group.  
 
Proportions of quality indicators fulfilled during the baseline and post-QI phases in the non-
QI group were 77.6% and 78.6%, and for the QI group 74.4% and 83.1%, corresponding to a 
within group change of 1% and 8.7% respectively. The relative probability of fulfilling a 
quality indicator after the intervention in the QI versus non-QI group expressed as an odds 
ratio was 1.69 (95% confidence interval 1.45 to 1.97, p<0.001; Table 5 and Figure 8). 
2.3.4  Individual indicators 
The individual components of the composite outcome were analysed separately, although 
the study was not powered to detect a difference in these. With the exception of clopidogrel 
maintenance dose, each of the remaining 7 indicators showed a trend to improve more in 
the QI centres. Risk stratification and clopidogrel loading dose were statistically more likely 
to improve in the QI centres. Table 5 summarises the results for the composite outcome and 
each individual indicator. 
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 Quality 
Indicators 
Non-QI centres 
(indicators 
achieved/indicators 
possible (%)) 
QI centres 
(indicators 
achieved/indicators 
possible (%)) 
Odds ratio* 
(95% CI) P value 
Baseline 
phase 
Post-QI 
phase 
Baseline 
phase 
Post-QI 
phase 
Primary outcome 3128/4032 (77.6) 
2557/3253 
(78.6) 
4158/5591 
(74.4) 
4106/4940 
(83.1) 
1.69 
(1.45-1.97) <0.001 
Risk stratification 347/580 (59.8) 
246/474 
(51.9) 
421/813 
(51.8) 
595/715 
(83.2) 
24.65 
(14.39-42.22) <0.001 
Coronary 
Angiography 
327/578 
(56.6) 
275/474 
(58.0) 
442/811 
(54.5) 
427/715 
(59.7) 
1.28 
(0.88-1.86) 0.205 
Anticoagulation 525/579 (90.7) 
437/470 
(93.0) 
729/811 
(89.9) 
660/709 
(93.1) 
1.08 
(0.59-1.99) 0.793 
Beta-blockers 162/196 (82.7) 
110/124 
(88.7) 
190/226 
(84.1) 
188/212 
(88.7) 
1.05 
(0.42-2.66) 0.911 
Statins 535/571 (93.7) 
440/464 
(94.8) 
717/791 
(90.6) 
668/699 
(95.6) 
1.54 
(0.75-3.15) 0.242 
ACE-inhibitors 355/433 (82.0) 
288/348 
(82.8) 
499/598 
(83.4) 
463/534 
(86.7) 
1.41 
(0.83-2.38) 0.205 
Clopidogrel 
loading dose 
463/574 
(80.7) 
387/463 
(83.6) 
591/805 
(73.4) 
591/706 
(83.7) 
1.91 
(1.22-2.99) 0.005 
Clopidogrel 
maintenance dose 
414/521 
(79.5) 
374/436 
(85.8) 
569/736 
(77.3) 
514/650 
(79.1) 
0.78 
(0.50-1.21) 0.265 
* Relative odds of achieving QI indicator(s) in the QI group compared to the non-QI group in the post-
QI intervention phase adjusted for country and ability to perform PCI on-site (stratification variables) 
 
Table 5. Primary outcome and key secondary outcomes 
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Key: Each centre is represented by a circle and the mean proportion is represented by the line of red 
crosses 
Figure 8. Primary Outcome: The proportion of patients fulfilling the primary outcome 
(composite of 8 quality indicators) at centres before and after the QI intervention 
2.3.5 Interpretation of Odds Ratio for ‘interaction term’ 
The Odds Ratios (ORs) presented in Table 5 are for outcomes in the QI group compared to 
the non-QI group, during the post-QI intervention phase. These ORs are for the ‘interaction 
term’ in each case which is a ratio of the odds ratios of each group. The interaction term is 
effectively estimating the difference in differences, i.e. comparing the improvement in the 
non-QI group to the improvement in the QI group over time. The OR of the interaction term is 
multiplicative as it takes the OR of each group compared to its baseline into account and 
should not be interpreted in the same manner as a traditional OR.  
 
Although the OR for the composite outcome and two of the individual outcomes is 
statistically significant, it does not give an indication of clinical significance. The OR for risk 
stratification is 24.65, (95%CI: 14.39-42.22, p<0.001) and this is comparing a reduction in 
use of risk stratification in the non-QI group with an increase of more than 30% in the QI 
group.  
 
Baseline        Post QI       Baseline                   Post QI                              
Non-QI centres                      QI centres 
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The marginal effect observed for risk stratification in each group and time-period has been 
estimated using STATA® and used to plot Figure 9 below which shows that the marginal 
effects for each group go in opposite directions.(Maarten 2010;Williams 2012) 
 
Key: ‘treatment’ represents allocation where 0 is the non-QI and 1 is the QI group. ‘d_period’ 
represents the study phase where 1 is the baseline phase and 3 is the post-QI intervention phase. 
 
Figure 9. Predictive margins for Risk stratification in QI centres vs non-QI centres 
2.3.6 Subgroup analyses  
The primary outcome was also analysed by key pre-specified subgroups to look for 
differences. The subgroups analysed were: gender, age (≤65 and >65 years), presence of 
PCI facilities and country. Improvement was found to be similar in both genders, both age 
groups and centres with or without PCI facilities. Four out of five countries showed an 
improvement with the QI intervention with two countries showing individually significant 
benefits although there is significant heterogeneity in the effect by country (Figure 10). 
These factors will be considered in more detail in a later chapter of this thesis. 
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Key: Odds ratios and 95% confidence intervals are shown 
Figure 10. Forest plot of primary outcome analysed by key subgroups: gender, age, 
ability to perform PCI on-site and country 
2.3.7 Exploratory analyses for coronary angiography 
Two exploratory analyses were performed to assess the coronary angiography results in 
more detail, as the proportion of patients receiving coronary angiography was lower than 
anticipated. For the first of these, the definition of intermediate to high risk was modified from 
the ESC guideline definition. Instead of including patients with positive troponin values 
according to local laboratory ranges (generally within the range 0.03-0.05 µg/L), a cut-off of 
>0.1 µg/L to indicate potentially clinically important myocardial damage was selected. Aside 
from this modification, the definition for intermediate to high risk was consistent with ESC 
guidelines and in line with that used for this indicator throughout the trial. The second 
exploratory analysis for this indicator included patients classified as intermediate or high risk 
by the centres only, irrespective of the method of risk stratification. These analyses are 
summarised in Table 6 below and it can be seen that these modifications did not alter the 
finding of a modest effect of the QI intervention on rate of coronary angiography. Results 
obtained from these additional exploratory analyses remained statistically non-significant. 
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hospitals. All hospitals were selected from the network of Swedish hospitals submitting data 
onto the RIKS-HIA database on an ongoing basis. Improvements observed in the 
intervention group ranged from 7 to 16%, compared with improvements of 1 to 6% in the 
control group. The exception to this was clopidogrel which improved by over 40% in the QI 
group and more than 25% in the control group. This large increase was explained by the 
very low baseline rate for this treatment, which was less than 30% at all sites. Baseline rates 
of treatments in general were lower than those observed for EQUIP-ACS.  
 
The CRUSADE initiative, which was a QI programme comprising a registry and educational 
programme for clinicians(Hoekstra et al. 2002;Mehta et al. 2006) showed similar 
improvements to EQUIP-ACS but there was no control group so changes due to temporal 
trends cannot be excluded.  Similarly, the GAP programme (Mehta et al. 2002), which 
compared results before and after a QI intervention based on reminder tools and checklists, 
showed modest improvement in use of beta-blockers and aspirin but there was no 
comparison with a control group.  
 
The DMACS study(Peterson et al. for the DMACS Project Group 2012) was a non-
randomised QI study comparing discharge management for all ACS, before and after an 
educational QI intervention. Improvements in prescription of key discharge medications 
(ACE/ARB, beta-blockers, statins, antiplatelet) were observed, ranging from 2 to 6% for 
individual medications and approximately 12% when considered as a composite measure. 
2.4.3 Comparison with other cluster-randomised QI programmes 
There have been a few cluster-randomised trials of QI initiatives in ACS management 
reported in the literature which show similarities to the EQUIP-ACS project and these are 
summarised here. 
 
The PROMIS study(Booth et al. 2006) included 38 centres in the UK and recruited 
approximately 1000 patients over the course of the study. Centres were allocated to receive 
an educational intervention or no intervention, using cluster randomisation. The educational 
intervention was delivered at the start of the study and consisted of a presentation on the 
ESC guidelines, pocket guidelines for the participating teams and a checklist of evidence-
based treatments for the patient notes. As for EQUIP-ACS, the primary outcome was a 
composite endpoint based on 5 evidence-based ACS treatments and this was reported as a 
score out of 5.The score achieved in the QI group was 0.2 points higher that the control 
group but this was not statistically significant. 
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The BRIDGE-ACS trial,(Berwanger et al. for the BRIDGE-ACS Investigators 2012b) a 
cluster-randomised trial of a multi-factorial QI intervention that took place after EQUIP-ACS, 
assessed improvement in (a) acute treatments i.e. those given within 24 hours of admission 
and, (b) those given at discharge. Baseline performance at the Brazilian hospitals was lower 
than at the EQUIP-ACS centres, meaning that there was more scope for improvement. 
BRIDGE-ACS also included both STEMI and NSTEMI patients. The primary outcome was a 
composite outcome based on direct comparison of the control and intervention groups after 
the intervention, rather than a comparison of the change from baseline. 
 
The QI intervention in the AFFECT trial,(Beck et al. 2005) consisted of a confidential report 
card summarising performance. No measurable improvements were noted in the pre-
specified primary and secondary outcomes. The EFFECT trial(Tu et al. 2009) also used a 
public report card as the QI intervention and centres were randomised to receive this in an 
early or delayed manner. There was no measurable improvement noted for the key 
outcomes in this trial. 
 
Another cluster-randomised QI project reported recently was the CPACS trial.(Du et al. 
2014) The study implemented clinical pathways for risk stratification, STEMI and 
NSTEMI/Unstable Angina patients as the QI tool. Centres were allocated to receive this 
either ‘early’ i.e. at the start of the study (intervention group), or ‘late’ i.e. 12 months later 
(control group). The study was conducted in 75 centres in China from October 2007 to 
August 2010 recruiting a total of 3500 patients, i.e. approximately 50 cases per centre. A 
statistically significant improvement of 10% was observed for prescription of discharge 
medications 12 months after the intervention. No improvements were seen in the other pre-
specified performance indicators including coronary angiography and functional testing for 
lower risk patients. Improvement in prescription of discharge medication was not 
accompanied by an improvement in clinical endpoints, but the study was not adequately 
powered to assess this. A companion qualitative study was conducted to identify barriers to 
optimal ACS management; this will be considered in the qualitative chapter of this thesis. 
2.4.4 Individual indicators 
2.4.4.1 Risk stratification 
Although the trial was not powered to show differences in the individual ACS treatments, a 
large improvement was noted for risk stratification, corresponding to an increase of 31% in 
the QI centres versus a decrease of 8% in the non-QI centres. Risk stratification is a 
relatively new strategy for management of non-ST elevation ACS, compared to statins or 
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anticoagulation and its routine use was recommended in the ESC guidelines(Task Force for 
Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of 
European Society of Cardiology 2007), published shortly before the start of the study. There 
are a number of factors that could have led to the increase observed for this indicator. An 
important factor to consider is that baseline levels were lowest for this indicator with some 
centres not using risk models at all, which meant that this indicator had the greatest scope 
for improvement. Furthermore, the process of carrying out risk stratification is a relatively 
simple one entailing a hand or computer-based calculation which takes a few minutes once 
all the relevant results are available. A later chapter of this thesis will focus on this indicator 
in more depth. 
2.4.4.2 Coronary angiography 
Coronary angiography showed a modest improvement after implementation of the QI 
programme despite the relatively low baseline level. Rate of angiography in the Non-QI 
centres was 57% during the baseline phase, increasing to 58% after QI intervention 
compared to 55% in the QI centres during the baseline phase, increasing to 60% after QI 
intervention; OR 1.28 (0.88-1.86), p=0.2. A series of exploratory analyses using modified 
definitions for intermediate to high risk patients in the trial gave the same result for this 
indicator.  
 
The algorithm for this indicator took timing into account due to the guideline recommendation 
that this should be delivered within 72 hours (Task Force for Diagnosis and Treatment of 
Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology  
2007) and it is likely that so soon after the publication of these guidelines, hospitals did not 
yet have systems in place to comply with this. In addition to this, a number of centres in the 
study did not have on-site angiography and PCI facilities, requiring transfer to a nearby site 
for the procedures.  If patients did not return to the original centre after the angiography 
procedure, data on timing of angiography was not always available, resulting in these 
patients not being included in the analyses for this indicator.  
 
This is the most organisationally complex of the eight indicators in that coronary angiography 
requires a number of steps and range of staff to be involved. It is possible that a different QI 
approach is needed for more complex treatment strategies such as this, or that more time is 
needed to allow the QI intervention to have an effect. Rates of angiography in both the 
QUICC and CPACS studies were approximately 10% higher than the control groups and the 
intervention phase in both studies lasted at least 6 months. Walshe has commented on the 
heterogeneity of treatment strategies and their responsiveness to QI(Walshe 2007;Walshe & 
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Freeman 2002) and it can be deduced that strategies involving multiple factors such as 
coronary angiography may not respond to the same QI intervention as simpler interventions 
e.g. prescription of discharge medications. 
2.4.4.3 ACS medications 
Improvements of 2-10% were noted for the 6 ACS medications assessed during the trial. 
Baseline prescription rates were over 75% for all with anticoagulation and statins starting at 
over 90%. This high baseline rate could explain the modest improvements observed. 
Clopidogrel loading dose improved the most and the improvement was statistically 
significant. 
2.4.5 Limitations 
The majority of the quality indicators assessed had high baseline rates, limiting the scope for 
improvement. The indicators were selected on the basis of guideline recommendations but it 
would have been useful to carry out a baseline survey or run-in phase to identify key areas 
for improvement prior to implementing the programme.  
 
Patients were not followed up beyond discharge from hospital, so the effect of improved 
management during the in-hospital phase on clinical outcomes could not be assessed. In 
addition, centres were not followed up beyond the end of the study so it was not possible to 
establish whether the improvement observed during the study was maintained. Only two out 
of 38 centres agreed to collect data for one year following the end of the study and this data 
will be considered in a later chapter. 
 
The QI intervention was delivered over a four-month period, which is shorter than some of 
the examples in the literature and may be too short a timeframe to effect a change in some 
of the more complex treatment strategies. This could be particularly important for coronary 
angiography as noted above, and it may be that a longer time period would have enabled 
the participating hospitals to streamline their processes for this quality indicator. The duration 
of the post-intervention phase is also important as QI work may continue throughout this 
phase and it is possible that further improvement would have been observed. 
 
The QI intervention was not tailored to the individual treatments. Although the QI teams were 
encouraged to identify their own improvement tools to address local barriers, the same 
overall strategy was used for all indicators which may not be appropriate. It is possible that 
complex interventions such as coronary angiography require a different approach to ACS 
medications. 
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CHAPTER 3. Secondary quantitative analysis 
of EQUIP-ACS: Use of risk stratification methods 
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The GRACE score was calculated retrospectively for all patients in the dataset, taking into 
account all components of the in-hospital risk model(Granger et al. 2003) as indicated below. 
On the basis of their GRACE score, patients were categorised as low, intermediate and high 
risk respectively, using the GRACE definitions for these categories. The GRACE definitions 
are based on tertiles of the scores from the population used to develop the score.(Granger et 
al. 2003) See Table 7 and Table 8. 
 
Patient characteristics were reported as number and percentage, N(%), in the case of 
categorical variables or for continuous variables as mean and standard deviation or median 
and interquartile range if they were not normally distributed. Statistical comparisons of 
characteristics were performed using analysis of variance (ANOVA) or chi-squared test as 
appropriate and in the case of outcome measures, using hierarchical logistic regression to 
take account of the clustered nature of the data. Analyses were performed using STATA 
version 12.1.  
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Risk factor  Value Points 
Age (years) <=30 
30-39 
40-49 
50-59 
60-69 
70-79 
80-89 
>=90 
0 
8 
25 
41 
58 
75 
91 
100 
Heart rate (bpm) <=50 
50-69 
70-89 
90-109 
110-149 
150-199 
>=200 
0 
3 
9 
15 
24 
38 
46 
Systolic blood pressure 
(mmHg) 
<=80 
80-99 
100-119 
120-139 
140-159 
160-199 
>=200 
58 
53 
43 
34 
24 
10 
0 
Creatinine (umol/L) 0 – 35.3 
35.4 - 70 
71 - 105 
106 - 140 
141 - 176 
177 - 353 
>=354 
1 
4 
7 
10 
13 
21 
28 
Killip Class 
 
I (no CHF) 
II (lung rales) 
III (pulmonary oedema) 
IV (cardiogenic shock) 
0 
20 
39 
59 
Cardiac arrest at 
admission 
Yes 39 
ST segment deviation Yes 28 
Elevated cardiac enzymes Yes 14 
Table 7. GRACE in-hospital score 
 
RISK CATEGORY  
(TERTILES) 
GRACE RISK SCORE 
LOW 1-108 
INTERMEDIATE 109-140 
HIGH 141-372 
Table 8. GRACE score categories (in-hospital mortality) 
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overall adjusted Odds ratio [OR] for the GRACE score is 10.42 (95% CI 8.18 to 13.27, 
p<0.001) and for the TIMI score is 4.57 (95%CI 3.64 to 5.74, p<0.001). 
 
Risk 
stratifi-
cation 
Non-QI centres Odds ratio 
(95%CI) for 
BL vs PQI 
QI centres Odds ratio 
(95%CI) for 
BL vs PQI 
Overall OR* 
BL QI PQI BL QI PQI 
N 580 647 474 813 956 715 
Using 
any 
method  
59.8 49.5 51.9 
0.66 
(0.45-0.97) 
p=0.037 
51.8 79.3 83.2 
12.06 
(8.71-16.68) 
p<0.001 
19.28 
(11.61-32.01) 
p<0.001 
GRACE 9.7 18.1 16.7 
1.79 
(1.48-2.18) 
p<0.001 
7.1 37.8 38.5 
18.95 
(16.35-21.97) 
p<0.001 
10.42 
(8.18-13.27) 
p<0.001 
TIMI 39.1 21.2 19.2 
0.25 
(0.21-0.31) 
p<0.001 
25.7 21.9 25.9 
1.16 
(1.03-1.31) 
p=0.013 
4.57 
(3.64-5.74) 
p<0.001 
Key: BL= Baseline phase, QI= QI implementation phase, PQI= Post-QI implementation phase 
*adjusted for country and PCI-facilities 
Table 9. Use of risk stratification by group and period 
 
3.4.2 Validation of risk stratification using retrospective GRACE score 
The GRACE score was calculated retrospectively for all patients and they were classified as 
low, intermediate or high risk using the GRACE in-hospital definitions for these 
categories(Granger et al. 2003). The GRACE cut-offs for risk categories were selected as 
these are recognised and implemented in management of ACS but a comparison was also 
made with tertiles of GRACE score derived from the EQUIP-ACS dataset to ensure they are 
appropriate for the study population. See Table 10. 
 
RISK CATEGORY  
(TERTILES) GRACE RISK SCORE 
EQUIP-ACS 
DERIVED TERTILES 
LOW 1-108 25-111 
INTERMEDIATE 109-140 112-142 
HIGH 141-372 143-271 
Table 10. Comparison of EQUIP-ACS tertiles with GRACE risk categories 
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3.4.2.1 Baseline characteristics 
Baseline characteristics for patients in each of the risk categories are summarised in Table 
11. The data in Table 11 demonstrate that the retrospective GRACE score has categorised 
patients appropriately as the following factors increase with risk: age, diabetes, 
hypertension, prior MI, ST depression on the ECG. Rates of angiography and percutaneous 
coronary intervention (PCI) performed in-hospital were lowest in the high risk category 
however and this will be explored further in later analyses. 
 
The distribution of GRACE scores calculated for this population is shown in Figure 12. 
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Table 11. Baseline characteristics of patients, by GRACE risk category 
Description GRACE Low risk GRACE  Intermediate risk GRACE High risk 
N 1,259 1,623 1,566 
Characteristics    
Age, years (mean [SD]) 55.3 [9.6] 66.1 [8.6] 72.0 [6.6] 
Male, N(%) 939 (74.6) 1,115 (68.7) 1,042 (66.5) 
Female, N(%) 320 (25.4) 508 (31.3) 524 (33.5) 
Diabetes, N(%) 199  (16.3) 389 (24.0) 527 (33.8) 
Hypertension, N(%) 660 (54.4) 1,057 (65.6) 1,130 (72.9) 
Smoker, N(%) 478  (40.8) 404 (26.0) 276 (18.9) 
Prior MI, N(%) 252 (20.7) 412 (25.7) 546 (35.4) 
ST-depression, N(%) 150 (12.4) 657 (40.6) 1,109 (71.0) 
Pathological T-wave, N(%) 545 (44.9) 439 (27.1) 134 (8.6) 
Cardiac marker positive  
(according to local cut-off),  
N(%) 
923 (76.0) 1,364 (84.2) 1,450 (92.6) 
Admission medications     
Clopidogrel on admission, 
N(%) 107 (9.7) 168 (11.5) 213 (15.3) 
Aspirin on admission,  
N(%) 342 (31.1) 606 (41.9) 731 (52.7) 
Statin on admission,   
N(%) 346 (31.4) 615 (42.6) 692 (50.2) 
ACE inhibitors /A2 receptor 
blockers on admission,   
N(%) 
365 (31.0) 685 (44.2) 773 (51.4) 
In-hospital procedures    
Angiography performed, 
N(%)    
Yes at this hospital 829 (68.2) 1,087 (67.1) 931 (59.5) 
Planned after discharge 32 (2.6) 40 (2.5) 38 (2.4) 
Yes transferred to another 
hospital 247 (20.3) 297 (18.3) 265 (16.9) 
Total 1,108 (91.1) 1,424 (88.2) 1,234 (78.8) 
PCI performed,  N(%)    
Yes at hospital 473 (39.7) 634 (40.3) 522 (34.6) 
Planned after discharge 10 (0.8) 10 (0.6) 16   (1.0) 
Yes transferred to another 
hospital 152 (12.7) 167 (10.6) 112 (7.4) 
Total 635 (53.2) 811 (51.5) 650 (43.0) 
CABG performed, N(%)    
Yes at hospital 43 (3.6) 61 (3.9) 58 (3.9) 
Planned after discharge 43 (3.6) 105 (6.7) 100 (6.6) 
Yes transferred to another 
hospital 37 (3.1) 53 (3.4) 74 (4.9) 
Discharge diagnosis     
Myocardial infarction, N(%) 706 (57.6) 1,022 (63.1) 1,117 (71.3) 
Unstable angina, N(%) 429 (35.0) 523 (32.3) 381 (24.3) 
Death in-hospital 
Death, N(%) 4 (0.3) 9 (0.6) 69 (4.4) 
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Figure 12. Distribution of retrospectively calculated GRACE score with risk categories 
shown 
3.4.3 Validation of risk scoring performed by centres 
Risk stratification performed by centres during the study was compared with the 
retrospective method to assess whether methods were performed appropriately by the 
centres. Table 12 and Figure 13 show the comparison between risk stratification performed 
by centres using any method or the GRACE score only, and by the retrospective GRACE 
score for all patients and for those that were risk stratified only. Although the proportions for 
each risk category are similar across all groups, it can be seen that the proportion of patients 
classified as ‘intermediate risk’ is highest for the group risk stratified by centres using any 
method.  
 
The Kappa statistic (κ) was calculated to assess agreement between the two methods. 
Comparison of risk stratification performed by centres using any method with the 
retrospective GRACE method showed ‘fair’ agreement, corresponding to a κ of 0.23 and 
49% agreement. Comparison of risk stratification performed by centres using the GRACE 
method only with the retrospective GRACE method showed slightly improved agreement, 
corresponding to a κ of 0.37 and 59% agreement. The definition of ‘fair’ agreement is based 
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on a kappa value in the range of 0.21-0.40 as defined by Landis et al and Viera et al in their 
papers about comparing categorical variables using the kappa statistic.(Landis and Koch 
1977;Viera and Garrett 2005) 
 
Risk category# 
Risk 
stratification by 
any method 
(performed by 
centres) 
N(%) 
GRACE score 
(performed by 
centres) 
N(%) 
GRACE score 
(determined 
retrospectively) 
N(%) 
GRACE score 
(determined 
retrospectively)* 
N(%) 
Low risk 670 (23.6) 210 (21.6) 1,259 (28.3) 770 (27.2) 
Intermediate risk 1,283 (45.3) 404 (41.5) 1,623 (36.5) 1,063 (37.5) 
High risk 882 (31.1) 359 (36.9) 1,259 (28.3) 1,002 (35.3) 
#Risk category defined by any score 
*Calculated for patients that were risk stratified only 
Table 12. Use of risk stratification in EQUIP-ACS centres 
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Figure 13. Comparison of centres’ own risk stratification and retrospective method 
using GRACE score 
 
Mean and median GRACE scores were determined for each risk category and are shown in 
Table 13. The medians and interquartile ranges for each category are also shown 
graphically in Figure 14. The risk categories overlap but GRACE score increases with risk 
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and the scores determined for intermediate and high risk are in line with GRACE definitions. 
The scores determined for patients classified as low risk are at the higher end of the GRACE 
definition for low risk. The distribution of GRACE scores in each category is shown in Figure 
15.  
 
GRACE score Low risk Intermediate risk High risk 
Mean [SD] 111.4 [29.9] 126.5 [28.9] 145.9 [34.3] 
Median [IQR] 109 [89,129] 126 [108,146] 146[123,167] 
Table 13. Comparison of Risk stratification performed by centres and retrospective 
validation 
 
 
Figure 14. Box and whisker plots comparing GRACE scores in Low, Intermediate, and 
High risk categories determined by centres  
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Figure 15. Distribution of GRACE score by risk categories determined by centres 
 
Key baseline characteristics for risk categories assigned by the centres using any risk 
stratification method were also assessed, and these are summarised in Table 14. 
Comparing these data with the baseline characteristics presented in Table 11 for the 
retrospective risk scoring method, reveals some minor differences. Mean age increases 
more with each risk category calculated using the retrospective method. Similarly, ST 
depression on the admission ECG increases more for each category defined by the 
retrospective method, compared to the risk categories defined by centres. Differences are 
also observed for the rates of coronary angiography and PCI; data for the categories 
determined by the centres are similar across all groups whereas rates for patients 
categorised retrospectively decrease as risk increases.  
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Table 14. Baseline characteristics for risk categories defined by centres 
Description Low risk Intermediate risk High risk 
N 670 1,283 882 
Characteristics    
Age, years (mean [SD]) 59.7 [10.8] 65.2 [10.0] 68.3 [9.5] 
Male, N(%) 465 (69.4) 875 (68.2) 617 (70.0) 
Female, N(%) 205 (30.6) 408 (31.8) 265 (30.1) 
Diabetes, N(%) 82 (12.2) 294 (23.1) 319 (36.3) 
Hypertension, N(%) 326 (49.0) 889 (70.4) 665 (75.9) 
Smoker, N(%) 227 (35.6) 328 (27.1) 207 (25.1) 
Prior MI, N(%) 81 (12.2) 349 (27.7) 357 (41.0) 
ST-depression, N(%) 235 (35.1) 592 (46.3) 517 (58.8) 
Pathological T-wave, 
N(%) 206 (30.8) 356 (27.8) 138 (15.7) 
Cardiac marker positive  
(according to local cut-
off),  N(%) 
503 (75.3) 1,040 (81.1) 820 (93.0) 
Admission medications     
Clopidogrel on 
admission, N(%) 30 (4.9) 113 (10.8) 149 (18.9) 
Aspirin on admission,  
N(%) 148 (24.3) 441 (42.6) 462 (58.5) 
Statin on admission,   
N(%) 154 (25.3) 409 (39.6) 439 (55.9) 
ACE inhibitors /A2 
receptor blockers on 
admission,   N(%) 
178 (27.3) 510 (43.4) 450 (53.2) 
In-hospital procedures    
Angiography performed, 
N(%)    
Yes at this hospital 432 (64.5) 856 (66.8) 564 (64.0) 
Planned after discharge 28 (4.2) 31 (2.4) 4 (1.6) 
Yes transferred to 
another hospital 120 (17.9) 235 (18.3) 183 (20.8) 
Total 580 (86.6) 1,122 (87.5) 751 (86.4) 
PCI performed,  N(%)    
Yes at hospital 236 (36.0) 519 (42.0) 329 (38.7) 
Planned after discharge 5 (0.8) 8 (0.7) 12 (1.4) 
Yes transferred to 
another hospital 62 (9.5) 101 (8.2) 89 (10.5) 
Total 538 (46.3) 628 (50.9) 430 (50.6) 
CABG performed, N(%)    
Yes at hospital 21 (3.2) 57 (4.6) 32 (3.8) 
Planned after discharge 26 (4.0) 90 (7.3) 53 (6.2) 
Yes transferred to 
another hospital 21 (3.2) 47 (3.8) 50 (5.9) 
Discharge diagnosis     
Myocardial infarction, 
N(%) 386 (57.7) 791 (61.7) 648 (73.5) 
Unstable angina, N(%) 232 (34.7) 440 (34.3) 208 (23.6) 
Death in-hospital 
Death, N(%) 7 (1.1) 17 (1.3) 25 (2.8) 
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3.4.4 Assessment of whether risk scoring is associated with an improvement in quality 
indicators 
Use of risk stratification methods showed the greatest improvement out of the eight quality 
indicators assessed during the EQUIP-ACS trial. The following analyses were performed to 
assess whether improved use of risk scores was associated with an improvement in any of 
the other indicators, i.e. whether assigning a risk score to patients led to improved use of 
other guideline recommended treatments for managing non-ST elevation ACS. 
 
Since the composite outcome of all eight treatments includes use of risk stratification as one 
of its components, a new composite outcome which excludes use of risk stratification was 
generated to assess whether improvement in the remaining seven treatments is still 
observed. 
 
Stratifying the risk categories by whether patients were risk scored or not showed an 
improvement in the composite outcome for all categories. Irrespective of patient risk, an 
odds ratio of 1.30-1.40 was observed for all categories, indicating that risk scoring a patient 
is associated with approximately 30% improvement in use of all ACS treatments assessed.  
 
In terms of the individual indicators, there was a trend for all indicators to improve and this 
was observed for all risk categories. A significant improvement was noted in use of coronary 
angiography for intermediate and high risk patients with an OR for intermediate risk patients 
of 1.65 (95% confidence interval 1.21 – 2.24, p=0.001) and OR for high risk patients of 1.63 
(95% confidence interval 1.20 – 2.22, p=0.002). Use of anticoagulation and ACE-inhibitors 
improved significantly for intermediate risk patients only, whereas use of statins showed 
significant improvement for low and high risk patients. Clopidogrel loading dose improved for 
all risk categories with ORs indicating at least a two-fold statistically significant improvement. 
These results are summarised in Table 15. 
 
The results were also analysed taking allocation to the QI programme into account as shown 
in Table 16. It can be seen that the composite outcome, coronary angiography, clopidogrel 
loading dose and clopidogrel as a maintenance dose improved more in the QI centres 
compared to the non-QI centres. 
 
These results are summarised in Table 15, Table 16 and Figure 16 to Figure 19. Figure 19 is 
a Forest plot comparing the effect of allocation to QI, time-period and risk stratification on the 
composite outcome of all 8 ACS treatments by GRACE risk category. The Forest plot 
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demonstrates that improvement in the composite outcome is observed in all cases, 
irrespective of risk category. 
 
Outcome 
(%) 
GRACE Low risk GRACE Intermediate risk GRACE High risk 
Risk stratified? Risk stratified? Risk stratified? 
N Y 
OR 
(95%CI) 
p-value 
N Y 
OR 
(95%CI) 
p-value 
N Y 
OR 
(95%CI) 
p-value 
Composite 
outcome 79.2 83.5 
1.39 
(1.20-1.61) 
P<0.001 
79.2 83.9 
1.43 
(1.26-1.62) 
P<0.001 
74.4 80.9 
1.34 
(1.19-1.52) 
P<0.001 
Coronary 
angiography 59.9 62.5 
1.23 
(0.88-1.73) 
p=0.229 
53.6 62.2 
1.65 
(1.21-2.24) 
p=0.001 
44.1 58.2 
1.63 
(1.20-2.22) 
P=0.002 
Anticoagulation 93.0 93.2 
1.85 
(1.00-3.45) 
p=0.051 
92.1 92.8 
1.81 
(1.11-2.95) 
P=0.018 
92.3 93.0 
1.18 
(0.75-1.85) 
P= 0.472 
Beta-blockers 78.9 82.6 
1.18 
(0.83-1.69) 
P=0.355 
80.3 84.0 
1.17 
(0.84-1.61) 
P=0.348 
75.7 82.0 
1.03 
(0.74-1.43) 
P=0.859 
Statins 93.2 95.2 
2.01 
(1.07-3.76) 
P=0.029 
94.1 95.0 
1.52 
(0.89-2.58) 
P=0.124 
90.5 94.6 
1.96 
(1.19-3.23) 
p=0.008 
ACE-inhibitors 73.4 80.3 
1.19 
(0.84-1.70) 
P=0.326 
76.3 84.6 
1.57 
(1.14-2.17) 
P=0.006 
70.9 78.5 
1.36 
(1.00-1.83) 
P=0.048 
Clopidogrel 
loading dose 77.7 88.4 
3.20 
(2.06-4.96) 
P<0.001 
76.2 87.8 
2.39 
(1.67-3.42) 
P<0.001 
73.7 85.2 
2.61 
(1.82-3.73) 
P<0.001 
Clopidogrel 
maintenance 
dose 
78.5 82.1 
1.19 
(0.85-1.66) 
P= 0.31 
81.9 80.9 
0.94 
(0.69-1.29) 
P=0.713 
73.7 75.2 
1.09 
(0.82-1.46) 
P=0.562 
Table 15. Effect of patient risk on outcome, by risk stratification performed (composite 
and individual outcomes) 
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Outcome 
(%) 
Non-QI QI OR (95%CI) 
p-value Not risk 
stratified 
Risk 
stratified 
Not risk 
stratified 
Risk 
stratified 
Composite outcome 80.4 82.0 74.5 83.0 1.32 (1.09-1.61) P=0.005 
Coronary angiography 59.7 63.2 44.1 59.7 2.10 (1.41-3.13) P<0.001 
Anticoagulation 93.2 93.4 91.6 92.7 0.98 (0.51-1.86) p=0.942 
Beta-blockers 78.1 82.7 78.4 83.0 0.80 (0.41-1.54) P=0.499 
Statins 94.0 94.9 91.1 94.9 0.97 (0.47-1.98) P=0.926 
ACE-inhibitors 73.7 76.9 73.4 83.3 1.18 (0.70-2.00) P=0.530 
Clopidogrel loading 
dose 82.1 85.7 69.3 87.7 
1.91 (1.15-3.18) 
P=0.013 
Clopidogrel 
maintenance dose 81.8 77.3 74.1 80.1 
1.75 (1.19-2.59) 
p=0.005 
Table 16. Effect of patient risk on outcome, by risk stratification performed and 
allocation to QI programme 
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Figure 16. Quality indicators for low risk patients, comparison of those risk stratified 
with those that were not 
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Figure 17. Quality indicators for intermediate risk patients, comparison of those risk 
stratified with those that were not 
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Figure 18. Quality indicators for high risk patients, comparison of those risk stratified 
with those that were not 
 
Figure 19. Forest plot showing effect of performing risk stratification, time-period and 
allocation to QI on the composite outcome of all ACS treatments, for each of the three 
risk categories 
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eight ACS treatments improved irrespective of risk. This implies that the QI intervention 
targeted all patients irrespective of risk. 
3.5.2 Comparison with literature 
Oliveira et al(Oliveira et al. 2007) observed that better use of the GRACE score did not lead 
to improved management of high risk patients. The analyses presented in this chapter 
however, provide evidence that improved risk scoring using validated scores such as 
GRACE and TIMI, as a result of a QI intervention, led to a meaningful improvement in 
management of non-ST elevation ACS patients. A three-fold improvement was observed in 
the composite outcome and importantly, improved rates of coronary angiography were seen 
for intermediate and high risk patients corresponding to a statistically significant difference of 
at least 10% in both cases, when comparing patients that were risk stratified to those that 
were not. This encouraging data supports early risk scoring of patients to ensure appropriate 
referral for angiography. 
 
Validated risk stratification methods were used in approximately 50% of cases prior to 
delivery of the EQUIP-ACS QI programme and this increased to more than 80% in the QI 
centres after the programme was implemented. In the remainder of cases, a decision to 
manage patients with an early invasive strategy was reached on the basis of global clinical 
evaluation. It has been reported that risk stratification based on clinical evaluation only can 
lead to under-estimating the true risk as important risk factors are frequently ignored. In 
some instances clinicians may react to extremes of one risk factor and ignore the overall 
picture, and risk factors are sometimes assigned the same weight even though some e.g. 
age, are known to drive risk more than others.(Fox & Langrish 2010;Henderson 2013;Scirica 
2010;Steg 2009)  
 
Risk-guided angiography and revascularisation where risk is determined by clinical 
evaluation has been assessed in a range of studies, but retrospective analyses using 
validated scores showed that clinicians were underestimating risk and due to a 
misperception that patients were not high risk enough, were not referring them adequately 
for invasive strategies.(Bagnall et al. 2010;Lee et al. 2008;Yan et al. 2007a;Yan et al. 2009) 
Results of risk stratification using validated scores identified intermediate and high risk 
patients that had been categorised as low risk by clinicians leading to sub-optimal treatment 
in all areas. 
Daphne Babalis PhD Thesis  Page 91 of 247 
 
3.5.3 Limitations 
The analyses reported in this chapter were performed retrospectively and are exploratory. 
Use of risk scores by centres has been validated via a retrospective method, validation of 
the method was not performed by monitoring medical records of each patient to ensure 
scores were calculated in accordance with the formal methods. It was also not possible to 
verify the score determined for each patient as the database only captured risk category as 
low, intermediate or high, rather than as an absolute score.  
 
It would also have been interesting to collect data on whether the outcome of risk 
stratification was used to determine further decisions on management of the patient, rather 
than just to satisfy the data collection requirements of the trial. 
 
The eligibility criteria for the EQUIP-ACS trial specified that, in addition to a clinical history of 
ACS, patients must have either ST or T wave changes on the admission ECG or a troponin 
rise indicative of myocardial necrosis. Presence of either of these criteria mean that true low 
risk patients may not have been included in the trial and therefore management of low risk 
patients cannot be fully assessed. 
 
The GRACE definitions for risk category are based on data-driven tertiles rather than clinical 
factors. The EQUIP-ACS database prompted participating centres to categorise patients into 
one of three categories i.e. ‘low’, ‘intermediate’ or ‘high’, rather than to specify an absolute 
score. While it is practical to assign a risk category to guide further management decisions, it 
should be acknowledged that risk is in fact continuous and the cut-offs selected may not be 
clinically meaningful. 
 
Rate of risk stratification for the Non-QI centres using any method remained approximately 
the same after the QI intervention. Assessment of the results by individual risk scores 
however showed that there was a reduction in use of TIMI and an increase in use of the 
GRACE score. This change in use of scores could be attributed to the release of the ESC 
guidelines which recommended GRACE over other methods. 
 
As for the primary analysis of the trial, data on outcome measures after discharge from 
hospital are not available so it was not possible to assess the effect of risk scoring in-hospital 
on clinical outcomes. 
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CHAPTER 4. The effect of patient and centre 
characteristics on outcome of the QI programme 
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Description Units Non-QI centres QI centres All centres 
N  19 19 38 
Population served for 
acute coronary 
admissions 
mean [SD] 432248.7 [237821] 
328284.9  
[222023.2] 
378780  
[266599.9] 
Median 
[IQR] 
350000 
[179500,600000] 
305000 
[198204,415000] 
350000 
[180000,500000] 
Angiography on site N (%) 13 (68.4) 13 (68.4) 26 (68.4) 
PCI facilities on-site N (%) 11 (57.9) 10 (52.6) 21 (55.3) 
CABG facilities on-site N (%) 4 (21.1) 6 (31.6) 10 (26.3) 
Number of cardiology 
beds (including CCU if 
applicable) 
mean [SD] 45.2 [36.5] 37.7 [27.0] 41.2 [31.6] 
Median 
[IQR] 36.5 [25.5,52] 31 [20,55] 32.5 [21,55] 
Number of ACS 
admissions per year 
mean [SD] 597.7 [430.3] 645.2 [496.7] 622.8 [460.3] 
Median 
[IQR] 494.5 [308,696] 490 [400,750] 492.5 [320,742] 
Number of 
cardiologists  
(full time equivalents) 
mean [SD] 7.8 [4.9] 9.1 [8] 8.5 [6.7] 
Median 
[IQR] 4.5 [4,12] 7 [3,13] 5.5 [4,12] 
Hospital with routine 
undergraduate 
teaching programme  
N (%) 12 (75) 14 (77.8) 26 (76.5) 
Baseline performance 
(proportion of 
composite outcome 
fulfilled during 
baseline phase) 
    
Median proportion Median [IQR] 76.9 [70.9, 82.6] 76.7 [60.3, 82.3] 76.8 [70.9, 82.3] 
 <70% N (%) 4 (21.1) 5 (26.3) 9 (23.7) 
 ≥70% & <90% N (%) 12 (63.2) 13 (68.4) 25 (65.8) 
≥ 90% N (%) 3 (15.8) 1 (5.3) 4 (10.5) 
Table 18. Hospital characteristics (data for baseline, QI-intervention and post-QI 
phases combined) 
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4.3.2 Effect of patient characteristics  
A series of unadjusted analyses were performed to assess the effect of individual patient 
characteristics on use of guideline recommended treatments as a composite and individual 
outcomes. The individual unadjusted analyses will be included in a multivariable regression 
model later in this chapter. 
4.3.2.1 Age 
Patients aged over 65 years were less likely to receive all recommended treatments. The 
proportion of patients aged over 65 years receiving all treatments was 75.7% compared to 
79.7% of those aged less than 65 years. The unadjusted odds ratio for this comparison is 
0.84, 95% confidence interval (0.78-0.90), p<0.001, favouring the lower age group. The 
rates of coronary angiography, statins and clopidogrel as a loading and maintenance dose 
were also significantly lower for the higher age group as shown in Table 19.  
 
Outcome, % Age =<65 Age >65 OR (95%CI) p-value 
Primary outcome 79.7 75.7 0.84 (0.78-0.90) <0.001 
Risk stratification 63.0 61.8 0.96 (0.78-1.19) 0.734 
Coronary 
angiography 63.1 52.4 0.63 (0.52-0.75) <0.001 
Anticoagulation 92.4 90.9 0.81 (0.60-1.09) 0.161 
Beta-blockers 83.3 79.3 0.82 (0.67-1.02) 0.071 
Statins 94.8 91.9 0.67 (0.48-0.93) 0.017 
ACE-inhibitors 78.2  78.9 1.12 (0.91-1.37) 0.272 
Clopidogrel loading 
dose 83.1 77.2 0.76 (0.61-0.94) 0.013 
Clopidogrel 
maintenance dose 80.2 73.3 0.70 (0.57-0.85) <0.001 
Table 19. Effect of age on outcome measures of QI programme 
4.3.2.2 Gender 
Female patients were less likely to receive all ACS treatments, 77.9% of male patients 
achieved the composite outcome of all eight treatments compared to 76.4% of female 
patients. This difference was statistically significant with an unadjusted OR of 0.88 
(95%CI=0.82 – 0.95, p=0.001) but a difference of 1.5% is unlikely to be clinically significant. 
There was a trend for all individual treatments to be prescribed less for female patients, 
although only clopidogrel at discharge achieved a statistically significant difference. 
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Outcome, % Male Female OR (95%CI) p-value 
Primary outcome 77.9 76.4 0.88 (0.82-0.95) 0.001 
Risk stratification 61.9 63.3 0.93 (0.74-1.17) 0.542 
Coronary 
angiography 57.3 56.4 0.90 (0.74-1.09) 0.270 
Anticoagulation 92.4 89.4 0.75 (0.56-1.02) 0.063 
Beta-blockers 81.4 80.1 0.88 (0.71-1.10) 0.265 
Statins 93.6 92.1 0.81 (0.58-1.13) 0.223 
ACE-inhibitors 78.7 78.2 0.87 (0.70-1.08) 0.214 
Clopidogrel loading 
dose 80.3 78.6 0.88 (0.70-1.10) 0.272 
Clopidogrel 
maintenance dose 77.5 73.5 0.76 (0.62-0.93) 0.007 
Table 20. Effect of gender on outcome measures of QI programme 
4.3.2.3 Diabetes 
There was no statistically significant difference observed for the composite of eight 
treatments between patients with and without diabetes. The composite outcome measure 
was achieved in 77.5% of non-diabetic patients compared with 77.4% of diabetic patients 
(OR (95%CI) = 1.01 (0.93-1.09), p=0.835). Rate of coronary angiography was statistically 
lower for diabetic patients however, corresponding to 58.8% in non-diabetic patients 
compared to 52.1% in diabetic patients (OR (95%CI)= 0.69 (0.57-0.84), p<0.001). Rates of 
prescription of beta blockers and ACE-inhibitors were statistically higher for diabetic patients. 
 
 
Outcome, % No diabetes Diabetes OR (95%CI) p-value 
Primary outcome 77.5 77.4 1.01 (0.93-1.09) 0.835 
Risk stratification 62.5 61.9 0.88 (0.69-1.12) 0.300 
Coronary 
angiography 58.8 52.1 0.69 (0.57-0.84) <0.001 
Anticoagulation 91.4 91.8 1.02 (0.73-1.42) 0.901 
Beta-blockers 80.3 83.1 1.28 (1.01-1.63) 0.045 
Statins 92.8 94.1 1.26 (0.87-1.84) 0.225 
ACE-inhibitors 76.7 84.0 1.80 (1.41-2.31) <0.001 
Clopidogrel loading 
dose 80.3 78.3 0.90 (0.71-1.14) 0.363 
Clopidogrel 
maintenance dose 77.1 73.9 0.88 (0.71-1.08) 0.220 
Table 21. Effect of diabetes on outcome measures of QI programme 
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4.3.2.4 Prior Myocardial Infarction (MI) 
Patients with prior MI at presentation were less likely to have coronary angiography and 
anticoagulation but more likely to receive statins, ACE-inhibitors and clopidogrel as a 
maintenance dose. Rates of discharge medications tended to be higher for patients with 
prior MI.  
 
Outcome, % No prior MI Prior MI OR (95%CI) p-value 
Primary outcome 76.8 78.8 1.08 (1.00-1.16) 0.061 
Risk stratification 61.0 64.7 1.03 (0.81-1.30) 0.820 
Coronary 
angiography 58.3 53.9 0.74 (0.61-0.90) 0.003 
Anticoagulation 92.4 89.4 0.74 (0.55-1.00) 0.011 
Beta-blockers 80.0 83.6 1.23 (0.97-1.56) 0.084 
Statins 92.3 96.0 2.06 (1.36-3.14) 0.001 
ACE-inhibitors 76.4 83.2 1.43 (1.13-1.81) 0.003 
Clopidogrel 
loading dose 79.0 81.0 1.16 (0.91-1.47) 0.220 
Clopidogrel 
maintenance 
dose 
75.3 78.8 1.26 (1.02-1.56) 0.034 
Table 22. Effect of prior MI on outcome measures of QI programme 
4.3.2.5 Chronic Kidney Disease 
Patients with chronic kidney disease (CKD) received fewer ACS treatments than those 
without chronic kidney disease. This was observed for the composite outcome measure 
which was 71.7% for patients with CKD compared with 78.0% for patients with no CKD (OR 
95%CI; 0.68 (0.60-0.76), p<0.001). Lower rates were noted for all the individual factors, with 
statistical significance achieved for coronary angiography, ACE-inhibitors and clopidogrel 
loading dose. 
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Outcome, % No CKD CKD OR (95%CI) p-value 
Primary 
outcome 78.0 71.7 0.68 (0.60-0.76) <0.001 
Risk 
stratification 61.8 66.5 0.87 (0.59-1.28) 0.481 
Coronary 
angiography 59.0 36.3 0.30 (0.22-0.41) <0.001 
Anticoagulation 91.5 91.5 1.00 (0.60-1.66) 0.997 
Beta-blockers 81.0 81.0 1.00 (0.69-1.44) 0.982 
Statins 93.4 93.2 0.97 (0.55-1.70) 0.903 
ACE-inhibitors 79.8 65.6 0.46 (0.33-0.63) <0.001 
Clopidogrel 
loading dose 80.8 68.2 0.51 (0.36-0.72) <0.001 
Clopidogrel 
maintenance 
dose 
76.8 71.0 0.75 (0.54-1.03) 0.073 
Table 23. Effect of chronic kidney disease on outcome measures of QI programme 
4.3.2.6 ST depression  
There was no difference observed for the composite outcome measure between patients 
with ST depression on their admission ECG and those with no ST depression on the 
admission ECG. No statistically significant differences were observed for any of the 
individual treatments. 
 
Outcome, % No ST depression ST depression OR (95%CI) p-value 
Primary 
outcome 76.5 78.7 1.02 (0.95-1.09) 0.672 
Risk 
stratification 59.3 66.9 1.23 (0.98-1.53) 0.070 
Coronary 
angiography 53.2 62.6 1.13 (0.94-1.36) 0.196 
Anticoagulation 92.0 90.8 1.03 (0.76-1.39) 0.845 
Beta-blockers 79.6 83.0 1.11 (0.89-1.37) 0.366 
 Statins 94.0 92.3 0.79 (0.57-1.10) 0.164 
ACE-inhibitors 78.5 79.4 0.88 (0.71-1.09) 0.239 
Clopidogrel 
loading dose 79.6 79.5 0.96 (0.77-1.20) 0.743 
Clopidogrel 
maintenance 
dose 
76.3 76.1 0.95 (0.78-1.16) 0.638 
Table 24. Effect of ST depression on the ECG on outcome measures of QI programme 
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4.3.2.7 Prior stroke 
Patients with prior stroke were less likely to receive recommended ACS treatments. The 
composite outcome of all treatments was lower for patients with prior stroke, 73.3% 
compared with 77.7% for those with no prior stroke (OR 95%CI = 0.80 (0.70-0.91), p=0.001) 
and statistically significantly lower values were also observed for coronary angiography and 
anticoagulation. 
 
Outcome, % No prior stroke Prior stroke OR (95%CI) p-value 
Primary 
outcome 77.7 73.3 0.80 (0.70-0.91) 0.001 
Risk 
stratification 62.4 60.7 0.80 (0.52-1.25) 0.331 
Coronary 
angiography 58.4 37.4 0.39 (0.27-0.56) <0.001 
Anticoagulation 91.8 87.1 0.55 (0.33-0.93) 0.025 
Beta-blockers 81.3 77.5 0.82 (0.55-1.24) 0.358 
 Statins 93.3 91.6 0.77 (0.41-1.41) 0.393 
ACE-inhibitors 78.6 77.5 0.92 (0.61-1.40) 0.704 
Clopidogrel 
loading dose 80.0 76.3 0.87 (0.56-1.33) 0.515 
Clopidogrel 
maintenance 
dose 
76.1 78.8 1.24 (0.82-1.88) 0.303 
Table 25. Effect of prior stroke on outcome measures of QI programme 
4.3.2.8 History of heart failure 
The proportion of patients with a history of heart failure receiving all eight treatments was 
statistically lower than the proportion of patients without a history of heart failure. This result 
was not clinically significant as the difference observed between the two groups was only 
0.2%. As the dataset for EQUIP-ACS is large, in this case over 4,000 patients, very small 
effect sizes can be statistically significant. 
 
Coronary angiography and prescription of clopidogrel loading dose were significantly lower 
for patients with a history of heart failure.  
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Outcome, % No Heart Failure Heart Failure OR (95%CI) p-value 
Primary 
outcome 77.5 77.3 0.75 (0.65-0.85) <0.001 
Risk 
stratification 61.4 68.1 0.56 (0.28-1.09) 0.087 
Coronary 
angiography 58.1 49.5 0.38 (0.16-0.88) 0.024 
Anticoagulation 92.1 87.9 0.86 (0.56-1.30) 0.464 
Beta-blockers 80.3 86.6 1.41 (0.67-2.99) 0.364 
 Statins 93.2 94.1 1.25 (0.72-2.17) 0.419 
ACE-inhibitors 77.5 86.6 1.19 (0.67-2.12) 0.545 
Clopidogrel 
loading dose 80.7 72.0 0.35 (0.14-0.92) 0.033 
Clopidogrel 
maintenance 
dose 
76.6 73.8 0.76 (0.56-1.04) 0.082 
Table 26. Effect of history of heart failure on outcome measures of QI programme 
4.3.2.9 Individual risk factors at presentation 
The individual factors assessed in sections 4.3.2.1 to 4.3.2.8 were combined so that patients 
could be analysed according to the number of ‘risk factors’ or comorbidities present. Patients 
were given a score of zero to seven and Table 27 and Figure 20 summarise the proportion 
of indicators achieved in each group. Data for a score of seven were omitted due to low 
numbers of patients. 
 
The proportion of indicators achieved for the composite outcome of all eight treatments 
decreased as the number of risk factors increased, and this pattern was also noted for 
coronary angiography, anticoagulation and ACE-inhibitors. Use of risk stratification however, 
tended to increase as the number of risk factors increased.  
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Outcome, % Risk factors 0 1 2 3 4 5 6 
Primary 
outcome 80.8 80.4 80.5 78.0 78.4 75.8 74.6 
Risk 
stratification 62.7 62.7 65.3 65.7 64.2 69.8 85.7 
Coronary 
angiography 61.6 59.7 60.1 52.5 51.8 43.4 20.0 
Anticoagulati
on 95.2 93.0 92.9 91.8 91.2 84.5 88.6 
Beta-
blockers 87.6 89.4 84.4 85.3 82.5 85.5 95.2 
 Statins 94.4 93.8 94.6 94.5 93.4 94.1 96.8 
ACE-
inhibitors 85.0 84.8 85.2 83.3 81.7 80.3 67.7 
Clopidogrel 
loading dose 85.5 84.5 83.2 79.7 82.6 73.8 74.2 
Clopidogrel 
maintenance 
dose 
82.9 83.9 82.4 76.8 83.3 81.6 79.3 
Table 27. Effect of number of risk factors/comorbidities on outcome 
 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6
%
 
Number of risk factors
Primary outcome
Risk stratification
Coronary angiography
Anticoagulation
Beta-blockers
 Statins
ACE-inhibitors
Clopidogrel loading dose
Clopidogrel maintenance dose
 
Figure 20. Rates of treatments for patients with 0-6 risk factors at baseline 
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4.3.2.10 Effect of patient risk category determined by GRACE on QI measures 
The primary (composite) outcome and individual treatments were evaluated for each of the 
three risk categories and the results are summarised in Table 28. There was a trend for rate 
of use of treatments to be highest in the low risk group and lowest in the high risk group.  
 
The composite outcome measure was significantly higher in the low risk group (78.6%) when 
compared with the high risk group (75.2%), with an OR of 0.79 (95% CI: 0.72-0.86, 
p<0.001), favouring the low risk category. A statistically significantly higher rate was also 
observed for the following individual quality indicators in the case of the low risk category:  
Coronary angiography, beta-blockers at discharge and clopidogrel maintenance dose.  
 
Significantly higher rates were also observed for the intermediate group compared with the 
high risk group for the majority of the indicators: the composite outcome measure, coronary 
angiography, beta-blockers at discharge, ACE-inhibitors at discharge and clopidogrel as a 
maintenance dose. 
 
Only one of the comparisons between the low and intermediate risk categories was 
statistically significant and that was coronary angiography at 61.5% in the low and 59.2% in 
the intermediate risk category. 
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Outcome 
% 
GRACE 
Low risk 
GRACE 
Intermediate 
risk 
GRACE 
High risk 
OR for inter 
vs low OR for high vs inter 
OR for high 
vs low 
Primary 
outcome 78.6 78.8       75.2       
0.98 
(0.90-1.07) 
p=0.657 
0.81 
(0.75-0.87) 
p<0.001 
0.79 
(0.72-0.86) 
p<0.001 
Risk 
stratification 61.3 63.9 61.5 
1.05 
(0.80-1.38) 
p=0.708 
0.80 
(0.62-1.02) 
p=0.076 
0.84 
(0.64-1.10) 
P=0.199 
Coronary 
angiography 62.4 58.1       52.2       
0.77 
(0.61-0.97) 
p=0.028 
0.73 
(0.59-0.89) 
p=0.002 
0.56 
(0.44-0.70) 
P<0.001 
Anticoagulati
on 92.5 90.6  91.7    
0.79 
(0.54-1.14) 
p=0.210 
1.14 
(0.82-1.58) 
p=0.432 
0.89 
(0.61-1.31) 
p=0.558 
Beta-blockers 81.9 82.6       78.7    
0.99 
(0.76-1.29) 
p=0.943 
0.76 
 (0.60-0.96) 
p=0.023 
0.75 
(0.57-0.97) 
p=0.031 
Statins 94.2 93.6       91.9   
0.88 
(0.58-1.35) 
p=0.563 
0.79 
 (0.55-1.13) 
p=0.197 
0.70 
(0.46-1.06) 
p=0.091 
ACE-
inhibitors 78.0 81.1  76.4     
1.15 
(0.89-1.49) 
p=0.277 
0.75 
 (0.59-0.94) 
p=0.015 
0.86 
(0.66-1.11) 
p=0.237 
Clopidogrel 
loading dose 81.0 81.2  77.3  
1.02 
(0.78-1.34) 
p=0.899 
0.79 
 (0.62-1.01) 
p=0.06 
0.80 
(0.61-1.05) 
p=0.110 
Clopidogrel 
maintenance 
dose 
77.6 79.3    72.2       
1.11 
(0.87-1.42) 
p=0.400 
0.66 
 (0.53-0.82) 
P<0.001 
0.74 
(0.58-0.94) 
p=0.013 
Table 28. Effect of patient risk on outcome for whole group (primary and secondary 
outcomes) 
4.3.2.11 Effect of risk category on treatment, taking time-period into account 
The effect of patient risk on treatment was also evaluated by time-period and the results are 
summarised in Table 29. The composite outcome improved for all categories after delivery of 
the QI intervention and the improvement was statistically significant in all cases. The only 
indicator which showed significant improvement for all risk categories after implementation of 
the QI programme was use of risk stratification. 
 
Anticoagulation and ACE-inhibitors showed significant improvement for patients classified as 
intermediate risk whilst use of clopidogrel loading dose improved significantly for both low 
and intermediate risk patients. Prescription of statins increased significantly for intermediate 
and high risk patients but the improvement noted for low risk patients was not statistically 
significant. 
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Outcome, % 
GRACE Low risk GRACE Intermediate risk GRACE High risk 
BL PQI 
OR 
95%CI 
p 
BL PQI OR 95%CI p BL PQI 
OR 95%CI 
p 
Primary 
outcome 76.7 82.6 
1.49 
(1.28-1.74) 
p<0.001 
76.6 83.0 
1.59 
(1.39-1.82) 
p<0.001 
74.2 78.8 
1.36 
(1.19-1.56) 
p<0.001 
Risk 
stratification 51.8 71.7 
4.66 
(2.95-7.37) 
p<0.001 
57.4 71.5 
3.88 
(2.64-5.70) 
p<0.001 
55.0 69.2 
4.14 
(2.78-6.18) 
<0.001 
Coronary 
angiography 63.4 61.4 
1.02 
(0.71-1.47) 
p=0.909 
54.2 62.6 
1.88 
(0.80-4.49) 
p=0.154 
51.1 53.6 
1.24 
(0.92-1.66) 
p=0.161 
Anticoagulation 91.7 93.4 
1.22 
(0.66-2.26) 
p=0.528 
88.4 93.4 
1.73 
(1.07-2.78) 
P=0.025 
91.1 92.5 
1.11 
(0.68-1.79) 
p=0.683 
Beta-blockers 87.7 96.2 
2.76 
(0.48-15.98) 
p=0.257 
87.6 89.9 
1.32 
(0.57-3.04) 
p=0.512 
79.8 85.8 
1.65 
(0.93-2.93) 
p=0.088 
Statins 93.4 95.0 
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(0.72-2.86) 
p=0.304 
91.9 96.1 
2.28 
(1.25-4.13) 
p=0.007 
90.9 94.6 
1.86
(1.07-3.25) 
p=0.028 
ACE-inhibitors 84.6 86.9 
1.16 
(0.65-2.08) 
p=0.618 
84.8 90.1 
2.08 
(1.28-3.38) 
p=0.003 
80.2 79.4 
1.02 
(0.70-1.49) 
p=0.908 
Clopidogrel 
loading dose 75.3 87.6 
2.70 
(1.71-4.27) 
p<0.001 
78.7 84.3 
1.66 
(1.15-2.39) 
p=0.007 
74.9 80.1 
1.29 
(0.91-1.83) 
p=0.148 
Clopidogrel 
maintenance 
dose 
78.3 81.7 
1.31 
(0.87-1.97) 
p=0.194 
80.8 83.2 
1.27 
(0.89-1.82) 
p=0.184 
75.3 80.3 
1.36 
(0.96-1.92) 
p=0.085 
Table 29. Effect of patient risk on ou tcome by time period (primary and secondar y 
outcomes). Data from baseline and post-QI intervention phase 
4.3.2.12 Effect of risk category on outcome, by allocation to QI intervention 
The outcomes were also evaluated by risk category and allocation to the QI intervention and 
the result are summarised in Table 30. Modest improvements were noted in all cases for the 
composite outcome but this did not achieve statistical significance. Use of risk stratification 
improved for all categories but again, this was not statistically significant. The remaining 
quality indicators showed either limited or no improvement. 
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Outcome 
% 
GRACE Low risk GRACE Intermediate risk GRACE High risk 
NQI QI OR NQI QI OR NQI QI OR 
Primary 
outcome 78.3 78.7 
0.92 
 (0.66-1.29) 
p=0.636 
78.7 78.9 
1.03 
(0.76-1.40) 
p=0.850 
74.6 75.7 
1.02 
(0.70-1.49) 
p=0.906 
Risk 
stratification 51.0 67.3 
1.60 
 (0.27-9.40) 
p=0.603 
60.5 66.2 
1.18 
 (0.22-6.25) 
p=0.849 
55.5 66.2 
2.07 
(0.32-13.32) 
p=0.445 
Coronary 
angiography 66.3 60.1 
0.58 
 (0.23-1.47) 
p=0.255 
57.7 58.3 
0.90 
 (0.37-2.15) 
p=0.809 
51.3 52.9 
0.79 
(0.28-2.22) 
p=0.648 
Anticoagulati
on 93.9 91.7 
1.26 
 (0.40-3.95) 
p=0.690 
91.6 90.0 
1.03 
(0.48-2.21) 
p=0.939 
90.5 92.7 
1.56 
(0.78-3.12) 
p=0.212 
Beta-
blockers 79.5 83.3 
1.27 
(0.74-2.19) 
p=0.383 
82.0 83.1 
1.07 
(0.64-1.78) 
p=0.791 
80.3 77.5 
0.91 
(0.48-1.74) 
p=0.774 
Statins 96.8 92.6 
0.45 
 (0.16-1.24) 
p=0.124 
95.1 92.6 
0.86 
 (0.38-1.95) 
p=0.726 
90.8 92.8 
1.65 
(0.67-4.04) 
p=0.275 
ACE-
inhibitors 74.6 80.0 
1.01 
 (0.46-2.18) 
p=0.986 
78.8 82.7 
1.18 
 (0.61-2.30) 
p=0.628 
74.4 77.8 
0.98 
(0.54-1.81) 
p=0.961 
Clopidogrel 
loading dose 83.3 79.8 
0.94 
 (0.37-2.36) 
p=0.895 
82.2 80.5 
1.47 
 (0.64-3.38) 
p=0.362 
80.9 74.5 
0.88 
(0.41-1.86) 
p=0.736 
Clopidogrel 
maintenance 
dose 
81.6 75.2 
0.65 
(0.41-1.04) 
p=0.07 
81.8 77.6 
0.77 
(0.48-1.24) 
p=0.285 
73.5 71.1 
0.87 
(0.54-1.42) 
p=0.582 
Table 30. Effect of patient risk on ou tcome by allocation (primary and secondar y 
outcomes) 
4.3.3 Effect of centre characteristics on outcome of QI programme 
4.3.3.1 Baseline performance 
The effect of baseline centre performance on the outcome of the QI intervention was 
assessed, taking time-period into account and the results are summarised in Table 31. 
Baseline performance was defined as the proportion of patients achieving the composite 
endpoint of all eight treatments at a centre during the baseline phase. Centres were split into 
two groups for this comparison; those below median baseline performance and those above 
the median, where median performance at baseline was 76.8%. The proportion of patients 
receiving all treatments increased by almost 10% in the low baseline performance group 
whereas in the high baseline performance group, this decreased by about 1%. Each of the 
individual treatments also increased more for the low baseline performance group, with four 
out of eight showing statistically significant improvements. 
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Outcome, % 
Baseline performance  
< median 
Baseline performance 
> median 
OR for 
below vs 
above 
median 
(95%CI) 
p-value 
Baseline 
phase 
Post-QI 
phase 
Baseline 
phase 
Post-QI 
phase 
Composite 
outcome 68.1 76.4 84.8 83.7 
1.62 
(1.40-1.86) <0.001 
Risk 
stratification 41.4 66.7 73.2 75.1 
8.28 
(5.09-13.48) <0.001 
Coronary 
angiography 43.7 48.7 70.8 70.2 
1.25 
(0.87-1.79) 0.23 
Anticoagulation 89.0 92.4 91.8 93.8 1.14 (0.62-2.09) 0.67 
Beta-blockers 76.3 73.3 89.0 87.6 0.94 (0.60-1.46) 0.78 
Statins 87.6 93.5 97.2 96.3 2.14 (0.98-4.70) 0.058 
ACE-inhibitors 71.9 78.1 85.6 80.9 1.85 (1.22-2.81) 0.004 
Clopidogrel 
loading dose 65.2 80.5 91.4 87.1 
3.45 
(2.12-5.61) <0.001 
Clopidogrel 
maintenance 
dose 
70.4 78.5 79.3 78.8 1.60 (1.15-2.40) 0.007 
Table 31. Effect of baseline performance (composite outcome) on outcome 
4.3.3.2 Country effect 
Analyses were performed to assess the effect of country on the outcome measures of the QI 
programme. Statistical tests have been omitted because the subgroups are small in each 
case. It can be seen in Table 32 that the composite outcome increased for all countries but 
the greatest improvement was observed for Spain. The lowest improvement occurred for the 
Polish centres which increased from 82% during the baseline phase to 85% after the QI 
intervention. 
 
Regarding the individual treatments, the largest improvements were observed for the 
Spanish centres which ranged from no change to an improvement of 45%, whereas the 
lowest changes occurred for the Polish centres which ranged from a decrease of 3% to an 
increase of 7%.  
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Outcome, % 
Spain Poland Italy UK France 
BL PQI BL PQI BL PQI BL PQI BL PQI 
Composite 
outcome 66.2 79.2 82.2 84.7 75.3 82.3 71.6 76.7 82.3 84.5 
Risk stratification 24.4 70.5 76.6 73.8 69.6 74.7 41.5 57.9 55.6 85.2 
Coronary 
angiography 52.6 58.0 65.7 73.3 62.6 60.3 27.7 30.1 76.9 79.1 
Anticoagulation 94.6 93.5 83.7 89.6 87.7 95.9 96.7 96.1 93.9 92.7 
Beta-blockers 75.9 77.8 95.7 92.7 65.5 93.3 71.4 95.7 87.1 81.5 
Statins 86.8 96.9 92.4 93.7 94.1 94.5 93.9 97.6 94.4 92.0 
ACE-inhibitors 72.5 84.0 95.8 94.9 70.7 81.4 81.8 76.4 68.0 75.3 
Clopidogrel 
loading dose 61.8 78.1 78.6 82.3 67.7 82.2 85.4 92.6 91.5 84.4 
Clopidogrel 
maintenance 
dose 
69.4 74.8 79.9 85.2 77.4 83.5 79.2 84.5 90.1 80.2 
Key: BL=Baseline phase; PQI=Post-QI implementation phase 
Table 32. Country effect 
4.3.3.3 Teaching hospital 
The effect of being admitted to a teaching hospital compared to a non-teaching hospital was 
also assessed. A teaching hospital was defined as any hospital with a routine undergraduate 
teaching programme. The results in Table 33 indicate that admission to a teaching hospital 
did not lead to improved management of non-ST elevation ACS as there is no difference 
observed between the two types of hospitals. 
 
The results for the two hospital types were also evaluated by comparing the pre and post-
intervention phases and it can be seen in Table 34 that the differences are similar in both 
groups. 
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Outcome, % 
Not a 
teaching 
hospital 
Teaching 
hospital 
OR for non-teaching 
vs teaching 
(95%CI) 
p-value 
Composite 
outcome 78.1 77.4 1.09 (0.73-1.62) 0.686 
Risk 
stratification 64.9 59.1 1.46 (0.18-12.19) 0.725 
Coronary 
angiography 59.4 57.0 0.77 (0.28-2.11) 0.606 
Anticoagulation 93.1 91.2 1.22 (0.58-2.57) 0.599 
Beta-blockers 79.6 81.7 1.19 (0.65-2.19) 0.572 
Statins 91.9 93.4 1.65 (0.70-3.89) 0.250 
ACE-inhibitors 78.5 79.9 1.11 (0.55-2.24) 0.779 
Clopidogrel 
loading dose 83.3 80.2 1.06 (0.45-2.50) 0.900 
Clopidogrel 
maintenance 
dose 
73.9 77.4 1.10 (0.67-1.81) 0.710 
Table 33. Effect of teaching hospital 
 
Outcome, % 
Not a teaching 
hospital Teaching hospital 
OR for non-
teaching vs 
teaching 
(95%CI) 
p-value 
Baseline 
phase 
Post-QI 
phase 
Baseline 
phase 
Post-QI 
phase 
Composite 
outcome 75.3 82.8 75.8 80.8 0.94 (0.77-1.15) 0.562 
Risk 
stratification 56.0 73.0 50.9 68.8 0.99 (0.47-2.06) 0.974 
Coronary 
angiography 56.5 62.0 55.2 59.0 0.96 (0.60-1.53) 0.852 
Anticoagulation 90.8 95.1 90.3 92.2 0.55 (0.23-1.28) 0.165 
Beta-blockers 82.1 90.2 85.5 87.8 0.90 (0.21-3.85) 0.889 
Statins 93.1 91.0 91.5 96.5 3.46 (1.46-8.20) 0.005 
ACE-inhibitors 82.1 86.1 84.5 84.9 1.03 (0.51-2.12) 0.926 
Clopidogrel 
loading dose 76.7 89.4 77.9 82.8 0.53 (0.28-1.00) 0.05 
Clopidogrel 
maintenance 
dose 
73.1 82.5 80.0 81.2 0.66 (0.38-1.17) 0.156 
Table 34. Effect of teaching hospital, taking time-period into account 
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4.3.3.4 Composite outcome by centres 
Individual centres were ranked in order of highest improvement to lowest to look for common 
factors which may influence the outcome of the QI intervention. The ranking of centres is 
summarised in Table 35 below which includes allocation, country and performance during 
the baseline and post-intervention phases respectively. The change from baseline to post-
intervention phase ranged from a decrease of 11% to an increase of 28%. 26 out of 38 
centres improved after the intervention, 10 centres showed a decrease in performance, one 
remained at the same level and one collected no data during the post-intervention phase. 
Fifteen out of the 26 centres that improved were allocated to receive the QI intervention 
whereas 6 out of 10 centres that decreased were non-QI centres. Three of the top five 
centres were Spanish hospitals. 
 
These results are also presented graphically in Figure 21 and Figure 22, split by allocation to 
QI. It can be seen that there is a trend for the QI centres to maintain or increase 
performance, whereas the majority of the non-QI centres either maintain or decrease 
performance. 
 
Centre 
rank 
Alloca-
tion Centre name Country 
Baseline 
phase 
(BL) 
Indicators 
achieved/ 
Indicators 
possible 
(%) 
Post-QI 
phase 
(PQI) 
Indicators 
achieved/ 
Indicators 
possible 
(%) 
Absolute 
change 
(PQI – BL) 
% 
1 QI 
Hospital 
Universitario 
Joan XXIII de 
Tarragona 
Spain 179/297 (60.3) 
284/321 
(88.5) 28.2 
2 QI Hospital de Terrassa Spain 
80/143 
(55.9) 
89/109 
(81.7) 25.8 
3 QI Szpital w Grojcu Poland 
117/204 
(57.4) 
179/223 
(80.3) 22.9 
4 QI 
Hospital 
Universitario 
Valle d’Hebron 
Spain 404/711 (56.8) 
518/678 
(76.4) 19.6 
5 Non-QI Ospedale Livorno Italy 
343/458 
(74.9) 
136/154 
(88.3) 13.4 
6 QI Antrim Area Hospital UK 
113/196 
(57.7) 
171/241 
(71.0) 13.3 
7 QI 
Swietokrzyskie 
Centrum 
Chorob Serca 
Poland 844/1107 (76.2) 
566/653 
(86.7) 10.5 
8 QI CHU de Grenoble France 
170/216 
(78.7) 
156/177 
(88.1) 9.4 
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Centre 
rank 
Alloca-
tion Centre name Country 
Baseline 
phase 
(BL) 
Indicators 
achieved/ 
Indicators 
possible 
(%) 
Post-QI 
phase 
(PQI) 
Indicators 
achieved/ 
Indicators 
possible 
(%) 
Absolute 
change 
(PQI – BL) 
% 
9 QI SPZOZ w Radomiu Poland 
150/183 
(82.0) 
202/222 
(91.0) 9 
10 Non-QI 
Hopitaux 
Drome de 
Romans-sur-
Isere 
France 70/92 (76.1) 
84/99 
(84.9) 8.8 
 11 QI 
Centre 
Hospitalier 
Guy Thomas 
de Riom 
France 46/60 (76.7) 
40/47 
(85.1) 8.4 
12 Non-QI 
Ospedale 
Civile di 
Mirano 
Italy 156/220 (70.9) 
167/214 
(78.0) 7.1 
13 Non-QI 
Hospital 
Universitario 
Germans Trias 
Spain 120/186 (64.5) 
174/245 
(71.0) 6.5 
14 Non-QI York District Hospital UK 
318/490 
(64.9) 
251/355 
(70.7) 5.8 
15 Non-QI 
Ospedale 
Generale 
Provinciale di 
Macerata 
Italy 146/209 (69.9) 
126/169 
(74.6) 4.7 
16 QI Barnet General Hospital UK 
402/489 
(82.2) 
465/538 
(86.4) 4.2 
17 QI Basildon Hospital UK 
297/393 
(75.6) 
244/307 
(79.5) 3.9 
18 Non-QI 
Centre 
Hospitalier 
d’Ussel 
France 10/13 (76.9) 
19/24 
(79.2) 2.3 
19 QI 
Ospedale 
Morgagni-
Pierantoni, 
Forli 
Italy 187/226 (82.7) 
133/157 
(84.7) 2.0 
19 Non-QI Hospital del Mar IMAS Spain 
162/200 
(81.0) 
151/182 
(83.0) 2.0 
20 Non-QI Hospital Josep Trueta Girona Spain 
290/356 
(81.5) 
346/415 
(83.4) 1.9 
21 QI 
Ospedale M. 
Bufalini - 
Cesena 
Italy 52/61 (82.3) 
291/347 
(83.9) 1.6 
21 Non-QI Szpital w Ciechanowie Poland 
174/217 
(80.2) 
117/143 
(81.8) 1.6 
21 Non-QI Szpital Zachodni Poland 
84/101 
(83.2) 
212/250 
(84.8) 1.6 
22 QI 
Medical 
Academy of 
Warsaw 
Poland 545/588 (92.7) 
330/352 
(93.8) 1.1 
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Centre 
rank 
Alloca-
tion Centre name Country 
Baseline 
phase 
(BL) 
Indicators 
achieved/ 
Indicators 
possible 
(%) 
Post-QI 
phase 
(PQI) 
Indicators 
achieved/ 
Indicators 
possible 
(%) 
Absolute 
change 
(PQI – BL) 
% 
23 QI 
Centre 
Hospitalier 
Pierre Bazin, 
Voiron 
France 45/59 (76.3) 
34/44 
(77.3) 1.0 
24 Non-QI Yeovil District Hospital UK 
116/183 
(63.4) 
97/153 
(63.4) 0.0 
25 Non-QI Szpital w Siedlcach Poland 
120/156 
(76.9) 
116/151 
(76.8) -0.1 
26 Non-QI Hopital G Montpied 2 France 
38/46 
(82.6) 
112/136 
(82.4) -0.2 
27 QI 
Royal Albert 
Edward 
Infirmary 
Wigan 
UK 174/238 (73.1) 
89/123 
(72.4) -0.7 
28 QI 
Centre 
Hospitalier de 
Chambery 
France 163/190 (85.8) 
54/64 
(84.4) -1.4 
29 Non-QI Dept A’ CHU G. Montpied France 
79/82 
(96.3) 
46/49 
(93.9) -2.4 
30 QI 
Centre 
Hospitalier 
d’Annecy 
France 113/135 (83.7) 
108/133 
(81.2) -2.5 
31 Non-QI 
Radomski 
Szpital 
Specjalistyczn
y 
Poland 157/173 (90.8) 
85/97 
(87.6) -3.2 
32 QI Szpital w Plocku Poland 
93/116 
(80.2) 
189/251 
(75.3) -4.9 
33 Non-QI Szpital we Wloclawku Poland 
605/669 
(90.4) 
259/317 
(81.7) -8.7 
34 Non-QI 
Hospital de 
Tortosa Virgen 
de la Cinta 
Spain 134/175 (76.6) 
86/133 
(64.7) -11.9 
N/A Non-QI Warwick Hospital UK 
39/53 
(73.6) 0/0 N/A 
Table 35. Composite outcome by centre 
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50
55
60
65
70
75
80
85
90
95
100
Baseline phase Post-QI phase
QI Centres
ES_TARRAGONA_JOAN_XXIII
ES_HOSPITAL_DE_TARRASA
PL_SZPITAL_W_GROJCU
ES_VALLE_DE_HEBRON
UK_ANTRIM_AREA_HOSPITAL
PL_SWIETOKRZYSKIE_CENTRUM
FR_CHU_DE_GRENOBLE
PL_SZP_SPZOZ_RADOMIU
FR_CENTRE_HOSPITALIER_DE_RIOM
UK_BARNET_GENERAL_HOSPITAL
UK_BASILDON_HOSPITAL
IT_FONDAZIONE_MZ_SACCO
IT_OSP_M_BUFALINI
PL_SP_CSK
FR_PIERRE_BAZIN
UK_ROYAL_ALBERT_EDWARD
FR_CEN_HOSP_DE_CHAMBERY
FR_REGION_D_ANNECY
PL_SZPITAL_W_PLOCKU
Figure 21. QI centres during baseline and post-QI phase 
 
50
55
60
65
70
75
80
85
90
95
100
Baseline phase Post-QI phase
Non-QI Centres
FR_ NORD_DE_ROMANS-SUR-ISERE
IT_OSPEDALE_CIVILE
ES_H_UNIV_GERMANS_TRIAS
UK_YORK_DISTRICT_HOSPITAL
IT_OSP_GENERALE_PROVINCIALE
IT_OSPEDALE_LIVORNO
FR_CENTRE_HOSPITALIER_D_USSEL
ES_HOSPITAL_DEL_MAR
ES_H_JOSEP_TRUETA_GIRONA
PL_SZPITAL_W_CIECHANOWIE
PL_SZPITAL_ZACHODNI
UK_YEOVIL_DISTRICT_HOSPITAL
PL_SZPITAL_W_SIEDLCACH
PL_SZPITAL_W_SIEDLCACH
FR_CHU_HOPITAL_G_MONTPIED
PL_RADOMSKI_SZPITAL_SPEC
PL_SZPITAL_WE_WLOCLAWKU
ES_HOSPITAL_DE_TORTOSA_VIRGEN
UK_WARWICK_HOSPITAL
Figure 22. Non-QI centres during baseline and post-QI phase 
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4.3.4 Multilevel mixed effects hierarchical model 
The influence of patient and centre characteristics on outcome of the QI intervention were 
considered in a mixed effects multivariate model. The model had two levels to account for 
factors at the patient and centre level. Allocation to QI, time-period and the interaction term 
for allocation and time-period were included as a co-variates. Two versions of the model 
were performed, the first using the composite of all eight ACS treatments as an outcome 
measure and the second using a composite of all ACS treatments except for risk 
stratification as the outcome measure. 
 
The results of the multivariate model assessing the composite of eight ACS treatments are 
summarised in Table 36. The factors associated with improved management, represented 
by the composite of eight treatments, were the interaction term of allocation to QI and post-
QI intervention phase, prior MI and number of cardiologists at a site. The factors associated 
with poorer outcome were female gender, prior stroke, CKD, history of heart failure and 
admission at a centre in the UK, Spain or Italy. Patients admitted to a QI hospital during the 
post-intervention phase were 84% more likely to receive all ACS treatments and those with a 
previous MI were 12% more likely to receive all eight treatments. Female patients were 8% 
less likely to receive all treatments and patients with a history of heart failure, CKD or prior 
stroke were 13-24% less likely to receive all eight guideline-recommended treatments.  
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Variable Odds ratio 95%CI p-value 
PQI phase 0.96 0.85-1.09 0.535 
Allocation to QI 0.93 0.79-1.09 0.374 
PQIxQI* 1.84 1.57-2.16 <0.001 
Female 0.92 0.84-0.99 0.046 
Age 1.00 0.99-1.01 0.939 
Age>65 0.94 0.81- 1.09 0.442 
Prior MI 1.12 1.03-1.23 0.011 
Chronic Kidney 
disease 0.76 0.66-0.88 <0.001 
Prior stroke 0.82 0.70-0.96 0.012 
History of HF 0.87 0.75-0.99 0.047 
Intermediate 
GRACE risk 1.15 0.98-1.27 0.109 
High GRACE risk 1.12 0.91-1.38 0.295 
Country 2 (France) 0.80 0.64-1.01 0.066 
Country 3 (Italy) 0.54 0.39-0.75 <0.001 
Country 4 (Spain) 0.63 0.48-0.82 0.001 
Country 5 (UK) 0.65 0.51-0.83 0.001 
Population served 1.00 1.00-1.00 0.012 
ACS admissions  1.00 1.00-1.00 0.749 
Cardiology beds 1.00 0.99-1.00 0.004 
Cardiologists 1.03 1.01-1.04 0.002 
PCI Facilities 0.97 0.80-1.17 0.751 
Baseline 
performance < 
median 
0.94 0.73-1.22 0.645 
*PQIxQI: Interaction of allocation to QI and post-QI intervention phase 
Table 36. Multivariate model to assess effect of patient and centre characteristics on 
composite outcome of eight ACS treatments 
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The results of the multivariate model assessing the composite of all ACS treatments except 
risk stratification are summarised in Table 37. The factors associated with improved 
management, represented by the composite of seven treatments, were the interaction term 
of allocation to QI and post-QI intervention phase, prior MI, risk stratification and on-site PCI 
facilities. The factors associated with poorer outcome were female gender, prior stroke, CKD 
and admission to a centre in Spain. Patients that were risk stratified were 22% more likely to 
receive the other seven ACS treatments. Patients admitted to a QI hospital during the post-
intervention phase were 26% more likely to receive all seven ACS treatments and those with 
a previous MI were 14% more likely to receive all seven treatments. Female patients were 
9% less likely to receive all treatments, patients with CKD were 30% less likely and those 
with prior stroke were 19% less likely to receive all seven guideline-recommended 
treatments.  
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Variable Odds ratio 95%CI p-value 
PQI phase 1.00 0.87-1.16 0.979 
Allocation to QI 0.82 0.66-1.02 0.071 
PQIxQI* 1.26 1.04-1.52 0.02 
Female 0.91 0.82-0.99 0.044 
Age 1.00 0.99-1.01 0.869 
Age>65 0.92 0.78-1.09 0.348 
Prior MI 1.14 1.03-1.26 0.013 
Chronic Kidney 
disease 0.70 0.60-0.82 <0.001 
Prior stroke 0.81 0.68-0.97 0.02 
History of HF 0.87 0.74-1.02 0.08 
Risk stratified 1.22 1.08-1.38 0.001 
Intermediate 
GRACE risk 1.11 0.95-1.29 0.181 
High GRACE risk 1.12 0.89-1.42 0.331 
Country 2 (France) 1.02 0.74-1.40 0.912 
Country 3 (Italy) 0.72 0.47-1.12 0.147 
Country 4 (Spain) 0.61 0.42-0.88 0.008 
Country 5 (UK) 0.78 0.55-1.10 0.152 
Population served 1.00 0.99-1.00 0.660 
ACS admissions  1.00 0.99-1.00 0.375 
Cardiology beds 0.99 0.98-1.00 0.036 
Cardiologists 1.01 0.99-1.04 0.193 
PCI Facilities 1.44 1.10-1.89 0.007 
Baseline 
performance < 
median 
1.29 0.91-1.83 0.148 
*PQIxQI: Interaction of allocation to QI and post-QI intervention phase 
Table 37. Multivariate model to assess effect of patient and centre characteristics on 
the composite of seven treatments 
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performance before and after the intervention indicated that centres allocated to the QI 
intervention showed, on average, greater improvement in the post-intervention phase. 
 
The influence of patient and centre characteristics on use of ACS treatments was assessed 
in two multi-level multivariate mixed effects models accounting for patient and centre effects 
The multivariate model assessing a composite outcome of eight ACS treatments showed 
that management of females, patients with CKD, a history of heart failure or prior stroke 
tended to be worse. Admission to hospitals in the UK, Spain or Italy was also associated 
with worse outcome. Patients admitted to a QI hospital during the post-QI intervention phase 
and those with a prior MI were more likely to receive all eight guideline-recommended 
treatments. The number of cardiologists at site was also associated with a small 
improvement in management. None of the other centre characteristics included in the multi-
variate model remained significant after adjusting for all covariates. It is reassuring that the 
effect of post-intervention phase and allocation to QI continues to be significant when 
adjusting for patient and centre characteristics. This suggests that the QI intervention was 
associated with improved management of non-ST elevation ACS patients irrespective of the 
type of hospital they were admitted to and the level of care before the intervention was 
delivered.  
 
A second multivariate model to assess the effect of patient and centre characteristics on a 
composite outcome measure of all ACS treatments excluding risk assessment showed that 
management of females, patients with CKD, prior stroke and those admitted to hospitals in 
Spain tended to be worse. Patients admitted to a QI hospital during the post-QI phase, those 
with a previous episode of MI, patients that have been risk stratified and those admitted to 
hospitals with on-site PCI facilities were more likely to receive all seven treatments.  
 
Comparison of the two multivariate models indicates that access to on-site PCI facilities may 
not be relevant for use of risk stratification but that this influences the composite of 
prescription of ACS treatments and use of coronary angiography. The effect of country is 
important when the endpoint considered includes risk stratification and this could be 
explained by the fact that risk stratification was low in each of Italy, Spain and the UK prior to 
implementation of the QI programme. When the outcome measure excludes risk 
stratification however, only Spain is associated with worse outcome. Importantly, use of risk 
stratification was independently associated with improved use of all other ACS treatments, 
indicating that appropriate risk scoring may lead to improved management of this group of 
patients. 
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4.4.2 Comparison with literature 
The paradox of higher patient risk and presence of co-morbidities corresponding to poorer 
management, observed in the univariate analyses performed in this chapter, is well-
documented in the literature.(Bhatt et al. 2004;Cohen et al. 2009;Fox et al. 2007b;Grabowski 
et al. 2011) Bhatt et al observed that patients with documented comorbidities or aged more 
than 75 years are less likely to be revascularised or managed with an early invasive 
strategy. Similarly, Fox et al noted that high risk patients were less likely to have 
angiography and PCI, irrespective of hospital or geography. Data from the CRUSADE 
study(Cohen et al. 2009;Tricoci et al. 2006) showed that high risk patients, defined as those 
with additional risk factors at presentation, receive less angiography and revascularisation 
but also reported that this leads to poorer prescription of ACS medications at discharge.  
 
Data published from the GRACE registry are consistent with the findings reported here, 
indicating that management of ACS patients with a history of heart failure is worse despite 
the fact that these patients have a poorer prognosis.(Steg et al. 2004) The literature also 
reports inferior use of guideline recommended treatments in the presence of chronic kidney 
disease, in line with the analyses presented in this chapter. Despite increased risk of MI and 
death patients with CKD are under-treated, receiving less angiography and lower rates of 
medications at discharge.(Asim and Jeffrey 2011;Department of Health 2013;Fox et al. 
2010a;Hanna, Chen, Roe, Wiviott, Fox, & Saucedo 2011;Patel et al. 2009;Tricoci, Peterson, 
& Roe 2006) 
 
It is possible that clinicians use a more conservative approach if co-morbidities are present 
but it is important to note that the ESC guidelines, which the goals of the QI programme 
were based on, recommend these treatments for all patients, except in the presence of 
contra-indications.(Hamm et al. 2011;Task Force for Diagnosis and Treatment of Non-ST-
Segment Elevation Acute Coronary Syndromes of European Society of Cardiology 2007)  
Both the 2007 guidelines and the update in 2011, specify that elderly patients, diabetic 
patients and those with chronic kidney disease, should receive the same first-line treatment 
as ACS patients without these risk factors.  
 
The fact that management of non-ST elevation in female patients is worse is also well 
documented in the literature, with data from the CRUSADE initiative demonstrating this in 
the case of catheterisation and medical treatment.(Blomkalns et al. 2005;Tavris et al. 
2010;Willingham and Kilpatrick 2005) The difference observed in the composite endpoint for 
the EQUIP-ACS study was small, at approximately 1%, but this remained statistically 
significant in both multivariate models. 
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 In contrast with the findings reported in this chapter, data from other quality improvement 
programmes indicate that hospital characteristics may influence management of ACS. Data 
from the Get-with-the-Guidelines Coronary Artery Disease (GTWG-CAD) programme(Lewis, 
Peterson, Cannon, Super, LaBresh, Quealy, Liang, & Fonarow 2008) indicated that teaching 
hospitals, volume and number of beds were associated with improved management. This QI 
programme is non-randomised which could account for the difference in findings between 
EQUIP-ACS and GWTG-CAD. In addition, the number of centres assessed is much higher 
than for EQUIP-ACS, so it is possible that EQUIP-ACS was not adequately powered to 
assess the effect of these hospital characteristics. 
 
A retrospective study of AMI care conducted in Japan also reported that a range of hospital 
characteristics are associated with variation in management. Volume of AMI admissions, 
number of cardiovascular specialists per case and whether a patient was treated in a private 
or public hospital were associated with improved management, whereas high performance 
at baseline was associated with poorer management.(Ukawa et al. 2014) Pooled data from 
three German AMI registries demonstrated that patients admitted to hospitals with cardiology 
departments received higher rates of recommended treatments than those admitted to 
hospitals without cardiology departments.(Gottwik et al. 2001)  
 
The BRIDGE-ACS trial, a randomised QI programme for ACS which took place in hospitals 
in Brazil, reported that presence of on-site PCI facilities was associated with improved 
management in a subgroup analysis.(Berwanger et al. for the BRIDGE-ACS Investigators 
2012b) This is consistent with the findings reported here for the composite outcome 
excluding risk stratification. 
 
It is possible that hospital characteristics explain some of the factors that facilitate improved 
management and guideline-adherence and that the EQUIP-ACS study was not adequately 
powered to demonstrate this, but there may also be other factors that have not been 
considered in the literature cited above. Bradley et al have shown that a range of hospital 
characteristics may explain improved prescription of beta-blockers for post-MI management 
but the effects observed are modest and the authors believe there must be other factors that 
drive improvement.(Bradley et al. 2004) In a separate study of AMI management, the same 
authors found a modest effect of hospital characteristics such as teaching status, number of 
hospital beds, volume of AMI admissions and location on mortality data. These 
characteristics provided a partial explanation for variation in mortality rates across hospitals 
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but the effect was limited and further factors were likely to explain the differences 
observed.(Bradley et al. 2010) 
 
Data from the CRUSADE study highlighted minor differences in management at teaching 
and non-teaching hospitals, with a trend for this to be superior at teaching hospitals. 
Management of ACS at both types of hospitals remained sub-optimal however and the effect 
was not consistent across all ACS treatments, i.e. prescription of medications was higher at 
academic hospitals whereas rates of invasive procedures were higher at non-teaching 
hospitals. The authors did not consider that hospital type was clearly associated with 
improved management but rather that individual hospitals had higher standards of care and 
that the reasons for this had not been determined.(Patel et al. 2007) 
 
The data presented in this chapter show that management of non-ST elevation ACS varies 
for different patient groups and is worse for female patients and those with co-morbidities. 
Adherence to guidelines varies at a range of hospitals but the reasons for this have not been 
elucidated. It is possible that hospital characteristics such as type, size and volume of 
admissions contribute to management of ACS admissions, but data from the EQUIP-ACS 
programme do not support this and the literature implies that these characteristics only 
provide a partial explanation for differences observed. There have been attempts to explain 
these differences using qualitative methods and questionnaires and these provide some 
evidence that factors such as involvement of senior managers and good teamwork may be 
important. (Brennan et al. 2013;Schouten et al. 2008a;Weiner et al. 2006) The effect of 
these and other contextual factors will be explored in a later chapter using qualitative 
methodology.  
4.4.3 Limitations 
The results reported in this chapter are based on retrospective, exploratory analyses of the 
data collected during the EQUIP-ACS programme. The trial was not powered to assess the 
influence of individual factors on the outcome of the QI intervention and particularly in the 
case of number of centres, it is likely that the number of hospitals is too low to detect an 
effect of hospital characteristics on the outcome of the QI intervention. 
 
The main trial excluded patients over 80 years of age so it is not possible to assess 
management of this patient group, nor whether the QI intervention could have improved this. 
The effect of age observed in univariate analyses was no longer statistically significant in the 
multivariate models but the effect of age cannot be excluded since patients over 80 years 
were not considered. 
Daphne Babalis PhD Thesis  Page 124 of 247 
 
? ???????????
??????? ????????????? ? ?????????? ??????? ??????? ?????????? ? ??????? ???? ????? ??? ???????
??????????????????????????????????????????????????????????????????????????????????????????
?????????? ??????????? ??? ??????? ?????????? ????????? ????? ????? ??????? ??? ????? ?? ???????? ???
??????????????????????????????? ????????????????????????????????????????? ????????????????????
????? ??? ??????? ??? ??????? ????? ??????????? ?????????????? ? ???????? ??? ??????????????
????????????? ???? ???? ????????? ????? ???????? ?????? ??? ????????? ????? ???? ??? ??????? ?????
???????????????????????????? ??????????????????????????????
? ?
?????????????????????????? ? ????????????????
?
 CHAPTER 5. Long term follow-up of EQUIP-
ACS project 
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 Baseline characteristics for the follow-up centres were similar to those for the whole group in 
each phase.  
Description  
All centres Follow-up centres only 
Baseline 
phase 
N = 1395 
Post-QI 
phase 
N = 1189 
Baseline 
phase 
N = 80 
Post-QI 
phase 
N = 61 
Post-study 
N = 218 
Demographics N(%)      
Age, years (mean [SD]) 65.4 [10.7] 65.8 [10.5] 63.7 [10.7] 64.3 [11.4] 64.5 [10.9] 
Male  973 (69.8) 823 (69.2) 53 (66.3) 45 (73.8) 159 (72.9) 
Diabetes 355 (25.6) 330 (27.8) 16 (20.0) 15 (24.6) 52 (23.9) 
Hypertension 923 (66.7) 787 (66.6) 50 (63.3) 33 (54.1) 106 (48.6) 
Smoker 357 (26.9) 287 (25.7) 25 (36.8) 15 (29.4) 76 (37.4) 
Prior MI 392 (28.6) 339 (28.7) 16 (20.0) 10 (16.4) 58 (26.6) 
History of heart failure 172 (12.5) 116 (9.8) 5 (6.3) 4 (6.6) 6 (2.8) 
Prior PCI 255 (18.4) 211 (17.9) 11 (13.8) 4 (6.6) 24 (11.1) 
Prior CABG 111 (8.0) 105 (8.9) 9 (11.3) 5 (8.2) 16 (7.3) 
Prior Stroke 86 (6.2) 69 (5.8) 3 (3.8) 6 (9.8) 15 (6.9) 
Renal disease 133 (9.7) 92 (7.8) 3 (3.7) 1 (1.6) 11 (5.1) 
Symptom onset to 
admission  
hours (median [IQR]) 
7 (3, 18.6) 6.8 (3, 17) 3.5 (1.5, 7.3) 3 (1.6, 7.7) 3.7 (2, 9.6) 
ST-depression on 
admission ECG 616 (44.4) 530 (44.6) 37 (46.3) 18 (29.5) 49 (22.5) 
Cardiac marker positive  
(according to local cut-
off) 
1,158 (83.3) 1,015 (85.4) 66 (82.5) 53 (86.9) 197 (90.4) 
Medications at 
admission      
ACE inhibitors  456 (37.6) 384 (36.5) 30 (37.5) 18 (29.5) 62 (28.4) 
A2 receptor blockers 144 (11.9) 130 (12.4) 8 (10.0) 5 (8.2) 20 (9.2) 
Warfarin 28 (2.3) 24 (2.3) 2 (2.5) 0 (0) 7 (3.2) 
Aspirin 542 (44.4) 456 (43.3) 38 (47.5) 27 (44.3) 87 (39.9) 
Clopidogrel 161 (13.1) 120 (11.3) 7 (8.8) 1 (1.6) 18 (8.3) 
Beta blockers 461 (38.2) 377 (35.8) 37 (46.3) 19 (31.2) 53 (24.4) 
Calcium antagonists  233 (19.3) 201 (19.1) 20 (25.0) 10 (16.4) 39 (17.9) 
Diuretics 304 (25.1) 234 (22.2) 19 (23.8) 9 (14.8) 42 (19.3) 
Statins 513 (42.2) 458 (43.5) 38 (47.5) 24 (39.3) 90 (41.3) 
Length of stay      
Length of stay, days 
(median [IQR]) 6 [4,9] 6 [4,9] 6 [4.5,11] 8 [6,10] 8 [6,12] 
Death      
Death in-hospital 24 (1.7) 20 (1.7) 5 (6.3) 0 (0) 7 (3.2) 
Discharge diagnosis      
Myocardial Infarction 857 (61.4) 770 (64.8) 55 (68.8) 49 (80.3) 182 (83.9) 
Unstable angina 468 (33.6) 342 (28.8) 19 (23.8) 7 (11.5) 32 (14.8) 
Table 38. Baseline characteristics 
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5.4.2 Composite and individual outcomes  
The composite outcome measure of all treatments and use of individual treatments were 
evaluated for the two follow-up centres during the baseline, post-intervention and follow-up 
phase of the study. The results are summarised in Table 39 and Figure 23 to Figure 31. 
5.4.2.1 Composite outcome measure 
The proportion of patients receiving all recommended treatments during the year following 
the study was 77.3% at the two follow-up centres, a result which was statistically significantly 
higher than the proportion during the baseline phase. The proportion of patients receiving all 
treatments in the follow-up phase is lower than that observed in the post-intervention phase 
but this result is not statistically significant. 
5.4.2.2 Individual treatments 
The rate of prescription for five out of eight treatments remained higher than at baseline 
during the follow-up phase, with two of these showing statistical significance; risk 
assessment and clopidogrel loading dose. Rate of prescription of individual treatments 
during the follow-up phase was lower than the post-QI implementation phase for each of the 
treatments but the results are not statistically significant. 
 
Use of coronary angiography at the follow-up centres was low throughout the study and was 
5% lower during the follow-up phase than at baseline. Rate of angiography was 28% during 
the baseline phase, 25% following implementation of the QI intervention and 22.5% during 
the follow-up phase. Use of anticoagulation and statins was maintained above 95% 
throughout. 
 
The proportion of patients receiving the individual treatments are shown by time period in 
Figure 23 to Figure 31 for the two centres and for the group overall. 
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Quality Indicators 
All presented as 
N/D(%) 
Baseline 
phase 
N = 80 
Post-QI 
phase 
N= 61 
Post-study 
N=218 
OR (95%CI) 
p-value 
(Baseline vs 
Post-QI) 
OR 
(95%CI) 
p-value 
(Baseline 
vs Post 
Study) 
OR (95%CI) 
p-value 
(Post-QI vs 
Post Study) 
Composite endpoint 375/531 (70.6) 
333/416 
(80.1) 
1,121/1,450 
(77.3) 
1.67 
(1.23-2.26) 
p=0.001 
1.41 
(1.12-1.76) 
p=0.003 
0.85 
(0.65-1.11) 
p=0.236 
Risk stratification 36/80 (45.0) 
47/61 
(77.1) 
148/218 
(67.9) 
4.44 
(2.06-9.59) 
p<0.001 
2.59 
(1.50-4.45) 
p=0.001 
0.61 
(0.31-1.19) 
P=0.147 
Coronary 
Angiography 
22/79 
(27.9) 
15/61 
(24.6) 
49/218 
(22.5) 
0.85 
(0.39-1.83) 
P=0.670 
0.77 
(0.42-1.38) 
p=0.379 
0.92 
(0.47-1.80) 
p=0.800 
Anticoagulation 80/80 (100) 
59/61 
(96.7) 
210/218 
(96.3) N/A N/A 
0.89 
(0.18-4.30) 
p=0.885 
Beta-blockers 11/18 (61.1) 
20/20 
(100) 
29/38 
(76.3) N/A 
2.05 
(0.61-6.86) 
p= 0.244 
N/A 
Statins 72/75 (96.0) 
60/61 
(98.4) 
201/210 
(95.7) 
2.50 
(0.25-24.66) 
p= 0.433 
0.93 
(0.25-3.53) 
p=0.916 
0.37 
(0.05-3.00) 
p=0.353 
ACE-inhibitors 37/53 (69.8) 
34/40 
(85.0) 
110/134 
(82.1) 
2.54 
(0.88-7.31) 
p= 0.084 
1.93 
(0.92-4.04) 
p= 0.083 
0.81 
(0.31-2.14) 
p=0.669 
Clopidogrel loading 
dose 
60/79 
(76.0) 
54/59 
(91.5) 
194/215 
(90.2) 
3.42 
(1.19-9.81) 
p= 0.022 
2.91 
(1.46-5.78) 
p=0.002 
0.86 
(0.31-2.37) 
p=0.764 
Clopidogrel 
maintenance dose 
57/67 
(85.1) 
44/53 
(83.0) 
180/199 
(90.5) 
0.86 
(0.32-2.31) 
p= 0.765 
1.64 
(0.72-3.74) 
p= 0.242 
1.88 
(0.79-4.48) 
p=0.152 
Table 39. Composite outcome and individual outcomes at follow-up centres  
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Figure 23. Percentage of patients receiving all treatments (composite outcome) 
Key 
Time period: 1 = Baseline phase; 2=Post-intervention phase; 3=Post-study phase 
● = Basildon hospital 
○ = Terrassa hospital 
+ = Mean percentage 
 
 
Figure 24. Percentage of patients risk stratified 
Key 
Time period: 1 = Baseline phase; 2=Post-intervention phase; 3=Post-study phase 
● = Basildon hospital 
○ = Terrassa hospital 
+ = Mean percentage 
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Figure 25. Percentage of patients receiving coronary angiography 
Key 
Time period: 1 = Baseline phase; 2=Post-intervention phase; 3=Post-study phase 
● = Basildon hospital 
○ = Terrassa hospital 
+ = Mean percentage 
 
 
Figure 26. Percentage of patients receiving anticoagulation 
Key 
Time period: 1 = Baseline phase; 2=Post-intervention phase; 3=Post-study phase 
● = Basildon hospital 
○ = Terrassa hospital 
+ = Mean percentage 
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Figure 27. Percentage of patients receiving beta-blockers 
Key 
Time period: 1 = Baseline phase; 2=Post-intervention phase; 3=Post-study phase 
● = Basildon hospital 
○ = Terrassa hospital 
+ = Mean percentage 
 
 
Figure 28. Percentage of patients receiving statins 
Key 
Time period: 1 = Baseline phase; 2=Post-intervention phase; 3=Post-study phase 
● = Basildon hospital 
○ = Terrassa hospital 
+ = Mean percentage 
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Figure 29. Percentage of patients receiving ACE-inhibitors 
Key 
Time period: 1 = Baseline phase; 2=Post-intervention phase; 3=Post-study phase 
● = Basildon hospital 
○ = Terrassa hospital 
+ = Mean percentage 
 
Figure 30. Percentage of patients receiving clopidogrel loading dose 
Key 
Time period: 1 = Baseline phase; 2=Post-intervention phase; 3=Post-study phase 
● = Basildon hospital 
○ = Terrassa hospital 
+ = Mean percentage 
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Figure 31. Percentage of patients receiving clopidogrel at discharge 
Key 
Time period: 1 = Baseline phase; 2=Post-intervention phase; 3=Post-study phase 
● = Basildon hospital 
○ = Terrassa hospital 
+ = Mean percentage 
 
5.4.2.3 Results assessed by age 
The composite outcome measure and individual treatments were also analysed by age, 
using median age of 65 years as the cut-off. The results are summarised in Table 40 and it 
can be seen that there is a trend for patients above 65 years to be under-treated. This is 
consistent across all three time-periods but, as the numbers analysed are small, the 
numerical differences observed were not statistically significant. 
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than at the start, with only 22% of patients receiving angiography in accordance with the 
ESC guideline recommendations.(Task Force for Diagnosis and Treatment of Non-ST-
Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, 
Bassand, Ardissino, Boersma, Budaj, Fernandez-Avila, Fox, Hasdai, Ohman, Wallentin, & 
Wijns 2007) Access to angiography facilities could be an important factor; Hospital de 
Terrassa did not have PCI facilities on-site and although Basildon hospital did, the same 
facility served three District General Hospitals and Basildon patients were not prioritised over 
the other hospitals despite their proximity to the service. Discussions during the QI 
programme meetings and the semi-structured interviews which will be discussed in the next 
chapter highlighted that delivering angiography within 3 days of admission was challenging 
at many of the sites. Taking this into account, the data were re-analysed to evaluate the 
number of days from admission to angiography. 
 
Figure 32 summarises the data for the follow-up centres, showing that the majority of 
patients received angiography within 6 days of admission. Comparing this to Figure 33 which 
summarises the data for all centres during the study phase, it can be seen that patients in 
the whole group received angiography in a shorter time-period than at the two follow-up 
centres. It can perhaps be assumed that patients admitted to these two centres were being 
referred for angiography but the centres were not able to deliver the service within 3 days, as 
recommended by the ESC guidelines. 
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Figure 32. Days from admission to angiography at follow-up centres 
 
Figure 33. Days from admission to angiography at all centres 
5.5.2 Long term results of other QI programmes 
The Get-With-The-Guidelines Coronary Artery Disease (GWTG-CAD) programme reported 
results from three 12-month time-periods for GWTG-CAD hospitals compared to hospitals 
not participating in the programme. The results confirmed that higher performance at the 
GWTG-CAD hospitals was sustained over time when compared with non GWTG-CAD 
hospitals. The hospitals participating in the programme maintained higher levels in six pre-
specified performance measures over the three 12-month periods but the difference 
between the groups decreased over time. Differences were also modest, ranging from 1 to 
3% for the six performance measures. GWTG is an ongoing QI programme involving public 
reporting of results and a performance recognition programme.(Xian et al. 2010) 
 
 
0
.0
5
.1
.1
5
.2
.2
5
D
en
si
ty
0 5 10 15 20
angiodays
0
.0
5
.1
.1
5
.2
D
en
si
ty
0 10 20 30
angiodays
Daphne Babalis PhD Thesis  Page 138 of 247 
 
The QUICC programme included a range of hospitals signed up to the Swedish RIKS-HIA 
myocardial infarction registry which enabled long-term results of the QI intervention to be 
assessed.(Carlhed et al. for the QUICC study group 2006) The authors reported results 
obtained during a 6-month measurement period which took place 6 months after the end of 
the initial programme.(Carlhed et al. Further improvement or sustained results were 
observed in four out of five quality indicators but this was accompanied by an improvement 
in the control group. The difference between performance at QUICC and control hospitals 
was smaller during the follow-up phase and only use of clopidogrel achieved statistically 
higher improvement. The authors explain the improvement observed at control centres by 
the fact that RIKS-HIA data was made public for all hospitals between the two measurement 
periods (May 2003 – Apr 2004 vs Aug 2004 to Jan 2005). One of the long term aims of the 
QUICC programme had been to assess whether the QI initiative led to improvement in 
measures that were not directly targeted by the programme, e.g. echocardiography or stress 
testing, but no effect on other indicators was observed. The authors hypothesised that all 
measures requiring improvement should be included in a QI programme from the start in 
order to have an impact on these. Continued data collection via a national registry also 
enabled the QUICC group to assess the effect of the QI intervention on clinical outcomes at 
one year. Numerical improvement was noted but this was not statistically significant.(Carlhed 
et al. 2009;Carlhed et al. 2012) 
 
The GAP investigators also reported results at GAP hospitals one year after the project. 
Rates of in-hospital medications remained high but were numerically lower than at baseline, 
with the exception of early beta-blockers which had increased. Use of discharge treatments 
however, had reverted to levels recorded before the GAP intervention was delivered. The 
authors suggest that continued data collection and real-time feedback to all participating 
hospitals would enable sustainability of increased guideline-adherence. (Olomu et al. 2014) 
 
Benzer et al reported evidence of long term sustainability following removal of a pay-for-
performance incentive across Veteran Health Administration hospitals. This was assessed 
by a range of measures including three for ACS. Data were observed over a seven-year 
period and it was noted that improvement achieved during the pay-for-performance period 
was sustained for up to three years following removal of the incentive.(Benzer et al. 2014) 
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5.5.3 Factors influencing sustainability 
A review of evaluation reports from five Health Foundation QI initiatives and associated 
literature identified 10 key challenges in delivering improvement work.(Dixon-Woods et al. 
2012) Two of these challenges focused on what happens after the end of an initiative and 
whether results are sustained. The first challenge affecting sustainability of a QI initiative is 
that QI work is perceived as a standalone project and there is no incentive to continue 
improvement work after the project has finished. Clinicians focus on other priorities which 
are considered more important once the project is complete. The authors also cite resource 
as an important factor i.e. if the intervention is not cost neutral or low cost, it is unlikely to 
continue or indeed spread to other work processes.(Ling et al. 2010) It is important to think 
about how change can spread to other work processes and departments and to put systems 
in place to enable this from the outset. (The Health Foundation. 2011a;Walmsley and Miller 
2008) The authors also noted that changes to policies and infrastructure at the 
organisational level would be required for results to spread beyond the initial project target 
group.(Bate et al. 2008) The second challenge relating to sustainability is that there could be 
unexpected side effects of a QI intervention; if the intervention is unsuccessful or requires 
clinicians to invest their own resource for it to succeed, their opinion of QI work in general 
could be tainted.(The Health Foundation. 2011b;Wachter 2006) 
 
Bowman and Sobo have also remarked that plans for long-term results of a QI initiative need 
to be implemented from the start to prevent performance reverting to baseline levels after 
delivery of a programme. They also noted that there are three models of sustainability: a) 
results drop but remain above baseline, b) results revert to baseline or drop to levels below 
those observed at baseline c) improvement is sustained due to continued low level QI 
activity at regular intervals. They consider that the first two could occur if resource or tools 
introduced during delivery of the QI intervention are withdrawn immediately following the end 
of a project. (Bowman et al. 2008)  
 
These observations from the literature support the results reported in this chapter as 
performance at the two EQUIP-ACS follow-up centres remained above that observed at 
baseline after the end of the study. Implementation of QI work did not require significant 
resource from the local teams, except for commitment of staff time, but there were no further 
meetings or publications of results planned during the follow-up phase. 
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5.5.4 Implications of results 
Further research is needed to understand how improvement can be sustained over time. 
Analyses reported in this chapter show that performance remains above baseline levels after 
the end of a QI programme but management of ACS remains sub-optimal as approximately 
20% of patients are not receiving guideline-recommended treatments. Further improvement 
is not observed and there is concern that over time, performance will revert back to baseline 
levels. Research using qualitative methodology could provide valuable insight into factors 
that enable or inhibit sustainability.(Bowman, Sobo, Asch, & Gifford 2008). In particular, this 
is because the influence of clinicians’ perceptions of QI work could explain a reluctance to 
continue improvement work and a resulting lack of sustainability. If clinicians are not 
convinced that improvement achieved by a QI intervention is clinically significant, they are 
unlikely to continue using the intervention, an effect that has also been observed for 
medicinal interventions.(Carlhed, Bellman, Bojestig, Bojö, Peterson, & Lindahl 2012)  
 
A qualitative study performed by Hovlid et al, revealed the importance of analysing work 
processes and reflecting on ‘defects’ or errors in systems in order to gain a deeper 
understanding of existing clinical pathways and how these can be improved. The authors 
refer to the concept of ‘double-loop learning’ which occurs when individuals correct or 
change inadequate practice and simultaneously, the underlying system responsible for the 
sub-optimal process is also corrected. This implies that local individual practice and 
organisational systems are aligned and leads to an improved care process which is 
sustained.(Hovlid et al. 2012) 
 
Researchers in whole system transformation, which is the practice of implementing 
improvement work across whole services or even health systems, have commented that 
sustainability can only be achieved when results achieved by QI work become standard 
practice. This happens when processes and standards of care have changed and 
importantly, the organisations and underlying systems supporting these processes have 
altered.(Greenhalgh et al. 2012;NHS Modernisation Agency 2002;Ovretveit 2011;Scheirer 
and Dearing 2011) 
 
In addition to sustaining improved standards of care, the goal of QI work should be for 
improvement to extend to other measures over time. An improved process should ultimately 
mean that all indicators of patient care are affected, irrespective of whether these were 
targeted by the QI intervention. It is likely that the EQUIP-ACS QI intervention was perceived 
as a standalone project by the clinical teams taking part. Following the end of the study, new 
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CHAPTER 6. Qualitative evaluation of EQUIP-
ACS 
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6.3.3 Selection of participants within centres 
The QI teams set up within each QI centre were approached in order to obtain a range of 
perspectives on how the QI intervention was delivered within a centre. Local QI teams 
consisted of key members of staff responsible for overseeing the implementation of the QI 
intervention at a local level during the EQUIP-ACS programme.  
 
15 interviews were conducted and participants approached included consultant cardiologists, 
cardiology registrars, research nurses, ward nurses and individuals involved in managing 
and delivering the QI programmes, defined as ‘QI researchers’.  
6.3.4 Semi-structured interviews 
The method selected for this aspect of the research was the semi-structured interview as 
this allows for some themes and questions to be pre-specified, based on assumptions about 
the delivery of the QI programme but also for individual views to be sought. In a semi-
structured interview, the interviewer prepares an interview guide in order to direct the 
interview and additional areas for discussion may arise during the course of the interview. 
The interview questions do not necessarily have to be asked in the order they appear in the 
guide, and this allows the discussion to flow naturally and means there is opportunity for new 
discussion topics to arise. The interview guide can be amended to include new relevant 
themes throughout the research process. 
 
Interviews lasted between 45 and 60 minutes and were conducted in a quiet room chosen by 
the participant, usually at the participant’s hospital. At the end of the interview the 
participants were shown results obtained at their individual centres throughout the QI 
programme as well as the main study results, and the final section of the interview was a 
discussion about these. 
6.3.5 Interview guide 
A pilot interview was conducted with one of the QI researchers in order to test the timing, the 
first version of the interview guide and the flow of the discussion. The interview guide was 
amended after 6 interviews to include some of the new recurrent themes that were 
considered relevant. The final version of the interview guide is provided in Table 41 below. 
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 1. Quality Improvement experience 
• Tell me about your experience in QI to date? Have you been involved in previous studies, 
audits, own projects? 
• What sort of QI work are you/your hospital/other department planning? 
2. EQUIP experience 
• Let’s talk about the EQUIP study.   
i. Could you summarise what you remember about the way the QI training was 
delivered? 
ii. Which of the tools or methods that were reviewed made the most impression if 
any? Could you expand on that? 
• Tell me about your QI team  
i. How did you decide who the members would be? 
ii. How often did you meet and what was discussed? 
iii. What would you change about your local QI team/meetings if you had a 
second chance? 
iv. Publication/sharing of results and local projects – reactions from those not on 
the QI team 
• You may remember that each team developed their own change concepts i.e. ideas to 
improve work processes. 
i. Describe some that you remember working on? 
ii. Please expand on that- why do you think it succeeded? Why do you think it 
didn’t succeed? Were they readily adopted? 
iii. What were the main problems you and your colleagues faced in managing 
patients with Acute Coronary Syndromes? 
iv. What are they now? Why do you think that is the case? 
3. Quality Indicators 
• Are these appropriate? 
• Talk about barriers to achieving optimal levels of each 
• Risk stratification 
4. Let’s look at some results from the study 
• Your centre after the QI programme- what do you think? 
• If you were able to measure the results for these same goals today how do you think your 
hospital would perform? 
• Summary of overall study results presented. What does this mean to you? Do you think this 
is worthwhile? 
Table 41. Interview guide 
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 Item Category Number 
Centres  5 
Participants  15 
Age 
30-39 1 
40-49 6 
50-59 8 
Gender 
Female 8 
Male 7 
Role 
Consultant cardiologist 4 
Cardiology registrar 1 
Research nurse 3 
Ward nurse 3 
QI researcher 4 
Table 42. Participant characteristics 
 
The participants are listed by pseudonym in Table 43. 
 
Pseudonym Role Hospital 
Adrian Consultant cardiologist 4 
Elsa Ward nurse 4 
Fatima QI researcher 1 
Fred Consultant cardiologist 2 
Gareth Cardiology registrar 2 
Jacob Consultant cardiologist 5 
Janet Research nurse 2 
Jim Consultant cardiologist 3 
Lisa Research nurse 3 
Louise Ward nurse 3 
Marina Research nurse 4 
Mike QI researcher 1 
Rima QI researcher 1 
Sara Ward nurse 3 
Tom QI researcher 5 
Table 43. Participants 
6.4.2 Key themes identified 
Analysis of interview content led to identification of 6 key themes. The key themes identified 
were: (i) barriers to delivering optimal patient care, (ii) Factors that facilitate outcome i.e. 
“success factors”, (iii) planning and implementation of QI work, (iv) Quality indicators or 
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Goals, (v) Reactions to the QI programme implemented and (vi) Interpretation and 
implication of results. 
 
The themes and sub-themes coded within them, are summarised in Table 44 below. 
 
Theme Sub-themes Number of 
interviews 
Number of 
references 
Barriers to delivering 
optimal patient care 
Resources 
Process 
Staff attitudes 
Disagreement with guidelines 
Organisational factors and policies 
High baseline performance 
14 
12 
10 
5 
5 
2 
100 
68 
22 
12 
12 
4 
Success factors Incentives 
Factors influencing QI programme & 
meetings  
Leadership 
Process 
Expertise and training/credibility 
Communication 
Room for improvement  
Organisational culture 
15 
14 
 
12 
14 
14 
9 
2 
1 
116 
69 
 
57 
56 
39 
17 
3 
2 
Planning and 
implementing QI 
work 
QI team 
Measurement 
QI tools/ ideas for improvement  
QI meetings 
15 
13 
12 
7 
80 
49 
48 
26 
Quality indicators Goals of the QI programme 
Risk stratification 
ACS medications 
Coronary angiography    
9 
14 
13 
13 
13 
137 
79 
61 
Reactions to QI Positive reactions 
Negative reactions 
15 
9 
60 
50 
Interpretation and 
implications for future 
work, sustainability 
Sustainability  
Interpretation of results 
Ongoing improvement work 
13 
9 
5 
43 
24 
8 
Table 44. Themes and sub-themes 
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6.4.2.1 Barriers to delivering optimal patient care  
Interviewees were asked to identify the main factors they believed prevented their centres 
from delivering optimal care to non-ST elevation ACS patients with reference to the 
guideline-recommended goals set for the QI programme. Results for each centre, based on 
the eight quality indicators chosen for the QI programme, were reviewed during the 
interviews to aid this process.  
(i) Resources  
Lack of resources was most frequently cited as the obstacle to achieving optimal patient 
care, this was discussed in 14 out of 15 interviews. Discussion around this topic revealed 
that lack of resource in terms of staff, time and funding were all important.    
 
One of the ward nurses who was a member of the local QI team, commented on the lack of 
time to carry out her work:  
“So I could start doing it and then I’d be bleeped and as I said, my 
colleague’s on mat[ernity] leave, so I’m doing the work of two, it’s a bit, 
clinical work has been severely compromised.” 
A consultant in the QI team at a different centre emphasised the problem of constant bed 
pressure affecting the level of care delivered:  
“One of the things that we all find a bit frustrating is the perpetual bed crisis 
that tends to exist in this hospital, and I suspect a lot of district general 
hospitals where there are often bed pressures, there are targets that A&E 
have to deliver, they’ve got, no guest is allowed to wait more than four 
hours, and those pressures are transmitted to the bed managers who are 
trying just to offload patients into whichever bed is available, rather than 
the most appropriate bed.”  
 
The same interviewee talked about the problems caused by frequent staff changes, 
particularly junior doctors and this was a theme that came up in 5 out of 15 interviews. 
“Well, it’s very difficult you know, because one of the problems is that 
every few months you have another change, another intake comes in, and 
again it’s a constant battle trying to keep that awareness.  They’re also, in 
fairness, stretched...” 
It was also noted, during at least half the interviews, that staff levels were reduced over 
weekends, holidays and out of hours. The exchange below demonstrates how, at one of the 
district general hospitals, patients would not usually be seen by a cardiologist if admitted 
over the weekend. 
“Interviewer: So when would they actually be seen by a cardiologist? 
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So, within 24 hours.   
Interviewer: Even if it’s a weekend? 
That’s a good point. Not on weekends. But during the week from Monday 
to Friday, 24 hours, within 24 hours unless it’s a weekend. 
Interviewer: Was there never a cardiologist on a weekend on-call? 
Not really, no.  They had a nominal cardiologist that you could phone I 
remember, but they wouldn’t necessarily do a ward round” 
A similar issue was described by staff at other centres and this was particularly relevant for 
patients that may need to be referred for angiography or PCI, if they were admitted just 
before or during a holiday period such as Christmas, they could be waiting up to a week for a 
referral. Sara described how patients admitted to her centre on a Friday afternoon would 
have to wait until Monday to be reviewed for angiography and over bank holiday periods this 
would be even longer: 
“Well if you come in on Christmas Eve this year, people are not back till 
Wednesday, because Monday, Tuesday are bank holidays, so nobody is in 
properly until Wednesday.  So you’ve got four or five days before you’re 
even actually seen and reviewed and, plus until all the lists then get up and 
running again because there’ll be smaller lists in between Christmas and 
New Year, so.” 
(ii) Process 
Factors relating to the way a work process is delivered or managed were also discussed 
frequently during the interviews. The more complex a process was and the more members 
of staff it involved, the less likely it was to be successful. Staff mentioned that additional 
administrative or screening steps could delay processes and lengthy paperwork could add 
further delays or result in important steps being missed if they are too cumbersome. One of 
the consultants cited an example of a clinical pathway that needs to be completed prior to a 
surgical procedure: 
“And the fundamental problem with it is that the key things like the 
checklist before the patient goes down to theatre, making sure this side is 
marked, all that, that is tucked away on page 20 of page 87, and when I 
spoke to some of the nursing staff, they didn’t even know it existed.” 
Processes involving steps that depend on a decision being made were clearly more difficult 
to control and staff accepted that it would be more challenging to achieve high standards in 
these cases. The requirement for a ‘decision’ could be any of the following: the need to 
confer with a consultant prior to a referral or prescription, the need to check contraindications 
in the case of ACS medications or choosing a treatment where there is more than one 
equivalent option available.  
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Similarly, if a process involves multiple members of staff, it is more difficult to have an impact 
on it and ensure that it is carried out correctly each time. Rima gave an example of this: 
“And I think the risk stratification and the drugs it’s because they’re easy to 
impact on because it’s just one person who’s got to prescribe and if it’s a 
nurse looking at it and then she goes to the doctor’s and says, well, you 
didn’t prescribe beta blockers in this patient, why didn’t you, blah, blah, 
blah.  And then the next time the doctor might remember that he’s 
supposed to do that whereas the whole angiography I think that is a whole 
different ballgame because it’s not just one doctor or one nurse it’s a lot of 
people involved.” 
(iii) Staff attitudes 
A range of factors that derive from staff attitudes and behaviour also appeared to be 
important. The majority of interviewees, nine out of fifteen, talked about members of staff 
being complacent and completing paperwork in the medical records absent-mindedly. New 
alert systems or pathways may have been introduced but once these have been in place for 
extended periods of time, they may no longer serve their purpose. 
 
Sara had observed that ACS prescriptions are sometimes missed even though the care 
pathway prompts this: 
“The more familiar people become with things they just tick boxes rather 
than actually look at what they’re ticking because there are still times when 
you find patients that although throughout their ICP they will have had, 
clopidogrel has been started and you find out that it hasn’t at the end of the 
day when they go home, so you know, things do get missed with the best 
will in the world.” 
Jim also felt that staff don’t always pay attention to the pathway documents and simply 
complete them without carrying out the required actions: 
“And the danger with pathways which are that long is you see people 
mindlessly go through, just tick all the boxes, because they know. All they 
have to do is tick, tick, tick, tick, tick, tick, sign, but actually all that people 
have done is tick the boxes, it doesn’t mean they’ve actually done the stuff, 
that’s the problem”. 
A poor knowledge of local standards of care meant that some staff did not query how a 
process was delivered. Interviewees commented that they had been unaware of their own 
standards of care and also talked about other members of staff that assumed treatments 
were appropriately prescribed and were not aware that paperwork was completed 
incorrectly, as per the examples cited above. This poor knowledge of how treatments are 
delivered led to incorrect decisions in some cases and to treatments being missed. 
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Individual as well as team attitudes are important in determining how a process is delivered 
and this means that if a change is required to overcome a barrier, it may be necessary to 
change the way an individual or team behaves, which is challenging. Interestingly, the action 
of simply missing or forgetting to prescribe a guideline-recommended medication is 
dismissed as a human error during the interviews, and accepted rather than questioned.  
(iv) Disagreement with guidelines 
The indicators used to evaluate management of patients with non-ST elevation ACS were 
based on the latest ESC guideline recommendations and whilst the majority of clinicians 
taking part in the QI programme agreed that these were appropriate, interviewees talked 
about colleagues that didn’t always agree with the recommended ACS treatments. If 
consultants were not convinced by the evidence for some of the treatments, they may not 
have prescribed these and it would have been difficult to alter their opinion. Rima recalled an 
example of this from the meetings: 
“And then there were other things to do with some of the doctors, not some 
of the doctors, when the evidence is out there some people take it on 
board and some people disagree with the evidence.  Because I can 
remember clopidogrel but say somebody might have a preference not for 
clopidogrel but one of the other antiplatelet agents so maybe if they’d been 
trained by another consultant or something that wasn’t quite in agreement 
then they may decide not to prescribe something.” 
(v) Organisational factors and policies 
As well as individual attitudes and views on management of patients, there may be 
departmental or organisational policies which define how patients are treated in any given 
hospital. A consultant cardiologist at one of the centres described the fact that a local policy 
did not support the use of clopidogrel, which meant that prescriptions for this were 
challenged. This was discussed during the interview and the doctor commented that whilst 
this opinion was held by only a few members of staff, they were influential in the 
development of local policies and practice. 
“…by having the idea that dual antiplatelet therapy may be had not enough 
scientific evidence to be recommended to all acute coronary patients 
before angiography.  So I commented to you that we have an internal 
protocol, management protocol that clearly stated was much more 
restrictive for me, use of clopidogrel and the guidelines.”  
(vi) High baseline performance 
The idea that complexity of a process could lead to sub-optimal care was discussed earlier 
and this could apply to a number of the quality indicators chosen for the EQUIP-ACS QI 
intervention. Complexity of a process may influence its ability to improve but another 
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important factor is the level of a treatment at baseline. If a treatment is already given at a 
very high level before the QI intervention is delivered, the scope for improvement is less than 
for a treatment that is barely given at the outset. 
 
Rima, commented on this and how it may be challenging to impact on a treatment that is 
already given at a high level: 
“And so there was quite a few changes going on, so it was a little bit 
challenging to work out when you’re, because if you’re already performing 
at quite a high level to make a change can take quite a lot more effort and 
involvement and motivation, buy in from everybody.  So if you’re already 
working at 80 or 90% prescription to move it up those extra percent can be 
much harder than maybe if you’re working in an institution that really are 
not performing at all”  
6.4.2.2 Success factors 
During the interviews, a range of factors that facilitated the outcome of the QI programme 
and led to improved standards of care were discussed. Analysis of the interview transcripts 
has led to the following themes being identified: 
(i) Incentives 
The theme that appeared to have the most influence on outcome was incentives and these 
could be personal or financial but also related to audits and publication of hospital 
performance. This theme was discussed in 12 out of 15 interviews.  
  
The idea of being in competition with the other hospitals in the EQUIP-ACS study was raised 
during half the interviews. Competition arose because results of all hospitals were presented 
at the QI meetings and also because individual hospital results accessed from the database 
were shown in relation to the top three hospitals. Marina recalled how this generated 
discussion in her QI team: 
“That can be a good thing, yeah, and that, and then, well, so it did lead to 
discussion as to why, oh, maybe if it was showing us not in such a good 
light, why, maybe, would it not be, you know, what’s going on?  So yeah, 
they were, they were a good tool for initiating discussion.” 
Sara also thought that competition was an important factor in maintaining momentum to 
improve standards of care: 
“It’s probably worked in, it’s again, how do you sustain that impetus in 
things?  Everybody if they know they’re being audited, it’s human nature, 
isn’t it?  I mean some people are very competitive, some people have that 
drive to, yes we want to improve, yes we want, but trying to keep that 
momentum going when you no longer are being looked at and audited is 
very difficult” 
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The idea that performance will be published in the form of an audit or report was mentioned 
in all of the interviews and this was sometimes considered important due to the competitive 
nature of teams as noted in the examples above, and on other occasions this was described 
as knowing you’re being observed. Sara noted that staff are more likely to pay attention to 
giving ACS treatments if they know their data is going to be reviewed: 
“So you know somebody is going to be looking at whether or not you have 
achieved those things, so therefore it makes you more aware of what 
you’re doing and you make sure it’s done.  As things, as time goes past 
and people are no longer looking then other things take priority in your day 
to day working life and you don’t necessarily check every single patient 
has had its 300mg of clopidogrel” 
Fred talked about the same concept with respect to data being collected on the MINAP 
database(Herrett, Smeeth, Walker, Weston, & on behalf of the MINAP Academic Group 
2010) and it is clear from his quote below that publication of the results, including sharing 
them with management, has an impact on patient care:  
“Yeah, the MINAP returns are every annual, every year.  Not only go into 
the public domain but they also go to the chief executive and so forth so 
we would have be pulled up if those returns are not up to scratch.” 
 
Gareth had worked on a separate improvement project after EQUIP-ACS which did not gain 
support from senior colleagues initially and he described how a presentation at a prestigious 
conference helped to gain their interest.  
“So luckily the initial study results that I had, we presented at TCT in 
America as a Late Breaking trial.  So their perception of what I was doing 
suddenly changed and they became more open to getting involved in 
research and ensuring that the quality that we produce has to be the best, 
or the best it can be.  We can try to be the best, so that certainly did 
change their minds.” 
 
Financial incentives were only discussed in 4 of the interviews, suggesting that they were not 
considered as significant as other types of incentives. Mike talked about the influence of 
financial reimbursement for procedures in the US health system and how this increased 
levels of angiography: 
“So in healthcare systems where, let’s say an angiogram gets reimbursed 
per procedure, people are more likely to do angiograms.  But in healthcare 
systems where there is no fee per procedure, payment for a procedure, UK 
is a typical one, that’s even more difficult to make changes, so.” 
It is interesting to note that financial incentives could also appear in the form of cost saving 
and Fatima noted that this was a significant driver for the QI work she was involved in: 
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“we have monthly meetings to review this information, how are we doing 
and also to try and translate, OK we can see that we’ve reduced some 
length of stay from this area here, how does that actually translate into a 
financial saving?  Because the whole thing was done under, the need to do 
it came from financial imperative rather than just, oh this’d be nice to do” 
Fred’s hospital had not had on-site PCI facilities while the EQUIP-ACS QI programme was 
ongoing but he described how his department were able to convince the hospital 
management and commissioners that this service was required, based on estimating 
financial savings: 
“Interviewer: And how were you able to achieve actually setting up the 
local service then?   
Financially?  Yes it was just persuading commissioners that there was a lot 
of money to be saved and a lot of length of stay to be saved.” 
 
Finally, some of the interviews revealed that personal incentives are required to motivate 
people to be involved in QI work. Elsa was a member of the QI team but her interview 
indicated that she did not consider the QI programme a priority and would have appreciated 
more explanation about the purpose of the QI programme. 
 “It wasn’t, not a priority in my job, but I felt quite pressured to produce 
something that maybe wasn’t as it should be and it wasn’t launched as I 
felt at the time, if you’re going to launch a new service or something new in 
A&E I’d want to educate everyone and make sure it’s utilised for every 
patient.” 
Fatima also talked about personal incentives and that people are more motivated if they 
have chosen to be a part of the QI programme or have had to apply or overcome a barrier to 
participate:  
“Whereas if you’ve had to invest something or you’ve had to try hard to get 
accepted onto some programme whether it’s training and development for 
you or whatever, quality or whatever it is, if you really wanted to do it you 
had to get over some hurdle to get there, you’re much more  
Interviewer: That’s an interesting way of looking at it 
Yeah, much more motivated.” 
 
Similarly, if staff felt a sense of responsibility for local standards of care and took ownership 
of this, interviewees considered that the outcome would be improved. Rima described how 
the QI trainers encouraged the QI teams to think about the significance of a proportion of 
patients not receiving ACS treatments by imagining that those not receiving the treatments 
are relatives: 
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“So I think avoiding a blame culture but how to make that improvement and 
something else X said that always stuck in my head is if that’s your relative 
or your friend in there you don’t want them to be that two out of ten that 
doesn’t get the right treatment and when you put it like that it’s very 
understandable, concepts like that.” 
Fatima described how including the QI teams in decision making helped to make them take 
responsibility for their own QI work: 
“I think the important thing was to get them all together and to say, this is 
important, we want to hear what you want to change because this is your 
Quality Improvement programme, this is not us imposing something.” 
 
Interviews indicated that another type of personal incentive to carry out improvement work 
was receiving recognition or being congratulated for results achieved. This led to staff feeling 
empowered and motivated them to continue working on improving care. 
 
Rima talked about what can make staff feel motivated: 
“Interviewer: But I suppose it is finding those triggers  
I think it’s engagement, isn’t it? 
Interviewer: Yeah. 
And people feeling that they’re valued and that they are making a 
difference” 
 
Fatima also thought it was important to share success stories and good news to encourage 
the teams:  
“You start with the people that are open to it and then you demonstrate the 
early wins and you demonstrate the good news and all of that.” 
Louise remembered her team receiving positive feedback following the central QI meetings 
and that this motivate them to continue working: 
“Yes, I think she fed back and said what, how well we were doing 
compared to other areas I remember, so we were quite pleased and so 
was Dr X, because he does like to be top of the list.” 
An example of how a lack of recognition can de-motivate staff can be seen from Elsa’s quote 
below. She recalls friction and pressure to work on an improvement idea, rather than positive 
feedback: 
“No, I can’t, as I said, I’ve had very little information, Doctor X and Y were, 
went to the meetings and just said, oh we’re doing this, and at the time I 
felt a little bit of pressure to produce a document that might not have been 
Interviewer: Did you produce that yourself then? 
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Yeah, yes, every, yes, all of them. 
Interviewer: Entirely on your own? 
Yes, yeah, there was a bit of, just sometimes a bit of friction about it so.” 
(ii) Factors influencing QI programme & meetings  
The QI programme meetings and implementation of QI work were discussed during the 
interviews and a number of factors that contributed to their success arose. The majority of 
staff interviewed talked about the importance stakeholder engagement in the development 
and delivery of improvement ideas so as to ensure they were relevant and applicable to local 
settings.  
 
Rima’s impression from the QI training was that teams were encouraged to analyse their 
work processes and develop their own ideas for improvement rather than just employing 
tools developed by external parties: 
“And the impression I got from X was that it was very much the local team 
need to work out what’s going to work for them so we can, it’s a bit like we 
can teach you to fish and then you can feed yourself so we’ll teach you 
some tools and then you need to work out what’s going to work best within 
your team and I think that’s perhaps a lot to do with people’s different 
personalities and challenges and just things how they are locally.” 
Sara gave an example of an improvement idea implemented at her hospital without 
engaging the cardiology department. Her hospital implemented a new care pathway for 
acute admissions that did not include all the fields required for ACS admissions and as a 
result, this was not successful: 
“I don’t think there were many specialities that had their own admission 
documentation, but they should have been aware that cardiology definitely 
did have its own documentation but they didn’t ask us at all.  Did we want 
any input and was there anything that needed to go in there?  They just 
brought out their new document.” 
In addition to engaging staff involved directly in delivery of care, it is important to engage 
them early in the QI process and Fatima alluded to this in her interview. She felt that if 
clinicians are not engaged early, it could be more difficult to convince them of the value of QI 
work. 
“You start with the people that are open to it and then you demonstrate the 
early wins and you demonstrate the good news and all of that  
Interviewer: Exactly. 
And then the later a doctor’s come on board, later on when they’ve seen, 
they need more evidence to prove to them that what’s the value of 
investing something in it to make a change.” 
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The working environment for QI meetings also appeared to be important as half of those 
interviewed talked about this during their interviews. This applies to the central training 
meetings but also the local team meetings. Jim recalled the pleasant, informal atmosphere 
of their team meetings and felt that this was productive: 
“And I think it just shows that if you say, right, we’re going to commit to 
this, we’re going to do it, and then you get everyone’s timetables together, 
and if you just put those meetings in the diary, they will happen.  I think 
what set those meetings apart, in a sense, from the kind of management 
meetings that we tend to get involved in, we never had a formal agenda, it 
was a more pleasant environment than we normally have.  We didn’t 
minute things, we just had a chat about things, we knew what we wanted 
to talk about, the ground we wanted to cover, but everyone was just 
allowed to say what they thought, and I think ideas come out better that 
way.” 
Rima also commented on the informal but productive environment of the central team 
meetings and it seems that this set the QI meetings apart from regular clinical training 
meetings: 
“Well, they had, although there were some formal presentations or what I 
think of as semi-formal presentations because they used slides etc., their 
delivery style was very relaxed, encompassing and welcoming to 
everybody and so the mixture of what I think of as semi-formal 
presentations and then the workshop aspect where you get people to be 
engaged to tell them about their experience, to work in their small groups 
around the table I thought was fascinating.” 
In addition to delivering the QI training in an informal, relaxed manner, the QI meetings 
provided the teams with protected time to reflect on their practice and think of ways to 
improve it. Mike talked about this and how rare it is to have this time in clinical practice: 
“The meetings I think were interesting and exciting in many ways, we had 
people together, very rarely do we get frontline health professionals 
actually talking about their practice and how to improve their practice, I 
think that’s one thing that we really do not have, is that time, maybe the 
time, they need time to reflect also about what they’re doing in their clinical 
practice, and in a way clinicians are very much about service delivery 
orientated, and if there’s, if there’s a deficiency, their solution is simply to 
correct the deficiency.” 
 
Fatima had similar feedback from the QI programme she was involved in where all 
participants had equal opportunity to participate, leading to productive discussion. 
“I think we had a fair number turn up out of curiosity, what’s this going to 
be then?  I think in general the feedback we had was really positive.  
Although I think that kind of, oh break out into groups and talk in a, 
everybody’s got the same, no holds barred about who says what, 
multidisciplinary groups, we want you to be all mixed up, nobody’s view 
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point is any more valuable than anyone else’s.  This was not a way of 
working that many of the staff at all were used to, clinicians or otherwise.”  
Finally, arranging QI training meetings requires a lot of administrative work to ensure that 
everything runs smoothly and it is important to ensure this work is adequately supported. 
Fatima commented that she would build in more of this support for future programmes if 
possible: 
“Oh yeah, I'd have more low level admin support because actually in a lot 
of the, all this stakeholder engagement, these big event stuff, there’s lots of 
general work that needed to be done, it didn’t need to be done by high 
banded people but we needed pairs of hands at crucial times to get some 
of that done.  So I would definitely have some more admin support”  
(iii) Leadership  
Staff talked about the importance of receiving support from senior staff and that they should 
be seen to be leading QI work. This theme was identified in 12 interviews. 
 
When Janet was asked about her department’s response to the QI work, she explained that 
staff became more engaged when they realised the consultant cardiologist was supporting it: 
“Yeah, but normally I’ll get to, I’ll go to Dr X first and then they have seen 
me with Dr X  talking and then next time when I go to them they’re more 
receptive to me, yeah.” 
 
Similarly, Gareth felt that support for QI work and encouragement from consultants was 
essential: 
“I think it has to be driven by the consultant.  He has to actively encourage 
you and make time in the day for you to go.” 
 
He also noted that senior staff did not consider QI work the main priority and this could have 
affected the implementation of improvement work on the wards: 
“Whilst we were encouraged to get involved and go to the meetings in 
terms of going to Amsterdam and getting involved in that way, if there was 
anything to be done on the wards then it was made very clear that this was 
something extra to your day practice and this needs to be done first.” 
Jacob’s quote below demonstrates a similar theme, the fact that a checklist tool developed 
by his QI team to ensure ACS treatments were prescribed, was completed more when the 
chief of the department mandated it. 
“I think it was perhaps the perception that it was an accessory thing, that it 
was only a study, it was not compulsory and maybe an important point 
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regarding that had been that the, that filling the form had been declared 
compulsory by the chief of the department or something like that.” 
Fatima considered that QI work should be led by senior members of staff to be successful: 
“…ideally to help win your cynical consultants over you’d have either your 
chief exec or your chief operating officer there for a good proportion of the 
time, leading from the front, demonstrating how important this is by the 
time they’re prepared to put in.” 
It was also noted that QI teams should include senior members of staff in order to succeed in 
improvement work. Lisa’s team engaged a Ward Manager for this reason:  
“obviously X, I think X is obviously the Ward Manager, so anything we 
wanted to implement we felt obviously it only polite and right that we go 
through her and got her involved” 
Finally, Tom explained that a key member of his QI team was selected for his leadership 
skills: 
“I chose X because I think in our group he’s a leader because he has a 
very good relation[ship] with residents and he’s very well appreciated with 
the other medical staff.  So the opinion of X is always very well 
appreciated.  So I thought, well I need a leader to improve because in, 
what’s happening in general in cardiology we always think that we are the 
best and we are doing everything very well.  And you need a leader to tell 
them, we are not the best, we, look at our results, so we have to change.  
So first to choose the leader.” 
(iv) Process 
Factors relating to process were considered earlier in terms of creating barriers to delivering 
optimal patient care. It is important therefore to consider those process factors which would 
facilitate improvement work. 
 
Simplification 
9 out of the 15 interviewees talked about the importance of processes being simple and this 
was also mentioned in the context of tools to improve care. 
Jim commented on the implementation of a rubber stamp in his unit to prompt staff to 
prescribe ACS treatments. This had been effective in improving rates of prescription and he 
attributed this to its simplicity: 
“I think it’s because it’s simple.  Fundamentally, it’s a simple idea.  Very 
easy to apply.  And the one thing that I’ve noticed over the years, all the 
pathways we have now, patients get put on standard pathways, and 
they’re just mountains of paper.” 
When asked what she thought would lead to a successful improvement idea, Rima also felt 
that it had to be simple and clear in order to be effective: 
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“But then there are, especially within clinical, there’s lots of doctors, there’s 
lots of nurses, there’s lots of other healthcare professionals.  So I think it’s 
simplicity, clarity about what you’re trying to do and then what you’re going 
to get out of it, what’s the benefit for us all if we do this?  So simple clear 
ideas that are easily implemented.” 
During a discussion about use of risk stratification methods, Gareth mentioned that he 
preferred to use the TIMI score because it is the easiest: 
“Interviewer: And is there any method that you would prefer to use or does 
it not make a difference? 
Rather than TIMI or? 
Interviewer: Of all the available 
Yeah, I would just use TIMI because it’s just easy.” 
 
Rima felt that some processes would be easier to change than others due to their simplicity 
and noted that angiography was more challenging to influence because there are more 
members of staff and steps involved in the process: 
“I remember particularly one of the doctors because he thought that all his 
patients were being done but he took it on board and then they tried to look 
at the reasons of why and then it came down to logistics of scheduling and 
then once you start to increase the number of people that you’ve got to get 
involved in something it seemed that that would take longer to make those 
changes whereas the thing like the risk stratification that nurse and those 
doctors could immediately implement that in a very simple way” 
Another factor that was considered to contribute to a successful process, was whether the 
process was centralised or automated. Adrian noted that this had improved the PCI service 
in his region as consultants were now on a regional rota and the on call system was 
managed centrally: 
“Now it is different because it’s more organised, we have a system, 
alternate the on call 24 hours, our consultants are in ward in that rota, it’s a 
regional rota, including people from [names of referring hospitals removed] 
everyone.  So every ward consultants just are rotating.” 
 
A ward nurse from the same site, Elsa, also noted that centralising the PCI service had led 
to improvements: 
“I think things have hugely tightened up, they’ve now got interventional 
cardiologists, we’ve got visiting interventionists as well that come, we’ve 
got a PCI coordinator that fills the lists on a daily basis so that she ensures 
that they’re actually full, each patient, each list, and there’s a, we’ve got an 
extra catheter lab now as well which outpatients come to for diagnostic 
angios.  So I think that it’s changed dramatically from probably 2000 and, 
Daphne Babalis PhD Thesis  Page 162 of 247 
 
even from last year, it’s always very high in post.  I think it’s, everything’s 
tightened up.” 
The issue of having control of a process also appeared to be important, Louise attributed the 
success of her ward to the fact that patients are treated there for their entire hospitalisation 
which enables staff to have control of each step of their care pathway: 
“And I think that’s one of the unique things about X ward is that we’ve, 
because we’ve got 23 beds we are able to keep our cardiology patients 
from admission to discharge, should we feel the need, yeah.” 
Conversely, Sara noted that her team had no control over angiography procedures and so, 
did not feel they could influence this treatment: 
“There were certain issues that we found we had no control over, 
particularly with the meeting the target for angio, that was completely out of 
our control”  
Finally, Janet recalled that she had more control over the use of ACS treatments during the 
EQUIP-ACS programme as part of her role, and this meant she could check when 
treatments weren’t being given: 
“But I have to say, during that time, because we were constantly in CCU or 
CDU looking through notes and stuff like that, so therefore there’s better 
control.  If things are not done or the card is not used I can go to the junior 
doctor and say, where’s TIMI score?” 
Another important process factor is ensuring that staff have clearly defined roles and 
responsibilities. This means that everyone knows which aspect of a process they are 
responsible for and avoids confusion. 
Sara clearly remembers that it was her responsibility to check prescription of ACS 
medications during her ward round: 
“Yes, if it was my cardiology ward round that day, then the patients that 
had come in overnight that were ACS patients and obviously that means 
that it was my responsibility to stick those into the notes and to check to 
see whether or not that things had been started, and if they hadn’t to 
highlight them to the consultant on the ward round, that this patient had 
come in, no ACE had been started, is there any reason why you do or 
don’t want to do that?”   
(v) Expertise and training/credibility 
The next most common success factor discussed in 14 of the interviews, was the importance 
of expertise and training. This related to staff in cardiology departments being appropriately 
trained but also to those delivering the QI training, in the latter case this gave the programme 
credibility. 
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Jim felt that the role of cardiac nurse practitioners in his department was crucial as they are 
very experienced: 
“And that’s why I think the model we have of trying to get our cardiac nurse 
practitioners to do as much as possible, I think is generally pretty effective, 
because as I say it’s 
Interviewer: Sounds very sensible. 
They’re very, they’re well qualified, they’re a constant feature of the 
service, and they can also help to disseminate that knowledge.” 
Jim also commented on the importance of involving consultant cardiologists in the delivery of 
ACS care. His view is that involving a cardiologist in ACS management leads to better care 
and he described a local study considering angioplasty during three different settings and 
how this was consistent due to presence of a consultant on each occasion: 
“And there’s some work just being put together now, which hopefully we’ll 
try and get submitted for publication which, we’ve broken down the primary 
angioplasty admissions to working hours, weekends, bank holidays, or out 
of, not working hours, so it’s three different groups there basically, so 
during the week, out of hours, non-working week and then bank holidays.  
And what we’ve found is mortality is identical 
Interviewer: Really? 
For all three, absolutely identical.  But that’s because it’s a consultant 
delivered service.  Every, there’s no case that happens without a 
consultant physically present.  So I think it might add weight to the 
argument that you need senior presence all the time.” 
 
He also stated that consultant input on a daily basis could significantly improve ACS 
management, something which was not yet provided at his centre: 
“I guess if, what we don’t have still is every single patient being seen every 
day by a consultant cardiologist.  We don’t have that.  And I don’t know if 
we will get to that stage or not.  That might make a big difference.”  
Elsa was asked about how she thought non-ST elevation ACS care could be improved and 
her opinion was that specialist staff were required, once again highlighting the importance of 
training in delivering optimal care: 
“A team of probably cardiac nurses, or a team of professionals specific for 
cardiology on call 24, not on call but covering the area 24/7 to ensure that 
this is addressed constantly and I think the in care would improve.  But at 
the time there’s only, at the moment, so I think that’s all I could, yeah, say 
about it.” 
Gareth was asked to summarise his view on the final outcome of the EQUIP-ACS study and 
he felt that education of staff can lead to improved care: 
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“I would probably say aggressive education from the bottom up can be 
translated into better outcomes for the patients really.” 
The importance of involving experts in QI work was also mentioned in the context of the QI 
training. The interviewees felt that involving experts in the delivery of QI training, gave the 
programme credibility and encouraged staff attending the training to participate in and 
implement the programme. Rima felt that involving experts in the delivery of the QI training, 
helped to engage the clinicians: 
“…working with very experienced people in this area who were accepted 
not only because of their expertise in quality improvement but because of 
their clinical expertise as well.  So I personally think that Bertil Lindahl is 
one, who’s one of the leading physicians in acute coronary syndrome in 
Europe and has enormous respect, definitely when you’ve got people of 
that leadership level on your team I think it definitely can’t be anything but 
very positive and I think that helped with the clinical members of the 
researchers that were involved in the study.”  
 
Fatima also felt that it was important to involve expert speakers in QI training and used a 
similar approach in another QI programme: 
“We had external speakers both times, we felt that was really important, 
external clinical speakers, one anaesthetist and one surgeon, at different 
sites and we felt that was really important for giving it external credibility 
and so it wasn’t just managers, it wasn’t just our own clinicians standing up 
and saying, we think this’ll be good” 
(vi) Communication  
Communication came up in 8 of the interviews as an important factor in delivering ACS care. 
This could be communication within and between teams, communication across specialties 
or even across a network of hospitals working to a common goal. 
 
Marina recalled that the opportunity to communicate with teams from other hospitals at the 
QI meetings was useful in order to exchange ideas and working practices: 
“And then you find out, through something like EQUIP, with talking to other 
people that somebody’s found a better way obviously.  You know, that’s 
where I think personally it, it was, it was a good thing to be able to, to 
exchange information like that.” 
 
Mike made a similar comment about the value of getting teams from different hospitals 
together to share practice: 
“But anyway, so I think it was that getting, people getting together and in 
fact that’s how it was planned, we were slightly sceptical that this would 
actually work, but that’s how it was planned, the most powerful bit was 
actually getting people together.  Now we got people together from all the 
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different hospitals, different countries, but the idea was that as we rolled it 
out you could get people together within a hospital and that kind of group 
approach again would help to change the procedures in practice.” 
In terms of communication within a centre, the idea of having some members of staff acting 
as a central contact point was raised during Jim’s interview in the context of nurse 
practitioners: 
“Interviewer: And I suppose they can act as a central contact point for the 
department as well, so people know that they’re there and know where to 
go. 
Very much so.  Yeah, the system we have here of course is that the nurse 
practitioners are on bleep, they’ve got their own bleep, there is always one 
on duty, and they’re a point of contact.  A&E know, the Medical 
Assessment Unit know that they contact them as the first port of call.” 
 
Sara noted that there is a good relationship between nurses and consultants at her centre, 
which leads to effective communication: 
“No, I mean we have a fantastic relationship with all of our consultants 
really, and that’s been positive through quite a few years, so all of us have 
done the job for quite a long while, so we’re quite able to approach them 
and they respect our role and our opinion on things, so.” 
Effective teamwork was considered important by Rima who thought hospitals should focus 
on this more. More detail on working as a team and the individual roles required will be 
provided in the section on QI teams in this chapter. 
“But I think it’s working within that team where you want to do, everybody 
wants to do the best they can but I think perhaps some teams get a little bit 
war weary and don’t realise that they’ve lost that je ne sais quoi maybe.  
And also giving people the tools.  So I think there’s a lot of emphasis put 
on if I train you or there’s a published paper and you read it you will know 
and there’s less emphasis on training teams on how to work together as a 
team and leadership within a team.” 
Fred talked about larger scale teamwork when he mentioned how his department work with 
the local network of hospitals to agree common goals for managing ACS patients: 
“No, we’re certainly given our, because what, with the network level every 
two months we have a meeting for the network and we look at these sorts 
of QI procedures and the QI data for every, all of six hospitals in the 
network routinely.  There are red, green, the traffic light models for QI for 
prescribing.  In fact now there is even a committee set up for QIs for all 
measures in cardiac as a separate task force.  Looking at trying to set up a 
QI markers for the pan London group, pan, so we’re actually trying to 
define for certain conditions what are the QIs.” 
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(vii) Room for improvement 
It was noted above, in the section on barriers to delivering optimal care, that a high baseline 
performance means that there is limited scope for improvement. It is expected therefore, that 
a more marked improvement would be observed if performance at baseline is very low. Two 
of the centres with low performance at the start of the study commented on this as follows: 
 “Interviewer: I remember [your centre] did actually improve 
Because we were very, very bad at the beginning.” 
(Tom) 
 
“We had a 0% of risk stratification. 
Interviewer: I remember. 
And a very low use of clopidogrel, so we had a big room between, to 
increase.” 
(Jacob) 
(viii) Organisational culture 
The idea of long term improvement and sustaining results achieved was discussed in 13 of 
the interviews and will be considered again towards the end of this chapter but it is important 
to note in this section that interviewees indicated that a change on an organisational level 
may be required to effect longer lasting results. Fatima talked about the need for a ‘cultural 
change’ to take place within an organisation: 
“And of course these problems are not click your fingers and solve them 
type issues 
Interviewer: Exactly. 
That we’re going to solve. 
Interviewer: That’s why they are problems.   
Yeah that’s why they are problems, that’s why we need quite a lot of 
stakeholder engagement to get working on them because they’re about 
cultural change and different ways of thinking about things, different ways 
of doing things.” 
6.4.2.3 Planning and implementing QI work 
The process of QI was considered during the interviews, with discussion focussing on how 
the teams planned their QI work, analysed their work processes and put systems in place to 
improve their practice. 
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(i) QI team 
As noted previously, each centre randomised to the QI group was asked to set up a QI team 
to manage local implementation of the QI programme. Two representatives from the team 
were expected to attend each of the central meetings. Questions in interviews focused on 
the composition of the local QI team as well as the content and frequency of team meetings. 
 
A range of roles are required to make a successful team(Institute for Healthcare 
Improvement 2003) and discussion during the interviews demonstrated that centres had 
considered this. Tom thought about this when setting up a team at his site, in particular with 
respect to identifying a team lead and including staff directly involved in care of ACS 
patients: 
“So I thought, well I need a leader to improve because in, what’s 
happening in general in cardiology we always think that we are the best 
and we are doing everything very well.  And you need a leader to tell them, 
we are not the best, we, look at our results, so we have to change…and 
the residents were very happy to participate, because at the end of the day 
the residents are the first that see the patient and the first that initiate the 
type, the treatment, so you need the residents to follow the guidelines.” 
Jacob also commented on the importance of including residents in the team: 
“I invited a resident to participate because I thought it was very important 
that the residents were involved because they were in charge of a 
substantial part of the management of the patients, particularly in the first 
moments of their admission.” 
Marina described her own role in the team as a facilitator: 
“Now, I was mostly facilitating the meetings and, and bit of a go between.  
So, although we were, I was there when they’re talking about things and 
what they were going to do, the actual implication and the putting into 
place of what was happening, really I wasn’t having anything to do with, 
apart from if they wanted a bit of help with the wordings” 
Gareth, a registrar at one of the QI sites, reflected on the success of his team working in a 
cohesive manner to improve patient care: 
“…support from the people on the shop floor like myself and everyone else 
... the consultants and the people who can facilitate education sessions, 
training, changing protocols, working all together.  This is phenomenal.  
Really good.” 
 
The teams at each centre were encouraged to hold meetings on a regular basis to review 
their data and work on improving their local work processes. The majority of the teams 
interviewed noted that it was challenging to find a meeting time that was convenient for 
everyone. 
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Sara remembered that their meetings took place after the consultant’s ward round: 
“Usually after Dr [X]’s ward round we would all meet up after that, because 
there would always be a nurse practitioner in and if it was Lisa’s research 
day and I was in on a practice development day then it’s kind of easy for 
us all to be around at the same time.” 
As well as the importance of finding a suitable meeting time, the teams preferred to hold 
their meetings in an informal setting which meant that everyone felt at ease and led to 
productive meetings. Lisa recalls: 
“I always thought about how positive it was that myself and X and Y and Dr 
Z were able to, it wasn’t always as easy as we’d have liked, but we were 
able to get together.  It was very informal it was over at [location] over a 
coffee and we would look at our practice and what we could do to improve 
it, obviously trying to meet the goals of EQUIP which you’ll probably have 
to remind me of some of them” 
It was recommended that teams should meet on a weekly basis to review their data but 
whilst this may have been the case initially, eventually the frequency was reduced to fit in 
with clinical workloads. Janet describes this in her quote below: 
“But towards the end, towards the end we did try to meet every week but 
then it drifted to once every four weeks but we still managed to get, keep 
the team together and that’s how we came up with this TIMI risk score little 
postcard.” 
Overall, the interviews indicated that most teams were able to meet regularly, even for brief 
meetings, and data extracted from the database in the form of reports was used to stimulate 
discussion and develop ideas to improve local practice. Jim reflected on the value of these 
meetings and the opportunity they provided to develop ideas for improvement: 
“And those were actually quite short meetings, they were only 20 or 30 
minutes maximum, but actually we’d have them down in the coffee bar, 
nice comfy seats, good coffee, bit of a chat, and actually you cared, that 
was actually where the rubber stamp came out, it was in that sort of 
environment.  And I think it’s a real shame actually that we don’t take a bit 
more time out to do things like that, because that would not, it just wouldn’t 
be regarded as time that you can put down on your job plan, for example, 
because that’s what we’re all expected to fulfil now, is this job plan, which 
is, Monday morning, this is what I’m doing, and so it goes for the rest of the 
week.  Where do you put one hour or two hours a week to be down in the 
coffee bar with your colleagues having a chat about things?” 
(ii) Measurement 
The theme of measuring performance came up in 13 out of the 15 interviews. Interviewees 
considered it important to collect and evaluate clinical data on patient management so as to 
assess the standard of care and identify areas requiring improvement. 
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One of the QI researchers Mike noted that data collection is valuable in that it provides 
evidence that there are deficiencies in compliance with guidelines: 
“we realised that actually, well [we were] not the first to realise this, but that 
it is a powerful tool for determining gaps between either what people think 
they’re doing, what they should be doing, what guidelines are telling [them] 
to do and indeed often what national guidance we’re stating, so there’s a 
big gap between reality and either belief or what should be doing” 
He added that clinicians would not know how their patients were being treated if this was not 
measured somehow. 
“The second thing is the reliability of information about how people are 
practising and in general hospitals, even in sophisticated healthcare 
systems, are not really gathering information in a reliable way.  So people 
actually didn’t really know what they were doing and that’s another 
problem.  So if you don’t know what you’re doing, how can you improve or 
how can you even comply with what is considered to be a reasonable 
Quality standard?” 
The database used for the EQUIP-ACS programme incorporated a feedback system that 
could provide real-time reports on the number of patients treated. This enabled the QI teams 
to evaluate their centre’s performance and Jim noted that this revealed performance at his 
centre was worse than they thought, triggering discussion within the team about what could 
be causing poor performance and how to address this. 
“And very early on it struck me from that we were not as good as we 
thought we were, and I think that’s where we realised, well look, we’ve got 
all these things in our pathway, these five therapies that are evidence 
based that we’re measuring for this study that we think we’re prescribing 
100% of the time, but we’re not, and it’s already in the pathway.  So clearly 
there’s an issue, what should we do about it?  Let’s have another check 
towards the end to make sure that people don’t get away.  So those figures 
were coming out, X would bring them along, we would have a look and 
work out what we could do differently.” 
A senior nurse Louise at another site also highlighted that her centre’s performance was 
worse than they had thought: 
“And I think, I thought we were quite good at most of those things and 
sometimes these show you that you’re not as good as you think you are.” 
 
Interviewees also commented on the challenges of collecting accurate data. In Elsa’s case 
she had to find a way to fit this in, in addition to her clinical workload, but also to get access 
to the medical records: 
“No, well I work very early because I’m, I come in early then finish early, so 
I can get all my audit done when it’s quiet, take the notes from the ward 
when the doctors and the pharmacists don’t need them.  And it’s far more 
effective that way, so I get rid of the audit like that.” 
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Mike highlighted the importance of having access to high quality data to continue 
improvement work, particularly in reference to any work that may be ongoing at the centres 
after the end of the EQUIP-ACS programme. 
 “And it is highly unlikely that they are collecting that high quality data as 
they go on.  And, but I know you’re working with some centres to continue 
collecting that data, but unless you can look at high quality data, you can’t 
improve your quality.” 
If a treatment hadn’t been prescribed, it was challenging to work out the reasons for this from 
the medical notes, since contraindications were not clearly recorded. Lisa noted: 
“Because that’s half the battle sometimes, if you, if you’re looking back on 
things, it’s why haven’t they gone home on that, then you have to try and 
find out why they didn’t go, was it just simply missed or was there a 
reason?” 
Rima also raised the issue of recording contraindications in relation to another study and 
noted that, even if these are recorded, often there is no clear rationale and it is difficult to 
know if it’s a true contraindication: 
“actually we did capture if somebody was contraindicated to it that I 
remember there was a bit of confusion with the nurses at the time because 
it’s also who’s collecting the data, about what that really meant and so 
sometimes we weren’t quite sure whether the patient was a 
contraindication in the sense that it was on the drug, reasons why you 
don’t give this patient because they’ve got chronic kidney failure or 
something like that or it was more like a physician decision without any 
rationale behind it.  They didn’t know.  They hadn’t investigated at the time.  
There was no way for them to go back.” 
Janet also commented on the challenge of recording contra-indications and how her centre 
is trying to address this in their medical records: 
“And the other day, after the audit that we did, apparently some patients 
are still not being discharged on the full requirement, required drugs.  So 
therefore I think one of the doctors has suggested to use the same sort of 
stickers to say it’s a must, take, if there’s any contraindication you must 
explain why.” 
In addition to the issue of contraindications, quality of data collection in general was 
discussed. Fatima, a QI researcher that works on separate projects, had experienced 
problems with data collection in the past and noted that this needs to be planned in advance 
to ensure that a database is well-designed and that data collected are of high quality. 
“Multifactor, because to solve those issues is multifactorial and with the 
bleeding there was quite a lot of, within the programmes that were just 
getting underway to address those issues, they had quite a lot of data 
collection issues where they thought it was all in the audit database, when 
they actually looked at the data it was, the quality of it was rubbish so they 
had to start doing prospective auditing.” 
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The teams were encouraged to review their data during their local meetings in order to 
analyse their work processes and identify any pitfalls. Lisa described reviewing reports of 
their data during a team meeting: 
“Yeah, I printed them off, everybody had a folder and I’d print it all off for 
them and we’d sit there and we’d look at it and we’d try and decide, look 
at, OK well why are we only getting this for, and I’d actually audit the 
patient’s notes as such and say to Dr X, OK this patient didn’t go home on 
an ACE but they should have gone home on an ACE and we’d look why, 
whether he actually ever fed that back to the doctors involved, OK we’ve 
missed an ACE for this patient, don’t know whether he actually did or not” 
It can be seen therefore that accurate measurement of patient care can provide a valuable 
tool to analyse work processes and identify areas for improvement. 
(iii) QI tools and ideas for improvement 
The QI teams were encouraged to analyse their work processes using the data collected 
and a range of established QI tools that can help to identify areas for improvement. Process 
maps were used to identify bottlenecks and barriers in patient care and teams then 
developed ideas for improving care during their meetings. These ideas were tested out 
initially using Plan-Do-Study-Act cycles (Deming 1986, Shewhart 1931), and were then 
implemented if initial tests proved successful. This section summarises some of the 
improvement ideas that were discussed during the interviews. Some of the teams developed 
tools to help with performing risk stratification such as the one Elsa describes here: 
“So I’d enter all the data into MINAP and she was, had study sheets and 
she was linking onto that, and we developed a tool for the treatment of 
patients with a differential diagnosis of acute coronary syndrome.  It was 
tailored to the consultants in post at the time in A&E with risk stratification, 
people had different ideas whether they wanted GRACE or TIMI so we 
ended up just calling it risk stratification.” 
Jim’s team focussed on the prescription of ACS medications for one of their tools and 
developed a rubber stamp to be used in the medical records that prompted staff to check the 
five treatments prior to discharge: 
“And I think it was because of that that we thought, right, these are the five 
things that everybody should be leading on, why don’t just have the final 
checklist of these five evidence based therapies, and to separate it out 
from just the standard pathway where people are just ticking boxes, there’s 
this rubber stamp which people put on just as the patient is about to leave.”  
Louise, a member of the same team, agreed that the rubber stamp tool was effective but 
also noted that it was improved and changed into a label when the team realised it was too 
impractical to carry a stamp around the various departments. Her quote below demonstrates 
the ongoing assessment of improvement ideas and that they were adapted and changed as 
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required during the implementation of the QI programme. 
“Yeah, which was quite cumbersome and what we said was that, that’s all 
very well and good but if we’re off on the medical assessment unit and 
we’re seeing patients there we don’t want to be carrying the stamp around 
with us.  So we went to sticky labels, that’s how it worked I think, yeah, it 
was a stamp to start with but the labels are definitely better.” 
Adrian described a tool in the form of a document that could be printed off the local intranet 
to document requirement for referral: 
“That was a referring tool, it is there on the intranet, they can print it out 
and you print it out, you put in the notes and you tick different things what 
has been done and what’s next.” 
Jacob’s team used a similar checklist which was monitored after use to assess its value and 
make changes to it where necessary: 
“Yeah, when the patient was discharged we collected the form and some 
of them were very complete and some of them were in the same status 
that we had left them.  And ways to improve, for example, discussion, 
changes that we had seen in the performance ... for that.” 
 
The interviewees described various checklists and tools such as the rubber stamp described 
earlier and the purpose of these was to remind staff completing the medical records about 
the key ACS treatments in a systematic way. Janet worked on a team that developed a 
pocket risk stratification card and she observed an improvement in the level of risk 
stratification as a result:  
“But towards the end, towards the end, after we have introduced the card 
it’s much better.  I think it’s just jogged people’s memory to say, right OK, 
I’ve TIMI risked them and blah, blah, blah.  And then subsequently they 
prescribe the relevant medication.” 
 
Lisa thought that the simple tools they used to remind staff about prescribing ACS 
medications were effective because they were acting as a simple memory jog: 
“Just prompting I think, it’s just a memory jog for people to remember to 
make sure they’ve considered everything and looked at the patient as a 
whole really, whether they’re on the right treatment, that they go home on 
the right treatment.  I think that was all it was, it was just, oh there’s a 
sticker there I need to, and it made them think about it” 
All of the improvement ideas described during interviews were simple and inexpensive but 
teams were able to design and implement them in a short timeframe and also to observe the 
effect they had on ACS treatments using the study database. 
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(iv) QI Meetings 
The QI programme consisted of 3 meetings held in a central location. Representatives from 
each QI centre were invited to attend and encouraged to hold their own local meetings prior 
to the start of the programme and throughout its implementation. Interviewees were asked 
about the meetings including the format and delivery of these. Feedback about the meetings 
was positive and participants considered that they were well organised and productive. Janet 
remembered that meetings were efficiently organised: 
“Everything was very well organised, very good communication with you 
especially whether, which hotel we’re staying, transport, everything, was 
no stress.  So therefore I don’t mind, I didn’t mind going abroad.”  
Adrian summarised his thoughts on the organisation of the meetings as follows: 
“Well organised, well located for all these people.  Some was in central 
position, in Amsterdam, things like that, which was obviously for different 
people to come to a common place, some in London in nice place and 
everything.  So it was well organised and well thought, and the people who 
were doing it, obviously you were involved in the organisation, but other 
people who were coming and discussing things, was good in their fields.”  
In addition to organisation, interviewees were positive about the content of the meetings for 
example, Jim found the meetings enjoyable: 
“But they were, they were very, they were enjoyable, they were interesting, 
they were informative, and I thought it was all really worthwhile actually.” 
 
The attendees involved in the organisation and delivery also considered the meetings 
enjoyable and commented on the positive atmosphere. An example of this can be seen 
below in a comment made by Rima: 
“And I think at the training I got the impression just from seeing people’s 
body language and the chatter that was going on that actually people quite 
liked meeting the other teams from the other hospitals etc. and so it wasn’t 
just them being looked at in terms of my performance but they were all in it 
together and I actually thought it felt like a really good environment to be 
in.  I enjoyed it.” 
So it is clearly important to consider the logistics of arranging a meeting as well as the 
content and format to ensure a positive outcome. Fatima talked about logistical 
considerations for arranging meetings for a different QI programme; 
“And difficult to schedule, we did it on an audit day but even that was not 
straightforward because staff have other commitments on audit days that 
…” 
In addition to scheduling considerations, she had to think about providing refreshments and 
making sure attendees were comfortable during meetings;  
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“we had breakfast and we started at 7:45 and did quite a lot of things about 
timing and feeding people and trying to make it a nice.” 
6.4.2.4 Quality indicators 
(i) Goals of QI programme 
The goals of the QI programme were based on the recommendations from the latest 
European Guidelines for management of non-ST elevation ACS(Task Force for Diagnosis 
and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European 
Society of Cardiology, Bassand, Ardissino, Boersma, Budaj, Fernandez-Avila, Fox, Hasdai, 
Ohman, Wallentin, & Wijns 2007) which were applicable to all participating countries and 
centres. Real-time reports summarising the proportion of patients receiving these treatments 
were available to each hospital via the web-based database. The eight guideline-
recommended quality indicators were: risk stratification, anticoagulants, beta-blockers, ACE-
inhibitors, statins, coronary angiography and clopidogrel as a loading dose and a 
maintenance dose. These were discussed during the interviews to ascertain whether they 
were considered appropriate goals and gain more information about how they are prescribed 
and why they might be under-used despite guideline recommendations. 
 
The staff interviewed agreed that the goals selected were suitable and that these guideline-
recommended treatments should be given to all non-ST elevation ACS patients. The 
evidence base for these treatments was widely accepted and the clinicians indicated that if 
patients did not receive these, it would be due to error rather than disagreement with the 
evidence and guidelines. 
(ii) Risk stratification 
The use of a formal risk stratification model was recorded during the EQUIP-ACS study. This 
quality indicator improved the most out of the 8 assessed and its use varied widely across 
the participating sites. Interviews revealed a range of views on the use of risk scores and 
these are outlined in this section. 
 
Risk stratification of patients using established models, i.e. GRACE(Goodman, Huang, Yan, 
Budaj, Kennelly, Gore, Fox, Goldberg, Anderson, & for the Expanded Global Registry of 
Acute Coronary Events (GRACE) 2009) and TIMI(Antman E.M., Cohen, Bernink, McCabe, 
Horacek, Papuchis, Mautner, Corbalan, Radley, & Braunwald 2000), was considered an 
easy thing to do and many felt that assigning a risk score to each patient was an important 
step in their management. One of the QI researchers commented as follows: 
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 “I think it makes it systematic, so if you’re doing it and you’re doing your 
score then everybody sees the score as well whereas if a doctor is doing it 
in his head, it’s just in his head. Whereas if we can all see like the nurses 
or the other allied professionals what you’ve identified as being the 
possible risk for this patient then I think that can definitely be of value and I 
think the evidence was out there to show that risk stratification helps 
because it’s just providing a systematic way of evaluating somebody” 
The interviewees described the use of risk scores to support decisions for further treatment 
including angiography, particularly in cases that are not straightforward clinically. Risk scores 
are often calculated in the A&E departments and used as a trigger for patients to be referred 
to the Cardiology Ward. A registrar who was responsible for training A&E staff to use risk 
scores as part of his role on the QI team, described how he uses risk stratification to support 
patient care.  
 “Yeah, I do find it useful, yeah.  Especially as it makes you objectively 
think whether or not you need to pick up the phone and alert the cath lab.  
So even if you’re in the tertiary centre I still do it. So I think it’s got two 
roles.  One admission and discharge and the other one is to escalate or go 
to the cath lab.” 
 
Discussion around the use of risk stratification revealed that it was not always considered 
valuable however and that the resulting score is not necessarily used to determine further 
treatment or prioritise one patient over another. Decisions are based on clinical judgement 
rather than a formal score in many cases. A senior ward nurse noted: 
“No, I don’t think the TIMI scoring itself has a bearing on whether they 
have the treatment started or not.  I think the clinical picture tends to 
suggest that the treatment is started.” 
And a similar comment was made during another interview with a ward nurse regarding 
patients’ referral for angiography: 
“And I do think that although you do TIMI score patients, the TIMI score 
isn’t used to prioritise patients as far as procedures are concerned.  So I 
can understand from people’s point of view, why bother doing it if it doesn’t 
influence what happens to the patient?  You could have a TIMI score of six 
but if you come in three days later than the one that’s got a TIMI score of 
one that goes date wise to have an angio, it doesn’t get prioritised on TIMI, 
so what is the benefit of doing TIMI?” 
She also noted that risk scores are never discussed during ward rounds and that it was 
difficult to find purpose in meticulously carrying out scores if they were not going to lead to 
prioritisation of higher risk patients or in fact be used for anything at all.  
 
It is clear that there is a lack of consistency regarding use of risk stratification methods as 
some centres consider it a valuable tool whilst others do not use a formal scoring method 
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and instead prioritise patients on the basis of clinical symptoms or waiting time.  
“So they are in a way risk stratified in the minds of the consultants who see 
them, but probably not formally written down.” 
Reflecting on the overall study results, one of the QI researchers commented on the 
improvement observed in use of risk stratification and noted that in his view, the main 
purpose of risk scoring patients is to reach a decision about angiography. 
 “Yeah, it’s interesting, but it is quite difficult to understand how we improve 
the risk stratification but not in coronary angiography.  Because then the 
main reason for the risk stratification is for perform a coronary 
angiography” 
The QI programme permitted use of any formal, documented risk stratification method but 
emphasis was on the GRACE method(Goodman, Huang, Yan, Budaj, Kennelly, Gore, Fox, 
Goldberg, Anderson, & for the Expanded Global Registry of Acute Coronary Events 
(GRACE) 2009) since this was recommended in the ESC guidelines. When asked about the 
different methods, teams indicated a preference for the TIMI score as this was simpler to 
calculate in an acute setting whereas the GRACE model requires creatinine to be measured 
and a computer to calculate the score according to an algorithm.  
“And the stumbling block was, the cardiologist wanted GRACE 
assessment, but it’s not always practical in the acute environment, you’ve 
not got blood results or the calculators to calculate, TIMI fits nicely in, it’s 
quite easy to do and user friendly.” 
(iii) Acute Coronary Syndrome medications 
Medications indicated for non-ST elevation ACS made up 6 of the 8 quality indicators for the 
QI programme. These were: statins, beta blockers, anticoagulation, ACE inhibitors and 
clopidogrel as a loading and maintenance dose. 
 
Rates of use of these medications were discussed during interviews using control charts 
showing each centre’s performance over time as a prompt. Use of statins and anticoagulants 
was generally high across all centres and review of this data did not lead to much discussion 
as these were considered straightforward and applicable to all ACS patients. Any 
medications that depend on a test result or consultant decision prior to prescription appeared 
to be less likely to be given consistently. 
 
One of the ward nurses Sara noted that ACE inhibitors and beta blockers have more 
contraindications than the other medications and these need to be taken into account when 
prescribing for non-ST elevation ACS patients. 
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“Well those out of anything are probably the more contra-indicated type 
medication, along with your beta blockers, Us and Es go off, patients can’t 
tolerate it, they get the cough, you know, there are, I think they’re possibly 
more reluctant to start patients on ACE inhibitors because of renal 
impairments and things, so.  And a lot of your patients are diabetic, a lot of 
them have got underlying renal problems anyway.”   
Contra-indications were in fact raised as a factor in prescribing ACS medications in 8 of the 
interviews and another research nurse Lisa also commented on the difficulty of identifying 
whether patients have contraindications to certain treatments since this is not well 
documented in the medical records. 
“Which would be a shame really, because they should perhaps, could have 
incorporated the type thing in with that, so that yes you are checking that 
they go home with everything they should be, but is it their five cardiac 
medicine that they were going home on and if not why not?  Because 
that’s half the battle sometimes, if you, if you’re looking back on things, it’s 
why haven’t they gone home on that, then you have to try and find out why 
they didn’t go, was it just simply missed or was there a reason?” 
The need to wait for a consultant to decide that a medication should be prescribed was 
described during 5 of the interviews. This is noteworthy as it could lead to delays in 
treatments being prescribed. 
“Most of the time when patients are admitted, as I said, cardiologists do 
your ward round and checking the drug board, so they’re usually started 
there in the first place.  But there will be a lot of people who may not have 
received, coming at night, not seen by cardiologist, and starting in on the 
ward or coronary care, you may, you’re transferring out to centre in 48 
hours, so it depends really, yeah.” 
A registrar from another centre also noted that ACE-inhibitors were usually prescribed by a 
cardiologist: 
“Yeah, they’ll wait, yeah, they’ll wait for probably the medic and most likely 
the cardiologist to come and start that one.” 
He also added that if a patient was not seen by a cardiologist for any reason, he or she may 
be discharged without an ACE-inhibitor ever being prescribed. 
“So they may have been, if they’re stable and then for some reason not 
seen a cardiologist, which is pretty rare, but they would have been 
discharged without and we would have missed them, but it’s pretty rare.” 
Some ACS medications may therefore be missed if the clinical team are waiting for a 
cardiologist to prescribe them and, in the case of beta blockers and ACE-inhibitors, two of 
the interviewees referred to staff on the wards feeling that it is not urgent to start these 
treatments or in the latter case that it is appropriate to wait. This can lead to prescriptions 
being missed completely. The first quote is from Gareth, a registrar on one of the QI teams; 
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“Because of the long term benefit they’re looking for they will feel it’s less 
urgent to start without speaking to a cardiologist I think.  That’s my 
experience.” 
The second quote is from Janet, a nurse on the same QI team: 
“And a lot of times there was still, we were told, when I was doing my 
training we were told that beta blockers shouldn’t be prescribed on the first 
day, you should prescribe it on the second day.  Maybe the doctors they 
had the same mentality as well, so maybe you don’t prescribe this until 
whenever.  So things got delayed and subsequently got forgotten, I think.  
But now I think, because, I think we were drummed it in by the consultant 
as well, aspirin, clopidogrel, statin, beta blocker and ACE, it’s a must.” 
The medication that seemed to trigger most discussion upon reviewing the control charts 
and local results was ACE-inhibitors, with 11 out of 15 interviews focussing on this 
treatment. The need for decision steps before a treatment can be prescribed was introduced 
above and this is relevant in the case of ACE-inhibitors as clinicians commented that they 
feel it is necessary to consider blood pressure and renal function especially when this is 
prescribed. One of the consultants, Jim, noted the following: 
“Yeah, I mean people are a little more driven by things like blood pressure 
and renal function, and they get a little bit concerned about sometimes just 
mild renal dysfunction, they’re probably not prescribed as often because of 
that.  But there again it’s one of the therapies that’s definitely on the 
pathway, it’s on our five rubber stamp as well, and you would expect the 
majority to have ACE inhibitors” 
One of the ward nurses, Sara, noted that giving ACE inhibitors is not as straightforward as 
the other medications since they are indicated for a proportion of non-ST elevation ACS 
patients and not all. 
“No, it’s not as straightforward and originally ACE inhibitors were only 
really given to patients with anterior infarcts, low ejection fractions, those 
that would really, they would feel benefit from them so if you’ve got 
somebody that’s come in with an inferior infarct who’s not got any failure 
issues, if their renal function was borderline, I think they would have 
problems actually seeing the benefit of giving an ACE to those patients.” 
Another senior nurse, Louise, made a similar comment and noted that this treatment may 
not be started immediately:  
“But I think for the ACEs we’re, you tend to hold off more particularly from 
the renal function point of view and then consider introducing it at a later 
date if applicable.” 
Finally, a registrar (Gareth) considered all these points relevant in the prescription of ACE-
inhibitors, noting that renal function and blood pressure, the need to wait for a cardiologist to 
support the decision, and the fact that there is more than one ACE-inhibitor to choose from 
may all contribute to this treatment being missed. 
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“Interviewer: Is there anything that’s different about the way ACE inhibitors 
are prescribed that would make it more complex or that might mean that 
some patients that seem to require it don’t get it? 
Well, there’s more than [one] ACE inhibitor that people know about, so 
they’re a bit worried about which one to use in which situation.  The other 
thing is renal function initially may be a bit of a blurred area for patients, for 
medics to work out whether or not the ACE is going to knock them over or 
not, relative hypotension as well and I suspect it’s not seen as one of the 
urgent ones that need to be started and would probably wait for a 
cardiologist to take a look and have a more considered approach to it.  So 
that’s why I don’t think it’s started immediately necessarily.” 
 
The final medication discussed was clopidogrel given as both a loading dose and a 
maintenance dose. This was generally considered straightforward and applicable to all non-
ST elevation ACS patients. The loading dose is usually given in the A&E department and it is 
included in the local care pathways for managing ACS patients. The only exception was one 
of the Spanish sites that were unable to prescribe clopidogrel in accordance with the ESC 
guidelines due to a restrictive local protocol. This local protocol was no longer in place at the 
time of the interview but had been implemented throughout the EQUIP-ACS QI programme. 
(iv) Coronary Angiography  
The final goal or ‘quality indicator’ considered was the use of coronary angiography at 
centres. The database recorded whether patients received angiography within 72 hours of 
admission, as per the ESC guidelines.(Task Force for Diagnosis and Treatment of Non-ST-
Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, 
Bassand, Ardissino, Boersma, Budaj, Fernandez-Avila, Fox, Hasdai, Ohman, Wallentin, & 
Wijns 2007) The rates of angiography did improve after the QI programme but still remained 
low and there could be a range of reasons for this. The main reasons that were considered 
by the interviewees are summarised below. 
 
Staff felt that patients requiring angiography were being referred for the procedure but that 
meeting the 72 hour timeline proposed by the guidelines was challenging. Jim’s site did not 
have access to angiography facilities on-site at the time of the QI programme but this had 
been implemented at the time of the interview and he still felt that the 72 hour timeline would 
not be met. 
“And I think, as you’ve seen, it’s not really altered dramatically, because in 
that tight timeframe, we’re still not achieving.  I think if you extended the 
timeframe, probably to, say, five days, you’d probably see the 
overwhelming bulk are being captured.” 
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Jim elaborated on the difficulty of meeting the 72 hour timeline and felt that an educational 
programme may not be adequate to achieve this goal. 
“Yeah.  Because angiography rates for example are not that different.  And 
I suspect what you find is that, as we’ve discussed, this is the three day 
constraint. Because that’s what the guidelines recommend, but we’re 
clearly not achieving that. So I don’t know that an education programme, 
for example, would change that.  You can make people aware and we all 
understand that we should try and do it within two or three days, but there 
are practical limitations in that.” 
 
One of the QI researchers Rima, also felt that the 72 hour timeline was too much of a 
challenge for the QI intervention and that more time would have been needed to overcome 
this barrier. 
“So I wasn’t, so I think some things were definitely, I felt there were some 
things that were very big barriers that this type of programme you’d have to 
have it rolling out over a much longer length of time and it would be things 
like the cath lab, so one of the things was trying to schedule an angiogram 
within the 72 hours as indicated in the ESC guidelines and it’s like when 
the clock starts ticking and so some people were surprised that they 
weren’t getting patients done within 72 hours.” 
3 of the 5 hospitals interviewed did not have on-site PCI facilities and the staff interviewed 
from these sites cited this as an important factor to explain the rate of coronary angiography. 
Marina believed that rate of angiography would have improved at her site since on-site 
facilities were now available: 
“That most of the straightforward angios can now be done here.  So, I 
would imagine the timelines for getting those done will hopefully now be 
shorter, because we can do them onsite.” 
Similarly, Fred noted that time to angiography had reduced considerably at his site since 
facilities were available on-site: 
“So I think the problem we were having was just meeting the 72 hour 
transfer time.  Because at the time we didn’t have our cath lab on site but 
in fact now we have, ours is the lowest inter-hospital transfer time, it’s 
down to a day.” 
 
In addition to availability of facilities on-site, it was considered important for the service to be 
provided 24 hours a day and every day of the week in order to meet the guideline 
recommendations. Jim noted that this service was available for STEMI patients but not non-
ST elevation ACS: 
“Well, no, well you see, I think if you did this, you still would find that, 
although transfer times have improved, three days, 72 hours from 
admission, is probably not achieved.  And the reason for that is we don’t 
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have seven day working.  And I think if we are going to walk down that 
route, we would have to have seven day working.  We’ve got 24/7 primary 
angioplasty for ST elevation MI, and of course you can say well, and we 
know this, the non STEMIs probably get a slightly less good deal, because 
they do, they’ve had their medical therapy, they’ve cooled off, and they 
come into the next slot.  We’ve sort of arbitrarily set a transfer time here of 
three to four days, but it’s working days.” 
Gareth felt that clinicians would ensure patients receive angiography within the required 
timelines, if the catheter laboratory was available 24/7: 
“If they had the keys to the cath lab that would be 100% I’m pretty sure.  
And the stays would be very short.  If they could open the cath lab seven 
days a week they would do it. So I think it’s just a, it’s a factor out of their 
control, which is unfortunate.” 
At one of the other sites, Sara also noted the importance of having 24/7 access to 
angiography facilities: 
“Well I think the one thing, the one stumbling block we had about 
everything is trying to meet that 72 hour to angio, which unless you offer 
24/7 you are never going to achieve in a million years.” 
The importance of staffing and resources being available 24 hours a day and during 
weekends and holidays was also introduced in the section on Barriers and in the examples 
above, it can be seen that this is also relevant for achieving guideline-recommended 
timelines for angiography procedures. 
 
The interviewees noted that clinicians wanted to meet the recommended timelines for 
angiography but factors outside their control prevented this. In some cases, as has been 
shown above this was due to lack of available facilities and in others, this could have been a 
range of administrative or other factors. Lisa described how their QI team tried to come up 
with ways to shorten time to angiography: 
 
“…and the one with getting an angio within so many days was always a big 
issue for us, we’d sit there brainstorming, what can we do to try and 
improve that?  But I think in the end we just said there wasn’t, it was out of 
our control as such, because it did all have to go over there and be done, 
so.” 
Sara, on the same QI team had a similar view: 
“There were certain issues that we found we had no control over, 
particularly with the meeting the target for angio, that was completely out of 
our control” 
Mike, one of the QI researchers, remembered that clinicians tried to approach this problem 
in a simple way initially and realised that there were other factors outside their control: 
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“If you’re not performing enough angiography then the clinician’s initial 
solution was, well just tell people to do more angiography and then when 
they went back to their hospitals they realised actually maybe it wasn’t 
quite that simple.  They don’t have control, they don’t, they don’t have the 
control over the, what, how angiography’s done, so I think that came 
through.”  
6.4.2.5 Reactions to QI 
In order to assess the uptake of the QI intervention and how motivated staff at the QI centres 
were, questions were asked to gain insight into individual opinions on QI, with emphasis on 
the intervention delivered during the EQUIP-ACS study. Reactions to the improvement 
programme can be broadly divided into ‘positive’ and ‘negative’. Clearly those that have a 
positive reaction are more likely to implement the principles of a QI intervention and work on 
methods to improve management of ACS at their hospital. One of the QI researchers 
commented on the varied responses to the QI intervention observed during the QI 
programme meetings: 
“We can’t do it like this because the A&E team won’t work with us or a 
different consultant says we can’t do it this way and they just create 
barriers whereas others were very, were I felt more receptive and didn’t 
necessarily know how to do a change but wanted to hear suggestions and 
were more taking on board the ideas.”  
(i) Positive reactions 
The majority of staff interviewed had reacted positively to the intervention and were 
motivated to improve their practice. The range of positive responses included staff 
expressing feelings of motivation, understanding the importance of improving patient care, a 
sense of ownership and responsibility regarding patient care and considering improvement 
work valuable. Teams experienced a sense of achievement when they observed 
measureable improvements and this motivated them to achieve further improvement. 
 
One of the ward nurses noted that having access to real data about how patients were 
treated as part of the QI programme was valuable: 
“And I think that, one of the brilliant things about the EQUIP study was it 
actually made us realise that even though we had these pathways and we 
all thought we were brilliant, actually we weren’t brilliant, we weren’t 
prescribing things at 100%, these evidence based therapies, even though 
we thought we were very good, and it really made us realise that.” 
A nurse from another site described her team’s reaction to the central QI training meetings. 
Results for all centres would have been presented at the meeting and teams were asked to 
look at their own results and evaluate their local work processes to identify areas for 
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improvement. This team took ownership of their results and felt motivated to find ways to 
improve the way they managed NSTE-ACS. 
“But it was always very motivating, the meetings, we did come away and 
think, right OK, what can we do now?” 
 
It was also apparent that experienced research staff found the QI programme to be valuable 
and enjoyed working on it because the outcomes were meaningful. The relevance of 
identifying goals or indicators that staff perceive to be a priority was considered in the 
section above, but it is worth noting that choosing the correct outcome measures will also 
motivate staff to improve their patients’ care. 
“I was interested in it, there are some data collection studies that you do 
and it’s just, you just feel like you’re doing it for the sake of doing it, but 
this, I think the outcome was going to benefit patients at the end of the day 
and as a nurse in particular, that’s what you want” 
A similar reaction was noted by a senior ward nurse who had been involved in clinical audit 
and improvement projects before.  
“Yeah, it’s things that whenever we try and initiate an initiative within the 
ward it all is about delivery of care and quality and not doing something 
just for the sake of doing it, but about changing the outcomes and 
improving outcomes and streamlining our service.” 
 
The training programme was delivered using an interactive approach, some traditional 
lectures were given but the majority of the sessions were based on workshops where teams 
were invited to work together to interpret results and recommend solutions to the problems 
presented. This approach was unexpected but meant that the teams quickly understood they 
were responsible for improving their own patients’ care and that the programme was not 
going to provide them with a magic bullet for delivering optimal patient care. 
 
Two consultants remarked on this aspect of the QI programme: 
 
“So, because when you go to these meetings you think, you always think, 
oh there will be a fast, a very magic rule to improve, there’s not, because 
you have to improve by yourself.” 
 
“Well, it was a surprise because yes we, I personally was not prepared to 
receive two sets of training and you expect to find some people with, 
passing slides and doing some theoretical work and lessons.  And it was 
quite, it was very open.  I think that, so that the work was that there were 
no recipes to improve that.  You had to try to manage by yourself.” 
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(ii) Negative reactions 
Most of the reactions described by those interviewed were positive but there were also some 
negative sentiments captured, mostly by the QI researchers involved in implementing the QI 
intervention. Negative reactions included cynicism about the intervention, a lack of interest in 
the programme and poor attendance at meetings, not perceiving QI work as a priority and 
finally, scepticism about the data presented.  
 
A QI researcher that had been involved in implementing other QI programmes noted that 
some people approached the programmes with cynicism: 
“And I think with the consultants there’s a fair bit of cynicism about what is 
this programme, just another of these management buzz words, the dah 
dah dah, if we shut up and put our heads down it will go away again, in 
another year there’ll be another flavour of the month.” 
Four of the interviewees cited scenarios that showed QI work was not always considered a 
priority. For some of the health professionals involved, it was just another research study to 
fit in around clinical work and others either didn’t turn up at meetings or left part-way through.  
 
In some cases, clinicians made initial attempts to improve their work processes but if these 
did not succeed immediately, they soon lost interest: 
 
“Having made an effort to improve, if they didn’t see an improvement they 
sort of gave up, so they would make an effort and then if things hadn’t 
improved immediately they would sort of, they would think, oh well made 
an effort, that’s the best I can do.” 
There was also a category of investigators that did not accept the data presented during the 
QI meetings and insisted on re-analysing the data to ensure their hospital’s results were 
represented accurately. Rather than accepting that the database used was reliable, they 
spent their time scrutinising the data only to find it was correct. Conversely, some did believe 
the results but did not appear to be concerned when it became clear that treatment was sub-
optimal. An example of this is seen in the quote below: 
“Whereas, health professionals would consider 70% compliance as being 
quite good, so that was one issue.” 
6.4.2.6 Interpretation, implications for future work and sustainability 
In addition to capturing reactions to the QI intervention, the interviews aimed to assess how 
the results of the programme were interpreted by the health professionals that had been 
involved and to look for evidence of continued improvement work at the centres. 
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(i) Sustainability 
Members of the QI teams realised that results of QI work were not necessarily permanent 
and that more work would be required to ensure that improvements could be sustained. 
Ideas for sustaining the results included regular or annual publication of hospital 
performance and repeated intensive QI training sessions.  
“I personally think a change of 8% is good and it’s when you go to certain 
meetings and people are talking about changes in a non-research 
orientated way then, that everybody, I think generally there seems to be a 
perception that 8% would be seen as a good improvement.  And then I 
think what you’d want to see is what would happen.  So if you were doing 
things quarterly or annually you’d like to see that trend of the increase 
keep going up and up and up.” 
The QI researchers in particular felt that more time to deliver the QI intervention would have 
led to more improvement as you need time to consider the evidence, analyse current work 
processes and implement a successful change. One of the researchers commented on this 
and noted that some people may be resistant to change initially but over time could become 
more engaged: 
“I think a longer period of time to actually make the changes because I 
think there is a time that you have to take on the evidence and the 
information and then it just takes time to get a change and if you’re dealing 
with people who are a little bit resistant it’s not to say they will always be 
resistant I think, it’s just that maybe with longer engagement and maybe 
trying different ways of giving them the information and challenging them 
etc. that might have had a bigger change, so.  And I don’t think we had 
very long.  We just had one methodology, three days, which isn’t actually a 
long time.” 
(ii) Interpretation of results 
In general, the results of the QI programme were considered meaningful and all those 
interviewed felt that the programme had been successful. They reflected on the variation in 
results, in particular the fact that some of the indicators improved more than others and also 
the fact that some hospitals improved more than others. It was acknowledged that more 
information about the centres and QI teams within them would be required to better 
understand the results. Interviewees also commented that more than one strategy would be 
required to result in a greater improvement and that a combined approach would be 
essential to improve overall service. 
(iii) Ongoing improvement work 
Some of the tools developed during the QI programme were still in use and development of 
new tools was also planned but the nurses noted that it was difficult to maintain motivation 
amongst their teams. 
Daphne Babalis PhD Thesis  Page 186 of 247 
 
???????????????????????????????????? ????????????? ???????????????????????????
?????????????????????????????????????????????????????????????????????????
????? ?????? ???????????? ??????????? ?????? ???? ??? ??? ?????????? ?? ?????? ????? ???
??????????
?? ??????????????????????????????????????????????????????????????????????????????????? ????????
???????????????? ???????????
??????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????
??? ?? ????????? ???? ????????? ????? ?????? ??? ?????? ???? ???????????? ????? ??? ????
??????????
? ???????????
?????????????????????????????????????????????????????????????????????????????????????????????
??? ? ???????? ??????? ????? ???????????? ??? ??????????????? ??????? ???????????????????????????
?????????? ????? ?????? ?????? ??????????? ?????? ????? ??????????? ????????? ???? ???????????????
???????? ??????????? ???? ?????? ????????? ???? ???????? ???????? ??? ???? ????????? ????? ?????
???????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????? ??????
?
???????????????????????????????????????????????? ?????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????? ??????????? ??? ???????? ???????????????????????????????????? ?????????????????
???????????????????????????????????????????????? ??????????? ????????
?
??? ???? ????? ??? ?????????? ???? ???????????? ??????? ??????????? ?????? ???????????? ????????????
??????????????????????????????????????????????????????????????????????????????????????????
????? ??????? ??? ??????????????? ?????? ??????? ??? ????? ?? ?????? ??? ?????????? ???? ???????????????
?????????????????????????????????????????????????? ????????????
?
?????????????????????????????????????? ????????? ?????????? ??????????????? ?????????????????
???? ????? ???? ?????????????? ???? ????? ???? ???????? ?? ???????? ???? ???????? ??? ?????? ????
??????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????? ????????????????
???????? ?????????? ?????????? ???? ?????????????? ????? ????????? ??? ????? ?? ???? ????? ??? ??? ????
?????????????????????????????????????? ???????????????????????????????????????????????????????
???????????????????????????????????????????????????????????? ???????????????????????????????
?????????????????????????? ? ????????????????
?
??????? ????? ?????????? ????? ???????? ??? ??????????? ??? ??????? ???? ?????? ???????? ???? ??????
???????????????????????????????????????????????
?
?
??????????????????????????????????????????? ???????????????
?
??????????? ?????????????? ??????????????????????????????????????????????????????????????? ???????
????????????????????????????????????????????????????????????????????????????????????????????????
?????? ?????? ?????? ??????? ???? ????????? ??????????? ??? ????????? ???????? ????? ??????? ????
?????????????????????????????????????????????????????????????????????????????????????????????????
??????? ?????????? ???? ???????????? ???????????? ???? ???? ??????? ??????????? ????? ????
? ?????????????????????????????????? ????????????????????????????????????????????????????????
????????????????????????
?
?
?
????????
???????
????????????
??????????
???????????
??????????????
????????
???????
??????
?? ????????
????????????
????????????????
??????????????????????
???????????????????????
?????????????????????
???????????
???????????
???????????
??????????
??????????????
???????????
??????????
?????????????????????????? ? ????????????????
?
The investigators of the CPACS trial, cited earlier(Du, Gao, Turnbull, Wu, Rong, Lo, Billot, 
Hao, Ranasinghe, Iedema, Kong, Hu, Lin, Shen, Huang, Yang, Ge, Han, Lv, Ma, Gao, & 
Patel 2014) conducted a qualitative evaluation in a sub-set of 10 centres participating in the 
programme(Ranasinghe et al. 2014) to explore system-level barriers to delivering evidence 
based care for ACS. The authors carried out 40 in-depth interviews and analysis using the 
framework method identified five barriers to optimal care: leadership, resources, fear of 
dispute and litigation, healthcare funding constraints or patient “out-of-pocket” expenses and 
patient-related factors. The barriers relating to potential litigation and healthcare resource or 
patient expenses are not applicable in the UK healthcare setting assessed in this chapter, 
but the themes of leadership and resources are consistent with findings reported in this 
chapter.  
 
A systematic review of determinants of success in QI collaboratives(Hulscher, Schouten, & 
Grol 2013) identified leadership, resources, baseline performance, teamwork and 
engagement of staff in delivery of QI work as key factors all of which are consistent with the 
findings of this research. The review also assessed factors influencing long term results and 
these were continuous measurement and involvement of experts to support improvement 
work, again consistent with findings reported here. 
 
A study consisting of 45 interviews was conducted in eight U.S. hospitals to assess factors 
that increase rates of prescribing beta-blockers at discharge for AMI patients. The study 
identified four prevalent factors in the highest performing hospitals: shared goals for 
improvement throughout the organisation, administrative support, physician leadership 
advocating beta-blocker use and access to high quality data feedback.(Bradley et al. 2001) 
These findings are in line with the themes of measurement, leadership and resource which 
were identified as important in this chapter. 
 
The Health Foundation commissioned an independent evaluation of five of their 
improvement programmes to identify key challenges to conducting QI work, also cited in the 
previous chapter. The authors of the evaluation analysed the reports from the programmes 
using qualitative methods in addition to reviewing the relevant literature. Ten challenges to 
conducting QI programmes were identified: convincing participants that the problem 
identified is applicable to them; convincing participants that the solution is appropriate; using 
reliable data collection and monitoring systems; unrealistic ambitions; organisational culture, 
capacity and context; ‘tribalism’ and lack of staff engagement; leadership; incentives; 
securing sustainability; risk of unintended consequences.(Dixon-Woods, McNicol, & Martin 
2012) The importance of data collection and measurement was also identified in the 
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research reported in this chapter as were the themes of leadership, incentives, 
organisational culture and staff engagement. The issue of sustainability was also highlighted 
in the interviews and discussions indicated that improvements achieved following QI work 
were not sustained in the long term. There was some evidence of ongoing QI work but this 
was limited and the interviewees noted that they were not motivated to continue 
improvement work after the end of the study when they were no longer being audited. 
 
Glickman and colleagues have discussed factors that impact on organisation culture and 
emphasise that not only is it important to consider all these factors, but also how they 
interact with each other. The key organisational factors their work has cited are executive 
management, culture, organisational design, incentives and information 
technology.(Glickman et al. 2007) The themes of management, culture, incentives and 
information are common with the findings reported in this chapter. 
 
The majority of themes identified in this chapter are also consistent with the NHS Institute for 
Innovation and Improvement’s ‘Sustainability Model’.(Maher et al. 2015) The NHS Institute 
developed a model for predicting sustainability of a QI initiative based on a range of QI 
programmes and literature sources. The three main areas considered to influence 
sustainability are staff, process and organisation. These three areas are divided into 10 
factors overall, each of which are weighted within the model in accordance with their relative 
importance. The staff factors are: training and involvement, clinical leaders, senior leaders, 
and attitudes. Training, leadership and attitudes were all found to influence outcome of 
improvement work during the qualitative evaluation. Process factors listed in the NHS 
Institute Sustainability model are: monitoring, adaptability, credibility of evidence, benefits 
beyond helping patients. Comparing these factors to the findings reported in this chapter 
overlap with the themes of measurement can be seen. Organisational factors of the 
Sustainability model are infrastructure and ‘fit with goals and culture’; in terms of 
infrastructure, the themes of resources and facilities were found to be important in this 
research and culture and suitability of goals were also discussed.  
 
This evaluation has shown that a number of factors can contribute to the outcome of a 
multifactorial QI programme. These should be taken into account in designing future QI 
initiatives and can be considered on two levels; local and organisational. At a local level, 
teams participating in a programme should analyse their own processes and endeavour to 
remove unnecessary steps and deliver these in a standardised manner. Data collection 
should be conducted throughout QI work and ideally should form an established component 
of patient management rather than limiting this to research studies or national initiatives so a 
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CHAPTER 7. Discussion and 
recommendations 
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significant improvement was noted for two of the individual treatments, use of risk 
stratification and clopidogrel prescribed as a loading dose.  
 
The greatest improvement was recorded for use of risk stratification which improved by more 
than 30% for the QI hospitals compared to the non-QI hospitals. This could be attributed to 
the low baseline use of risk stratification methods and also to the fact that this is a simple 
task to complete. A risk score is straightforward to calculate based on the patient’s medical 
history and admission investigations. Improvement in prescription of ACS medications 
ranged from 2 to 10% but the baseline rate for all treatments was more than 75%. Coronary 
angiography had a low baseline rate and increased by 5%. The modest improvement 
observed for coronary angiography could be attributed to the fact that this is the most 
complex of the eight treatments, requiring a number of steps and members of staff in order 
to take place. 
7.2.2 Chapter 3: Use of risk stratification methods 
Use of risk stratification was the quality indicator that improved the most after delivery of the 
QI intervention. Use of risk stratification was defined as documented use of any formal 
score, e.g. GRACE or TIMI, within 24 hours of admission. This indicator improved by more 
than 30% for the QI group compared to the non-QI group, driven by an increase in use of the 
GRACE score among QI centres. The GRACE score was calculated retrospectively for all 
patients included in the study and patients were categorised as low, intermediate and high 
risk according to the GRACE definitions. The results were compared to risk categories 
derived by the centres throughout all phases of the EQUIP-ACS trial and found to be similar, 
indicating that centres were calculating risk scores appropriately. Assessment of baseline 
characteristics for both risk scoring methods, i.e. (i) defined by the centres during the trial 
and (ii) determined retrospectively for this thesis, highlighted some minor differences as age 
and presence of ST depression on the admission ECG increased more across the 
retrospectively determined GRACE categories. This could be explained by a combination of 
overestimation of risk for some low risk patients and under-estimation for some high risk 
patients since the intermediate category was the largest.  
 
Improved risk scoring was associated with improved management of non-ST elevation ACS 
overall, as rates of the quality indicators were higher for patients that had been risk stratified. 
Importantly, risk stratified patients had higher rates of angiography and this was 10% higher 
for intermediate to high risk patients. There was a trend for all treatments to be higher for risk 
stratified patients. Improvement in the composite outcome measure was observed for all risk 
categories, indicating that the QI intervention targeted all patients, irrespective of risk. 
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 Guidelines for management of non-ST elevation ACS recommend risk stratification using a 
formal method within the first 24 hours of admission. The results obtained in this chapter 
provide evidence that appropriate risk scoring leads to improved management of patients 
during the in-hospital phase. 
7.2.3 Chapter 4: Patient and centre characteristics 
A series of analyses were performed to assess the influence of individual patient and 
hospital characteristics on the outcome of the QI programme. The univariate analyses 
highlighted that patients with individual risk factors were less likely to be optimally managed. 
The proportion of patients receiving all eight ACS treatments was lower in the following 
categories: age more than 65 years, diabetes, female gender, previous stroke, previous MI, 
history of heart failure and high GRACE risk. In terms of hospital factors, lower performance 
at baseline was associated with improved management after the QI programme and the 
result varied across the five countries. 
 
The influence of patient and centre characteristics was assessed in two multi-level 
multivariate mixed effects models, adjusting for patient and centre effects. Factors 
significantly associated with poorer management in the multivariate model assessing the 
composite outcome of eight ACS treatments were: female gender, history of heart failure, 
chronic kidney disease, prior stroke and Spain, UK or Italy. Factors significantly associated 
with improved management of ACS were: prior MI, admission to a QI centre during the post-
QI implementation phase and number of cardiologists.  
 
A second multivariate model to assess a composite outcome of seven ACS treatments, 
excluding risk stratification was conducted. Factors significantly associated with poorer 
management in the second multivariate model were: female gender, chronic kidney disease, 
prior stroke and admission to a centre in Spain. Factors significantly associated with 
improved use of ACS treatments were: prior MI, risk stratification, admission to a QI centre 
during the post-QI implementation phase and access to on-site PCI facilities. 
 
The results of the multivariate analyses provide evidence that the QI intervention improved 
non-ST elevation ACS management irrespective of hospital size and type. Management of 
female patients, those with a history of heart failure, stroke or chronic kidney disease 
remained sub-optimal when all factors were accounted for, implying that further work is 
needed to ensure that healthcare professionals implement QI interventions consistently for 
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all patients admitted to their hospitals. Use of risk stratification was independently associated 
with increased use of all other ACS treatments expressed as a composite measure.  
7.2.4 Chapter 5: Long-term follow-up 
In order to look for sustainability of the improvement achieved by the QI intervention, two of 
the 38 hospitals continued to collect data for a year following delivery of the QI intervention. 
Both hospitals were in the QI group and data for 218 patients were collected during the 
additional year. The data collected showed that the effect of the QI intervention was 
relatively well maintained and performance, assessed by use of the eight guideline-
recommended treatments expressed as a composite, remained higher than at baseline. The 
composite outcome measure and two of the individual treatments continued to be 
statistically higher than at baseline but further improvement was not observed. Prescription 
of treatments during the follow-up phase was lower than during the post-QI phase, indicating 
a possible trend for decline over time, although this was not statistically significant.  
 
The results presented in this chapter provide evidence that improvement achieved by the 
EQUIP-ACS QI intervention was sustained up to a year after the QI intervention was 
delivered, but further improvement was not observed for any of the eight guideline-
recommended treatments and the data indicate a trend for performance to decline after the 
study observation period. Further intervention may be required to ensure longer-term 
sustainability of results achieved and a different approach is needed to effect further 
improvement or improvement in areas other than those targeted by the initial QI programme. 
Plans for long-term or continuous evaluation of QI work should be built into a programme 
from the outset.  
7.2.5 Chapter 6: Qualitative evaluation 
A qualitative evaluation was designed to assess the impact of contextual factors on delivery 
of the QI intervention. Semi-structured interviews were conducted with 15 healthcare 
professionals that took part in the QI programme and this included nurses, clinicians and QI 
researchers. The interviews focused on delivery of the QI intervention, the goals selected, 
results achieved after the intervention, and the implications of these.  
 
Analysis of the interview content revealed a range of themes that may facilitate or inhibit the 
successful delivery of the QI intervention. The themes identified were categorised into three 
main areas; people, process and environment. The sub-themes within these areas that 
appeared to be important were: leadership, incentives, training, teamwork, communication, 
simplicity of a process, automating or centralising a process, low baseline performance, 
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 Results obtained from the qualitative evaluation do not fully explain delivery of the QI 
intervention either, though they have provided valuable insight into contextual factors that 
may be important. Analysis of the semi-structured interviews identified three key areas which 
should all be considered when designing and delivering a QI intervention. ‘Process’ factors 
are relevant for assessing how a treatment is given within a hospital and all the steps 
involved. Complexity of a process was considered important and this helps to explain why 
rates of angiography were still low after the QI intervention, since it is the most complex of 
the eight treatments assessed. ‘People’ factors explain individual and organisational 
incentives, the role of leadership, teamwork and involvement of stakeholders from design all 
the way through to interpretation of findings. In order to ensure all process and people 
factors are adequately addressed, ‘environment’ must also be considered to take account of 
organisational culture, available resource and organisational goals. 
 
Considering these findings in concert highlights that QI is itself a complex process. In this 
research, the QI intervention targeted eight clinical management goals that were based on 
accepted clinical guidelines. During the randomised clinical trial, measurement was 
conducted using quantitative techniques only. The response to the intervention was variable, 
with variability present at both the individual and organisational level. Walshe et al have 
previously commented on the heterogeneous nature of QI as an intervention.(Walshe & 
Freeman 2002) The intervention is delivered in a complex, heterogeneous environment and 
yet the approach used is the same across all organisations. There is a need for QI 
interventions to be tailored to the setting and individuals working within that setting. 
 
QI for healthcare attempts to bring two different schools of thought together to achieve a 
common goal; better patient care. Improvement scientists have developed tools based on 
proven industry models that can streamline work processes and clinicians use audit and 
publication of performance metrics to strive for optimal patient care. Attempts have been 
made to merge these two approaches but this has not yet succeeded. The original QI 
models were developed for the manufacturing industry which is likely to respond well to a 
standardised approach and is also driven by profit. Healthcare is delivered by people rather 
than technology and a standardised approach is not sufficient as it does not take account of 
behavioural factors. Whilst profit may be a driver in the U.S. healthcare setting, this is not the 
case for U.K. and European healthcare which are publicly funded.(Boaden, Harvey, 
Moxham, & Proudlove 2008;Simmons 2002) 
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Clinicians follow guidance for adoption of a new licensed treatment based on publication of 
convincing quantitative data. If the data for a new treatment show clear benefit to patients, it 
will be implemented in practice in due course. A similar approach is needed for QI work. If 
improvement scientists can present convincing efficacy data for QI interventions that 
translate to measurable benefit for patients, the uptake of QI work will increase. At present, 
QI initiatives are delivered by teams that are not directly involved in clinical practice or as 
part of a research study, so clinicians may not have input into the design and implementation 
of these. 
7.3.2.1 Risk stratification 
Interestingly, the only factor relating to patient management that was shown to improve 
overall adherence to guidelines was use of a formal risk score such as the GRACE or TIMI 
score. Analyses showed that there was a trend for rates of all treatments to increase if a 
patient was risk stratified and the greatest effect was noted for coronary angiography in 
intermediate and high risk patients. This is an important finding as rates of angiography 
remained low, at about 60%, after delivery of the QI programme and this provides evidence 
that appropriate risk stratification could have informed decisions about referral for 
angiography.  
 
Discussions with healthcare professionals during the semi-structured interviews highlighted 
that clinicians are not convinced that formal risk scoring is valuable and consider that a 
global clinical evaluation to assess patient risk is adequate. The data presented in Chapters 
3 and 4 however, indicate that clinicians did not make decisions on management strategy on 
the basis of clinical risk factors. This implies that when formal risk scores were not used, 
appropriate treatment was not always given. Treatment was sub-optimal for all patients and 
was worse for high risk patients and those with comorbidities, irrespective of whether risk is 
defined by a formal risk score or individual clinical factors.  
7.3.3 Sustainability 
The results obtained from this research show that more work is needed to ensure that 
improvement achieved can be sustained over time. Performance at the two centres that 
continued to collect data for an additional year remained higher than at baseline, but no 
further improvement was noted. As management of non-ST elevation ACS remained sub-
optimal after delivery of the QI intervention, it would be expected that improvement should 
continue until near-optimal performance is achieved.  
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successful QI programmes during training or launch meetings, using metrics that are 
clinically meaningful.  
 
QI interventions 
This thesis has shown that response to QI is variable. Some treatment goals increase more 
than others and some individuals and organisations are more susceptible to change than 
others. The choice of QI intervention should take all factors into account; those relating to 
patients, healthcare professionals delivering care, work processes involved, involvement of 
leadership and managerial staff, existence of teams that can deliver QI work and factors that 
motivate and incentivise stakeholders.  
 
There cannot be one single QI approach and on the contrary, the approach needs to be 
tailored to suit the situation and clinical need. Encouraging clinicians to develop their own QI 
strategies locally, as was the case for the EQUIP-ACS project, ensures that the local teams 
take ownership for the planned QI work which in turn increases the likelihood of this being 
delivered effectively. 
 
It would be valuable to conduct qualitative research in the form of semi-structured or in depth 
interviews prior to implementing a QI intervention, in order to identify potential areas for 
improvement, potential barriers and the likely response to the planned QI intervention.  
 
Measurement 
Availability of high quality data on an ongoing basis would enhance research of QI methods. 
The programme analysed for this thesis made use of a web-based data collection tool for the 
purposes of the study, but consideration should be given to using existing databases and 
registries to minimise the workload for participating clinicians. This will ensure that reliable 
data on practice patterns prior to delivering the intervention are available, but also that 
performance can be assessed in the future to evaluate the long-term effects of QI work. 
 
Linking QI to existing registries is already possible for QI programmes conducted in the US 
where the ACTION registries are ongoing(Peterson, Roe, Rumsfeld, Shaw, Brindis, 
Fonarow, & Cannon 2009), or in Sweden where SWEDEHEART has been in place and is 
accessed by all hospitals(Jernberg, Attebring, Hambraeus, Ivert, James, Jeppsson, 
Lagerqvist, Lindahl, Stenestrand, & Wallentin 2010). QI work in the UK could benefit from 
collaborations between existing registries such as MINAP(Herrett et al. on behalf of the 
MINAP Academic Group 2010) and researchers planning QI programmes.  
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Consideration should also be given to the format of data used for QI research. Summary 
data or totals are not sufficiently informative for QI. Data on performance should be 
presented over time and broken down by regions, hospitals or departments where possible. 
This allows variation in performance to be identified so that improvement work can be 
targeted at the areas of greatest need.  
 
Teams at the sites taking part in QI programmes should have access to data about their own 
performance and should attend central meetings where they can report on their performance 
to their peers. Knowledge that performance will be reported at public meetings will contribute 
to creating a culture of transparency and accountability. 
 
Sustainability 
Plans for long-term evaluation of QI interventions should be incorporated from the start and 
these should include quantitative and qualitative methods. Participating centres should be 
informed about plans for long term follow-up from the outset and this should be integral to 
taking part in the programme, not an optional aspect. 
 
Consideration should be given to incentives associated with taking part in a QI programme, 
especially in the longer term. Incentives may take the form of monitoring or feedback reports 
and do not necessarily need to be financial. The centres participating in the EQUIP-ACS 
programme did not receive notable financial incentives, the only fee provided was a 
reimbursement to their organisations for time taken to enter data onto the trial database. 
Staff interviewed for the qualitative evaluation reported that presenting their results at local 
and central project meetings motivated them to continue improvement work and that this 
motivation waned when they knew they would no longer be required to present their data. 
 
Cost-effectiveness 
Estimating cost effectiveness of the EQUIP-ACS QI programme was beyond the scope of 
this thesis. Future QI research should focus on estimating the cost and cost-effectiveness of 
delivering QI interventions. Availability of cost-effectiveness data would enhance the 
evidence base for QI work and support decisions to implement interventions on a wider 
scale. 
7.4.2 Management of non-ST elevation ACS 
The data presented in this thesis show that management of non-ST elevation ACS remains 
sub-optimal with respect to guideline-recommendations. The research conducted for this 
thesis also provides evidence that use of formal risk stratification is associated with improved 
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prescription of ACS treatments and referral for coronary angiography. These data show that 
formal risk scoring is crucial as it can lead to appropriate decisions about invasive strategy 
and prescription of treatments.  
 
It has been noted that clinicians interviewed during the qualitative evaluation were not 
convinced of the usefulness of risk scoring and it is important to address this issue so that 
this valuable tool for management of ACS is performed as a matter of routine. If more 
research focused on the effectiveness of risk scores at guiding management decisions 
compared to non-formal scores, use of scores would be more widely accepted. There is a 
need for robust evaluation of risk stratification methods in order to obtain convincing efficacy 
data. 
 
Female patients and those with comorbidities including previous stroke, chronic kidney 
disease and a history of heart failure should receive the same standards of care as all other 
patients with ACS. In the absence of contraindications, clinicians should ensure that 
guideline recommended treatments are prescribed for all patient groups. Reports 
summarising rates of treatment in these populations should be provided to centres to raise 
awareness and encourage improved management. 
7.4.3 Education 
It has already been noted that engagement of clinicians at all stages of QI work is crucial to 
ensuring its successful delivery. It is necessary to provide formal training in QI concepts and 
methods to encourage health professionals to be engaged in improvement work. If health 
professionals have a good understanding of the methods required to improve healthcare, 
they will be more motivated to evaluate their own work processes and to set up their own 
initiatives. 
 
Currently in the UK training courses are available for health professionals as part of 
continual professional development. Modules on evidence-based medicine and clinical audit 
are included in undergraduate medical training but this does not extend to implementing 
tools for improving healthcare. 
 
An evidence scan conducted by the Health Foundation in 2012 to evaluate QI training noted 
that QI is now a mandatory component of education for medical students in the U.S.(The 
Health Foundation 2012) Training in QI methods is included from the early stages of 
undergraduate medicine in U.S. universities and includes a range of lectures and practical 
exercises to develop skills in QI tools and methods.(Ogrinc et al. 2011)  
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 Research to assess the effect of QI training on outcomes is limited but a systematic review 
conducted by Wong et al reported that there is some evidence that introducing training at 
this early stage is effective.(Wong et al. 2010) The systematic review evaluated 41 curricula 
that targeted either medical students, residents or both, to assess the effect of QI education 
on associated evaluations conducted in healthcare settings. 32% of the studies conducted 
implemented changes in delivery of care and 17% improved processes of care. 
 
The integration of QI methods into undergraduate medical training in the UK would develop 
future health professionals that possess the skills to analyse their own work processes, to 
identify areas for improvement and ultimately to implement methods to improve quality of 
care. If the key QI concepts and tools are introduced early in their training, clinicians will be 
capable of assessing their own processes on an ongoing basis. It is important to equip 
clinicians with the skills to improve quality of care, not just to enhance their understanding of 
the importance of guideline adherence.  
7.4.4 Healthcare policy 
It is important to consider the implications that this research has for healthcare policy. This 
section focuses on the implications for the NHS since the integrated results from quantitative 
and qualitative findings were mainly focussed on the UK setting. Over the course of this 
research there has been a change of government from Labour to Coalition, leading to 
changes in healthcare policy and extensive re-structuring of the NHS. It is timely to consider 
the government’s position on quality improvement, as the elections for a new parliament 
approach. 
 
Current government policy 
The current government presented plans for healthcare reforms in the White Paper entitled 
“Equity and Excellence: Liberating the NHS”.(Department of Health 2010) In terms of QI 
measures, the paper emphasised the importance of reporting outcomes which led to 
establishing the NHS Outcomes Framework. Five domains for reporting key outcomes were 
identified through the Outcomes Framework and these are reviewed on an annual basis with 
suggestions for additional indicators made as required.(Department of Health 2015)  
 
The Department of Health (DOH) published a report on cardiovascular outcomes in 2013, 
describing improvement in cardiovascular outcomes but identifying actions for NHS 
Commissioners so as to ensure further improvement.(Department of Health 2013) Outcome 
data reported for all cardiovascular disease, including Acute Coronary Syndrome, identified 
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a wide variation of outcomes according to region. Poorer treatment for patients admitted 
during the weekend was also reported. ACS patients with chronic kidney disease were found 
to receive substantially fewer treatments despite higher mortality rates, which is consistent 
with the findings reported in this thesis. (Department of Health 2013;Fox, Muntner, Chen, 
Alexander, Roe, Cannon, Saucedo, Kontos, & Wiviott 2010a) The issue of worse treatment 
being delivered over the weekend emerged as a theme from the qualitative evaluation 
conducted as part of this thesis. Patients admitted for ACS should receive the same level of 
care irrespective of the time of day or day of the week, something which has not been 
achieved yet. 
 
The DOH report on cardiovascular outcomes also noted that, despite recommendations 
made by NICE guidelines(National Institute for Health and Clinical Excellence (NICE) 2010), 
not all ACS patients are seen by a cardiologist or member of the cardiology team. The latest 
MINAP annual report reports an improvement of this as over 90% of non-ST elevation ACS 
patients were seen by a cardiologist or member of the team.(Myocardial Ischaemia National 
Audit Project 2014) 
 
The recent move to make clinical outcome data publicly available via the “Everyone Counts” 
initiative was cited in the introduction of this thesis and demonstrates implementation of 
some of the goals set out in the 2010 White Paper.(Department of Health 2010;NHS 
Commissioning Board 2014) The importance of accessing good quality data has been 
acknowledged throughout this thesis, but access to data does not constitute a complete QI 
strategy. Publication of outcome data can help to identify areas for improvement but NHS 
staff need to receive guidance on how to achieve improvement.  
 
The King’s Fund, an independent charity that focuses on improving healthcare in England, 
has published reports on the government’s implementation of NHS reform.(Gregory et al. 
2012) The mid-term report highlighted that treatment continued to be variable particularly 
with respect to weekends compared to mid-week hospital admission, but also with respect to 
geographical location. The latest report entitled “The NHS under the coalition government: 
Part One” recommends less emphasis on regulation and more focus on supporting NHS 
staff to improve patient care. Inspections conducted by the Care Quality Commission (CQC) 
in response to the Francis report on the Mid-Staffordshire disaster are considered useful in 
that they identify areas requiring improvement, but the King’s Fund do not feel that this is 
sufficient to justify the huge cost of CQC inspections.(Francis 2013;Ham et al. 2015)  
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The Berwick report “A promise to learn – a commitment to act”, written in response to the 
Francis enquiry, also emphasised that reforming healthcare and implementing more complex 
regulations will not lead to improved patient care.(Berwick 2013) Endless healthcare reforms 
create an atmosphere of insecurity rather than a proactive workforce. Berwick stresses that 
NHS staff need to be trained in QI methods in order to achieve a culture of continuous 
improvement in the NHS. He believes that investing in professional development in this way 
will create health professionals that would identify and resolve problems such as those that 
led to the Mid-Staffordshire disaster.  
 
Emerging and future healthcare policy 
The NHS “Five Year Forward” publication developed by the organisations that deliver health 
services in England represents emerging and future goals for the NHS.(NHS England 2014) 
Planned policies for QI include focussing on performance measurement and reporting of 
outcomes. This approach will continue to reveal areas for improvement but neglects to 
identify who is responsible for addressing these areas. The onus is on local authorities and 
organisations to improve their care but tools for them to achieve this are not to be provided. 
Emerging policies do not seem to include a robust strategy for quality improvement despite 
continuing reports of sub-optimal standards of care. 
 
The current government aimed to save £20 billion over four years on the NHS and the Five 
Year Forward report hints at future plans for further cost saving in order to reduce the current 
deficit. Appleby, chief economist at the King’s Fund, does not feel that further cuts to NHS 
funding are realistic. The cuts proposed would require almost 5% saving per year and at 
present, the NHS is struggling to achieve a saving of 1%.(Appleby 2012) 
 
Future plans for healthcare QI appear to be inadequate and NHS staff will struggle to 
improve standards of care in a continuing climate of financial hardship. Healthcare policies 
need to include robust plans for evaluation of QI interventions in order to generate reliable 
evidence that these strategies are effective. Results of QI programmes should be publicised, 
including details of the resources required to run these. Funding bodies should be 
encouraged to support well-conducted QI research. 
 
The need for further clinical research has been recognised but this does not include 
evaluation of existing QI strategies. Investment in QI-focussed education is needed so that 
NHS staff will have the skills to be able to detect areas of sub-optimal care, develop 
strategies to resolve these and achieve sustainable improvements.  
 
Daphne Babalis PhD Thesis  Page 206 of 247 
 
????????????????????????????????????????????????????????????????
????????????????????? ?????????????????????????? ????? ????????????????
???????? ????????? ???? ???? ??????? ?????? ????? ??? ????? ???????? ??
???????? ??????? ??????? ??? ?????????? ? ??????????? ??????? ???????????
????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????
????????????????????
????????????????????????????????????????????????????????????????????????????????
???????????????
? ?? ?????????
?????? ???? ?? ??????? ??? ?? ????????? ????? ?????? ????? ????????? ???? ????????? ?????????? ??? ?????
??????????????????????????????????????????????????????????????????????????????????????????????
??????????????? ? ??????????? ??? ?????????????????? ??????????? ?????????????????????????????
? ????????????????????????????????????????????????????????????????????????????? ????????????
?????????????????????? ??? ??????? ?????????????? ???????????????? ?????? ???? ????? ???????????
???????????????????????????????????????????????????????????????????????????????? ????????
???????????? ???? ?????????????????????????????? ????????????????????? ????????????????? ?????
????? ?????????? ??? ?????? ??? ??????? ???????????????? ????? ???? ? ?????????? ??? ???? ???? ??? ????
???????????????????????????????????????????????????????????????
?
???? ? ????????? ??? ??? ????? ?????? ?? ??????????? ???????? ???? ????? ????????????? ???? ????
????????????????????????????????????????????????????????????????????????????????????
??? ???? ???????????????????? ??? ???????????????????????????? ???????????????????? ?????????? ????
??????????????????????????????????????????????????????????????????????????????????????????????
? ?????????????????????????????????????????????
?
???? ?????????? ?????? ???? ???? ???????????? ????????? ????????? ????? ????? ???? ????? ??????
???????? ??????????? ??? ???? ?????? ???? ?????????? ?????????????? ??? ??????? ??????????? ??? ??????
????????????????? ??? ??????????????????????? ?????????? ???????? ?????????? ???????? ???????????
????????????????????????????????????????????????????? ??????????????
?
??? ??? ????? ? ???????? ??? ????? ????? ???? ?????????? ???? ???? ???????? ???? ??????? ??????????????
?????????????????????????? ??????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????
??? ????? ?????? ???? ??? ????????????? ???? ???? ????? ?????????? ???????????????? ?????? ???
?????????????? ??????????????????????? ???????????????????????????????? ??? ???????????????????
?????????????????????????? ? ????????????????
?
??????????????? ???? ?????? ??? ????? ????????? ????? ? ??????? ?????????? ?????????? ????
????????????????????????????????? ???????????????????????????????????????
?
???? ?????????? ???????????? ????????? ????? ????????? ????? ????? ?????? ????????? ?????? ?????????
???????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????
????? ??? ????? ??????????? ??? ???? ??????? ?????????? ???? ????????? ?????? ??? ??????????????
??????????
?
???????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
????????? ???????? ???? ??????????????????????????????????????????????????????????????????????
??????????????????????
?
???????????????????????????????????????????????????????????????????????????????????????????
????? ?? ??????? ??? ???? ????????? ????? ????? ?????????? ???? ??? ??????????? ????? ?????? ?????
??????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????
? ???????????
???? ??????????? ??? ????? ????????? ???? ????? ?? ??? ?????????? ???? ??????????? ??????????????
????????? ????????? ????? ??????? ?????????? ???? ???? ????? ??? ???????????? ??????????? ????
??????????? ? ?????????? ??? ?????????? ??? ?????? ???? ?????????????? ??? ????????????? ??????????
???????????????????????????????????????????????????????????????? ?????????????????????
??????? ?????????? ????? ?????? ??????????? ???? ????????? ??? ???? ??? ?????? ??????????
???????????? ????? ????? ??? ?? ?????????? ???????? ???? ??? ??????????? ????? ?????? ????
?????????? ?????????????????????????????????????????????????????????????????????????
??????????? ???????????? ?? ????????? ??? ??????? ??????????????? ??????? ????? ?????????? ??? ?????
????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????? ?????????????? ??????????????????????????????
? ????????????
?
??????????????????????????????????????????????????? ??????????????? ??????????????????
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?
Qualitative interviews conducted with healthcare professionals that took part in the EQUIP-
ACS project however, indicated that the value of risk stratification methods is not recognised. 
 
A range of process, staff and organisational factors must be considered prior to designing 
and implementing a QI intervention and notably, clinicians must be central to the entire 
process of QI. Investment in robust QI research must continue in order to obtain convincing 
evidence that patient care can be improved. Evidence that QI is successful coupled with in-
depth training in QI methodology will lead to routine implementation of improvement work. 
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APPENDIX 2. EQUIP-ACS CASE REPORT FORM   
Admission – Personal Information 
 Initials  
Gender  
Date of birth  
Admission – Arrival information  
Onset of symptoms Date:  Time:     
Admitted to hospital Date:  Time:     
Admission - Risk factors 
Diabetes 0 No            1 Yes  9 Unknown  
Hypertension      0 No    1 Yes  9 Unknown  
Smoking 0 Never smoked        1 Ex-smoker >1month 2 Smoker 9 Unknown 
Admission - Previous diseases 
Previous MI 0 No    1 Yes  9 Unknown  
CHF 0 No    1 Yes  9 Unknown  
Previous PCI 0 No    1 Yes  9 Unknown  
Previous heart surgery 0 No   1 CABG 2 Other heart surgery   9 Unknown  
Previous stroke 0 No        1 Yes  9 Unknown  
Chronic renal disease 0 No        1 Yes  9 Unknown  
Medications taken prior to admission 
ACE-inhibitors 0 No 1 Yes   9 Unknown 
A2- receptor blockers 0 No 1 Yes   9 Unknown 
Anticoagulants 0 No  1 Warfarin 2 Ximelagatran  9 Unknown 
Aspirin 0 No 1 Yes   9 Unknown 
Other platelet inhibitors 0 No             1 Clopidogrel 2 Ticlopidine 3 Other 9 Unknown 
Beta-blockers 0 No 1 Yes   9 Unknown 
Calcium antagonists 0 No 1 Yes   9 Unknown 
Diabetes treatment-
Insulin      0 No           1 Insulin   9 Unknown 
Diabetes treatment-oral 
med.     0 No           1 Oral medicat.   9 Unknown 
Cardiac glycosides      0 No 1 Yes   9 Unknown 
Diuretics 0 No 1 Yes   9 Unknown 
Statins      0 No 1 Yes   9 Unknown 
Other lipid-lowering 
agents 0 No             1 Ezetimibe 2 Fibrates 3 Other 9 Unknown 
Long-acting Nitrate  0 No 1 Yes   9 Unknown 
 Admission - ECG and status at arrival 
ECG rhythm at 
arrival 1 Sinus      2 Atrial Fibrillation 3 Other     9 Unknown 
ECG QRS  1 Normal  2 Pacemaker 3 LBBB 
4 Pathological  
Q-wave 
 
5 
RBBB 6 Other 
9 
Unknown 
ECG STT 1 Normal   2 ST-elevation 3 ST-depression 4 Pathol. T-wave 5 Other 9 Unknown 
Heart rate: Bloodpress:         /     
Lung rales 0 No      1 Basal  2 More than half of lung fields lungorna 3 Pulmonary edema 9 Unknown 
Cardiog. shock 
at arrival 0 No 1 Yes   9 Unknown 
Actions performed within 24h 
Risk stratification 
(performed 0 No 1 Yes with Grace score 2 Yes with TIMI score 3 Yes with other method 
Result risk stratification  1 Low risk   2 Intermediate risk 3 High risk  
Clopidogrel loading 
dose (>300 mg)* 0 No   1 Yes    
Hospitalisation - Medications 
Reperfusion 
treatment 0 No 1 Yes  
Iv/sc Anticoagulants 0 No         1 iv Heparin 2 sc lmw Heparin 3 Fondaparinux  
 
9 Unknown   
Statins within 4 days 0 No   1 Yes    
Iv Platelet inhibitors 0 No          1 Abciximab 2 Tirofiban 3 Eptifibatide 9 Unknown   
Iv/oral Beta-blockers 0 No         1 Iv Beta-blockers 2 Oral Beta-blockers  9 Unknown 
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Iv Diuretics 0 No   1 Yes    9 Unknown   
Iv Inotropic drugs 0 No   1 Yes    9 Unknown   
Iv Nitrate 0 No   1 Yes    9 Unknown   
Hospitalisation - Investigations and Treatments 
Type of stresstest 0 Not performed    
1 Myocardial    
  Scintigraphy  
2 Stress Echo-
cardiography 
3 Exercise ECG 
 9 Unknown   
Result of stresstest   1 Normal 2 Pathological 3 Not evaluable 9 Unknown   
LVEF evaluated by 0 Not performed 
1 Echocardio-
graphy 
2 LV-angio-
graphy   3 Other method   9 Unknown 
LVEF        1 Normal 2 Mildly reduced     (45-50%) 
3 Moderately reduced 
(30-44%) 
4 Severely 
reduced 
(<30%) 
9 Unknown 
Coronary 
angiography 0 No       1 Yes. 2 Planned after discharge  
Date of coronary 
angiography:    
PCI 0 No  1 Yes 2 Planned after discharge 9 Unknown 
Date of PCI:       
CABG 0 No        1 Yes  2 Planned after discharge  
Hospitalisation - Laboratory results 
Cardiac marker 0 Not analyzed  1 Troponin-T 2 Troponin-I 3 CKMB   4 Myoglobin 9 Unknown 
Maximum value of marker  _ _ _ _ _ _ _ 
Total 
Cholesterol _ _ _ _ _ _ _ _   
  
Triglycerides _ _ _ _ _ _ _ _    
HDL _ _ _ _ _ _ _ _    
Creatinine _ _ _ _ _ _ _ _     
Hospitalisation - Complications 
New infarction during 
hospitalisation 0 No 1 Yes   9 Unknown   
Bleeding during hospitalisation 0 No 1 Fatal        2 Cerebral   
3 Requiring 
operation/transfusion 9 Unknown   
CPR or cardioversion in assoc. 
with circulatory arrest 0 No           1 VT/VF 2 Other     9 Unknown   
Cardiogenic shock 0 No 1 Yes     9 Unknown   
AV-block 0 No/AV-1 1 AV-II/AV-III   9 Unknown   
Discharge - Medications 
ACE-inhibitors 0 No 1 Yes   9 Unknown  
A2-receptor antagonists 0 No 1 Yes   9 Unknown  
 Oral anticoagulants 0 No 1 Warfarin 2 Exanta  9 Unknown  
Aspirin 0 No 1 Yes   9 Unknown  
Other platelet inhibitors 0 No        1 Clopidogrel 2 Ticlopidine 3 Other 9 Unknown  
Beta-blockers 0 No 1 Yes   9 Unknown  
Calcium antagonist 0 No 1 Yes   9 Unknown  
Diabetes treatment - 
Insulin 0 No 1 Insulin   9 Unknown  
Diabetes treatment - Oral 
medication 0 No 
1 Yes, oral 
treatment   9 Unknown  
Cardiac glycosides 0 No 1 Yes   9 Unknown  
Diuretics 0 No 1 Yes   9 Unknown  
Statins 0 No 1 Yes   9 Unknown  
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Other lipid-lowering drugs 0 No        1 Ezetimibe 2 Fibrates 3 Other 9 Unknown  
Long-acting Nitrate 0 No 1 Yes   9 Unknown  
Discharge – Diagnosis 
Diagnosis 1 Myocardial infarction 
2 Unstable  
  Angina 
3 Other cardiac 
   disease 
4 Other specified  
non-cardiac disease  
5 Unspecified chest 
pain 
Death 0 No       1 Yes      
Date of Discharge or 
Death:  
 
  
Daphne Babalis PhD Thesis  Page 242 of 247 
 
APPENDIX 3. ETHICAL APPROVAL FOR EQUIP-ACS PROJECT 
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APPENDIX 4. ETHICAL APPROVAL FOR INTER-EQUIP STUDY 
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